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Abstract 
Many studies have shown that the computed tomography dose index 
(CTDI100) which is considered to be the main dose descriptor for CT 
dosimetry fails to provide a realistic reflection of the dose involved in cone 
beam CT (CBCT) scans. The main reason for this failure is that CTDI100 
measurements are performed within standard head and body phantoms 
made of polymethyl methacrylate (PMMA) that are only 150 cm long, which 
is less than or similar to beam widths used for CBCT scans. Therefore, much 
of the scatter that would contribute to the dose received by a patient is 
not recorded. Several practical approaches have been proposed to 
overcome drawbacks of the CTDI100. The aim of this project was to 
investigate the various dose indices based on the approaches proposed. The 
dose indices studied were: (1) CTDIIEC proposed by the International 
Electrotechnical Commission (IEC) and based on measuring CTDI100 using a 
reference beam and the application of a correction factor based on free-
in-air CTDI measurements, (2) 𝑓𝑓(0,150) the cumulative dose measured with 
a small ionization chamber within the standard PMMA phantoms, (3) 
𝑓𝑓100(150) the cumulative dose measured in the standard PMMA phantoms 
with a 100 mm pencil ionization chamber, (4) 𝑓𝑓(0,∞) proposed by the 
American Association of Physicists in Medicine (AAPM) TG - 111 and similar 
to 𝑓𝑓(0,150), but measured in infinitely long phantoms made of PMMA, 
polyethylene, and water, (5) 𝑓𝑓100(∞) similar to 𝑓𝑓100(150), but measured in 
infinitely long phantoms. The project also aimed to facilitate the use of 
indices defined in long phantoms through the generation of correction 
factors that could be applied to measurements in standard phantoms. 
This project was based on the use of the Monte Carlo (MC) technique. MC 
EGSnrc-based user codes namely BEAMnrc and DOSXYZnrc were used to 
simulate the On-Board-Imager (OBI) imaging system mounted on a Varian 
TrueBeam linear accelerator. The MC model was benchmarked against 
experimental measurements and good agreement shown. PMMA, 
polyethylene, and water head and body phantoms of various lengths and 
diameters were simulated including a new polyethylene phantom named 
ICRU/AAPM phantom made by the International Commission on Radiation 
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Units and Measurements (ICRU) and AAPM. A wide range of beam widths 
with different beam qualities were employed. Four scanning protocols using 
two acquisition modes (full and half), employed in routine clinical practice, 
were utilized. In addition, organ doses resulting from three CBCT scans 
(head, thorax, and pelvis) were evaluated in terms of absorbed dose to 
organs and tissues using MC simulations on the International Commission on 
Radiological Protection (ICRP) 110 adult male and female reference 
computational phantoms. The suitability of the dose indices for CBCT 
dosimetry was investigated by taking three factors into consideration: (1) 
the efficiency of the approach as a dose descriptor to report CTDI∞, which 
is close to the dose received by body tissues near to the middle of a CBCT 
scan of a patient, (2) the simplicity of the application of the approach in 
the clinical environment in terms of availability of the measuring 
instruments, simplicity of the technique, and the number of the scans 
required to accomplish a quality assurance (QA) assessment, i.e. the QA 
time, and (3) the ability of the approach in providing an evaluation of organ 
doses resulting from CBCT scans. To facilitate the use of long phantoms, 
the relationship between 𝑓𝑓(0,150) and 𝑓𝑓100(150) measurements obtained 
within the standard PMMA phantoms and those for 𝑓𝑓(0,∞) obtained within 
longer phantoms of different compositions were studied. 
Considering the three factors for the dose indices investigated, all the dose 
indices were found to be comparable, but each index has advantages and 
disadvantages. Overall, 𝑓𝑓(0,150) was considered to be the most suitable 
with 𝑓𝑓100(150) providing an alternative for wider beams. Therefore, the 
dose indices 𝑓𝑓(0,150) followed by 𝑓𝑓100(150) are recommended for practical 
CBCT dosimetry. In addition, a function called 𝐺𝐺𝑥𝑥(𝑊𝑊)100 was proposed for 
evaluating the cumulative dose in long phantoms, and correction factors 
were also provided to avoid the use of long phantoms. The 𝐺𝐺𝑥𝑥(𝑊𝑊)100 
function did not vary significantly with tube potential, but the tube 
potential did influence the correction factors. The use of the 𝐺𝐺𝑥𝑥(𝑊𝑊)100 
function is recommended for estimation of 𝑓𝑓(0,∞) values from 𝑓𝑓100(150) 
measurements taken in the standard PMMA phantoms.  
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Chapter 1  
Introduction 
1.1 Rationale 
Medical imaging is the basis for a wide range of medical applications, which 
play a critical role in diagnosis and treatment of numerous diseases. One of 
these applications is the use of imaging for cancer treatment. The imaging 
is considered an essential part of cancer treatment over all the treatment 
stages from diagnosis of the disease using different imaging modalities 
through the treatment stage to the inspection of treatment output and 
follow up of patients after the treatment. The treatment stage is different 
for each patient, but for patients undergoing radiotherapy, an essential 
part of the treatment is to scan patients to localize the position of the 
tumour and organs at risk (OAR) and upon this treatment planning is 
developed. The imaging is also utilized in this stage to enhance the 
treatment output by using a procedure known as image guided radiation 
therapy (IGRT) (Bujold et al., 2012). IGRT is based on using various imaging 
modalities to precisely position patients prior to radiotherapy treatment 
and hence assist practitioners to deliver the prescribed doses to patients 
with a high level of accuracy. Moreover, IGRT is important for adaptive 
radiotherapy, which is based on re-planning the treatment plan used in 
earlier fractions to account for the change in patient geometry and tumour 
shrinkage (Ding et al., 2007a). 
Although the continued development in the imaging modalities and their 
utilization in the different treatment stages are considered to have enabled 
a paradigm shift in the treatment outcome, there is a cost, as the majority 
of these modalities employ ionizing radiation. Therefore, the extensive use 
for imaging over the treatment course becomes a concern, particularly 
those employed for IGRT procedures (AAPM, 2007a). At the present time, 
the use of IGRT with modern radiotherapy delivery modalities has become 
essential in most of the major radiotherapy departments worldwide. IGRT 
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is different for each patient, and the number of scans required over the 
treatment course is based on different factors such as the type of 
treatment, the treatment site, and the availability of the imaging 
modalities. The number of scans is also based on the clinical protocol 
applied in each department.  
One of the imaging modalities commonly used for IGRT procedures at the 
present time is cone beam computed tomography (CBCT) in the kilo-voltage 
(kV–CBCT) and mega-voltage (MV-CBCT) ranges (Midgley et al., 1998, 
Jaffray and Siewerdsen, 2000, Siewerdsen and Jaffray, 2001, Jaffray et al., 
2002). CBCT scans are acquired for patients prior to the treatment 
fractions, and the scans are then compared with the CT scans obtained for 
the treatment planning, which are considered as reference images. Based 
on this comparison, a correction for the patient’s position is applied by 
shifting the treatment couch according to the difference between the CBCT 
and CT scans. These scans have great benefits in guiding the practitioners, 
enabling them to minimize the potential set-up errors associated with 
positioning the patients for the treatment. However, as a CBCT scan is 
acquired multiple times or on a daily basis for some patients, the 
cumulative dose resulting from these scans becomes non-negligible. For 
example in our centre, a daily kV–CBCT scan prior to each treatment 
fraction is acquired for patients undergoing Stereotactic Ablative 
Radiotherapy (SABR) treatment, whereas multiple kV–CBCT scans are 
obtained over the treatment course for patients undergoing Intensity 
Modulated Radiation Therapy (IMRT) or Volumetric Modulated Arc Therapy 
(VMAT) treatments. The doses resulting from IGRT procedures and those 
delivered to patients by other imaging modalities such as CT and 4DCT scans 
obtained at the different stages of the treatment may increase the risk of 
developing second malignancy cancer, thus a trade-off between the 
benefits and the risk should be taken into consideration (AAPM, 2007a, 
Brenner and Hall, 2007, Hall and Brenner, 2008, Fazel et al., 2009, Pearce 
et al., 2012, Spezi et al., 2012).  
In order to utilize the significant benefits of employing IGRT procedures in 
enhancement of the treatment output (Bujold et al., 2012), and optimizing 
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the larger concomitant doses resulting from these scans at the same time, 
inclusion of these doses in the treatment dose using the treatment planning 
systems (TPS) has been suggested (Miften et al., 2007, Ding et al., 2008b, 
Alaei et al., 2010, Ding et al., 2010a). Inclusion doses from MV-CBCT scans 
to the treatment dose has been shown to be possible due to the capability 
of TPS calculating doses in the MV range (Miften et al., 2007). The TPS, 
however, is unable to calculate doses resulting from kV-CBCT scans 
accurately. The differences between organ doses measured experimentally 
with a Varian CBCT scanner and those calculated with the Philips PINNACLE 
TPS were found up to 20% for soft tissues and 68% for bony structures (Alaei 
et al., 2010), and between a Siemens CBCT scanner and the Philips 
PINNACLE TPS were <10% and 30%, respectively (Dzierma et al., 2014). 
Moreover, organ doses calculated with the Philips PINNACLE TPS were 
within ±17% of those measured experimentally with an Elektra CBCT 
scanner for soft tissues and body structures (Alaei and Spezi, 2012). To 
avoid this limitation, several calculation algorithms have been developed 
with the aim of extending the TPS to account for doses not only for kV-
CBCT but also for other imaging modalities in the kV range such as 
conventional kV radiographic images (Ding et al., 2008b, Pawlowski and 
Ding, 2011, Pawlowski and Ding, 2014). The ability of calculating doses 
resulting from all IGRT procedures using TPS is still unavailable, but this 
feature may be introduced in the near future (AAPM, 2015b). 
Besides the inability of the TPS in calculating kV-CBCT doses, the dosimetric 
methods used in quality assurance (QA) procedures to monitor performance 
of CBCT scanners and to estimate doses received by patients are also 
problematic. Note that CBCT from now on refers to kV-CBCT. This issue is 
not only associated with CBCT employed in IGRT procedures, but also with 
the other imaging modalities acquired with wide beams such as 
conventional CT scans, dental CBCT scans, and interventional radiology and 
cardiology scans acquired with C-arm CBCT scanners. As the ionizing 
radiation involved in these various CBCT applications may involve a risk of 
initiating a cancer not only for cancer patients undergoing IGRT procedures 
but also for non-cancer patients who are scanned with other CBCT devices 
(Brenner and Hall, 2007, Hall and Brenner, 2008, Fazel et al., 2009, Pearce 
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et al., 2012), monitoring the doses involved for the CBCT scans is necessary 
(AAPM, 2007a, COMARE, 2014). Therefore, it is important to have effective 
ways for evaluating doses from CBCT scans and hence estimating the risks 
to patients. 
The dose descriptor that has been employed for CT dosimetry for many 
years is known as the CT dose index (CTDI) (Shope et al., 1981). The CTDI 
concept is based on integrating the axial dose profile resulting from a single 
axial rotation over an arbitrary length at the middle of the scan (z = 0). The 
CTDI has been adapted several times to accommodate advances in CT 
scanner technology. Different derivatives of the CTDI concept have been 
developed based on the CTDI measured with a 100 mm long pencil 
ionization chamber known as (CTDI100). The CTDI100 is the main index, from 
which other derivatives are derived such as the weighted CTDI (CTDIw), 
volume weighted CTDI (CTDIvol), and dose-length product (DLP) (IEC, 2001, 
McNitt-Gray, 2002, Kalender, 2014). The CTDI100 characterises a CT scanner 
by integrating a dose profile resulting from a single axial rotation using the 
pencil ionization chamber set up free in air at the isocentre parallel to the 
rotation axis (IEC, 2001). The CTDI100 is also used as an indicator for the 
dose received by a patient undergoing a CT scan by performing the dose 
measurements within standard cylindrical polymethyl methacrylate (PMMA) 
phantoms of length 150 mm with diameters of 160 mm representing an 
adult head or a paediatric body, and 320 mm representing an adult body. 
The dose measurements within these phantoms are made on the central 
axis and at four peripheral positions 1 cm below the phantom surfaces set 
up at a specific source isocentre distance (SID). 
With the continued evolution of CT scanner technology, preservation of the 
CTDI100 as a dose index becomes problematic (Dixon, 2003, Brenner, 2005, 
Dixon and Ballard, 2007, Boone, 2009), as the main concept of CBCT scans 
is to use an x-ray beam, which is usually wider than the length of the 100 
mm ionization chamber and sometimes wider than the standard 150 mm 
long PMMA phantoms (Mori et al., 2005, Boone, 2007, Kyriakou et al., 2008, 
Geleijns et al., 2009). Moreover, the efficiency of the CTDI100, which is the 
ratio of the CTDI100 parameter measured in a PMMA phantom of standard 
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length to the equivalent CTDI∞ parameter measured in an infinitely long 
phantom, is limited even for narrow beams (Boone, 2007). The CTDI∞ 
includes the dose from all the scattered radiation generated within a 
phantom undergoing a CT or CBCT scan that reaches the measurement 
chamber, and will be closer to the radiation level from a scan within a 
human trunk. The efficiency values are approximately constant for beams 
of width ≤ 40 mm at ~75% and ~60% at the centre of the standard PMMA 
head and body phantoms, respectively, and ~84% at the periphery of the 
phantoms (Boone, 2007, Dixon and Ballard, 2007, Perisinakis et al., 2007, 
Ruan et al., 2010, Martin et al., 2011, Li et al., 2011, Li et al., 2012). The 
efficiency values, however, decrease with increasing beam width reaching 
~25% of CTDI∞ for wide beams for both the head and body phantoms (Boone, 
2007, Kyriakou et al., 2008). As a result, the CTDI100 concept is no longer 
appropriate for CBCT scans. The main shortcoming is its inability to 
accommodate and record the whole primary beam and the scattered 
radiation. 
In order to avoid the underestimation of dose associated with the use of 
CTDI100 for wide beams, various practical methods have been suggested 
(Mori et al., 2005, Islam et al., 2006, Fahrig et al., 2006, Amer et al., 2007, 
Kyriakou et al., 2008, Geleijns et al., 2009, IEC, 2010, AAPM, 2010). Two 
methods have been proposed by international organisations. One by the 
International Electrotechnical Commission (IEC) (IEC, 2010) is based on 
modifications to measurement of the CTDI100, and this has been 
recommended by the International Atomic Energy Agency (IAEA) (IAEA, 
2011) and the Institute of Physics and Engineering in Medicine (IPEM) 
(Platten et al., 2013). However, the methodology proposed by the American 
Association of Physicists in Medicine (AAPM) Task Group TG–111 (AAPM, 
2010) aimed to replace the CTDI100 with a concept based on measuring the 
cumulative dose under a scatter equilibrium condition by using an infinitely 
long cylindrical phantom made of PMMA, polyethylene, or water. The 
International Commission on Radiation Units and Measurements (ICRU) 
Report-87 has recommended the cumulative dose concept proposed by 
AAPM, but a practical method has been suggested to overcome the 
difficulty of using the long phantoms in the clinical environment (ICRU, 
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2012). All these methods will be discussed and described in detail in the 
thesis chapters.  
1.2 Project Objectives 
Dosimetric methods for CBCT are still not yet well established, as are those 
employed for dosimetry of standard multi-slice CT (MSCT) scanners, CTDIvol 
and DLP. Moreover, different approaches have been recommended by 
various international organizations to tackle the problem. For example, 
IPEM has recommended the IEC method to be followed in the UK, whereas 
the AAPM TG-111 method has been recommended for use in the USA. 
The project was based on Monte Carlo technique, which is a valuable tool 
for assessing not only the doses received by patients undergoing CT or CBCT 
scans, but also dose distributions within phantoms for evaluation of the 
performance of different dosimetry techniques. The project had two main 
objectives: 
1. To investigate the various possible dosimetric methods for CBCT including 
the IEC and AAPM methods proposed for CBCT dosimetry. This required 
several studies to investigate features and limitations of each method. This 
included various aspects such as the consistency of the evaluations, the 
inclusion of all the radiation exposure, and the ability of the method to 
evaluate organ doses resulting from CBCT scans. Subsequently, results of 
these investigations were used to recommend a method that is more 
practical in the clinical environment.  
2. To facilitate utilizing some methods such as the AAPM method that requires 
using infinitely long phantoms by developing functions and conversion 
factors, from which doses within long phantoms made of different 
compositions can be estimated using the standard PMMA phantoms that are 
widely available in hospitals worldwide. 
The aim has been to make the study generic and as comprehensive as 
possible so that the method recommended is not only suitable for CBCT 
scans employed in IGRT procedures, but also for other CBCT applications. 
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Therefore, a wide range of parameters such the beam widths and tube 
potentials were studied. It is hoped that the results arising from this project 
will add beneficial content to the body of knowledge on CBCT dosimetry, 
make an effective contribution to the literature, and provide some 
evidence to assist the scientific community and international organizations 
in reaching consensus on CBCT dosimetry methods. The recommendation of 
an agreed specific dosimetric method suitable for all CBCT applications 
would be beneficial at this time with the rapid development of CBCT 
applications. 
1.3 Thesis Structure 
The project was divided into five different subprojects, which are 
presented in five chapters. The thesis is comprised of ten chapters: 
• Chapter 1: gives an introduction and overview for the project. It also 
presents the research problem and objectives of the project.  
• Chapter 2: provides a background for the main concepts in the project and 
a literature review for studies related to the project topic. The kV system 
employed to generate CBCT scans and parameters of the scanning protocols 
studied in this project are described. An overview of the dose index CTDI 
used for CT dosimetry and its limitations in CBCT scans are explained. The 
various dosimetric methods proposed for CBCT dosimetry are discussed in 
detail. 
• Chapter 3: gives an overview for the Monte Carlo (MC) technique and some 
historical overview for the technique. It also presents an overview for the 
way of transporting particles using the MC technique to study quantities of 
interest. Different MC codes used for Medical Physics applications are 
discussed. A description for the MC code utilized in the project is given, 
and the MC parameters used for theses codes are described briefly. 
• Chapter 4: describes the methodology of designing the kV system with the 
MC code. Various experimental measurements performed to validate the 
MC model are presented. In addition, the calibration method, which was 
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required to convert the MC output to absolute absorbed dose values in (Gy), 
is described.  
• Chapter 5: presents the first subproject, which investigated the efficiency 
of the IEC method and CTDI100 for evaluating CBCT scan doses with beams 
of width 20 – 300 mm using four different head and body scanning protocols. 
The failure of CTDI100 for CBCT scans and overcoming the drawbacks 
obtained with the IEC method are shown. Dose measurements for the IEC 
method and CTDI100 were also measured experimentally using three 
scanning protocols commonly used in the clinic.  
• Chapter 6: shows the results conducted for the second subproject, which 
studied the efficiency of four different dosimetric methods based on the 
cumulative dose concept, one of which was the AAPM method, using beams 
of width 40 – 300 mm and four different head and body scanning protocols. 
In addition, experimental measurements using the methods studied were 
made for three scanning protocols commonly used in the clinic. The 
influence of measuring the cumulative dose with the standard 100 mm 
pencil ionization chamber and a small ionization chamber of an active 
length of 20 mm was investigated. Additionally, the influence of using the 
long and short phantoms on the cumulative dose measurements was 
studied. A comparison between the methods investigated in this subproject 
and those studied in the first subproject is presented.  
• Chapter 7: investigates the practical method proposed by ICRU to utilize 
the AAPM method, but avoiding the use of the long phantoms. The ICRU 
method was proposed for conventional CT scanners, thus the third 
subproject investigated the suitability of extending the ICRU method for 
CBCT scans. Simulations were conducted for two different head and body 
scanning protocols using phantoms of different compositions namely PMMA, 
polyethylene, and water. A wide range of CBCT scans with beams of width 
40 – 500 mm and tube potentials of 80 – 140 kV were studied. The suitability 
of using this method to the other CBCT scanners was also discussed.  
• Chapter 8: presents the fourth subproject, which studied the possibility of 
using a small ionization chamber within the standard PMMA head and body 
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phantoms to measure the cumulative dose and evaluate the result based on 
the AAPM method within infinitely long head and body phantoms of 
different compositions made of PMMA, polyethylene and water. The study 
was conducted with two different head and body scanning protocols and a 
wide range of CBCT scans for beams of width 40 – 500 mm and tube 
potentials of 80 – 140 kV. The feasibility of using short polyethylene head 
and body phantoms 150 mm in length to estimate doses within the long 
polyethylene phantoms was also investigated. The suitability of using this 
method for other types of CBCT scanners was also discussed.  
• Chapter 9: the fifth subproject is presented in this chapter, and it aimed 
to study the ability of the dosimetric quantities proposed for CBCT 
dosimetry and investigated in the first and second subprojects to be used 
for evaluation of organ doses resulting from CBCT scans. Organ doses for 
three scanning protocols employed in the clinic were calculated using MC 
simulations on the ICRP-110 adult male and female reference 
computational phantoms. This study covered a wide range of organs, and 
more attention was paid for those with weightier coefficients in effective 
dose.  
• Chapter 10: gives the main conclusions resulting from the five subprojects 
presented in Chapters 4 – 8. These conclusions included a recommendation 
for a dosimetric method that was considered to be more practical in terms 
of the simplicity of the implementation in the clinical environment and 
estimating organ doses for patients undergoing CBCT scans. In addition, 
possible future works were suggested.  
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Chapter 2  
Background and Related Works 
2.1 CBCT in Image Guided Radiation Therapy (IGRT) 
The use of CBCT in IGRT procedures was initially developed by Jaffray and 
Siewerdsen in early 2000’s (Jaffray and Siewerdsen, 2000, Siewerdsen and 
Jaffray, 2001, Jaffray et al., 2002), and was characterized and 
implemented in radiotherapy departments during the mid 2000’s 
(Létourneau et al., 2005, Islam et al., 2006, Amer et al., 2007, Wen et al., 
2007, Ding et al., 2007). The kV imaging system used for CBCT scans is 
mounted on the treatment machine, i.e. the linear accelerator (Linac), 
with retractable arms as shown in Figure 2.1. It consists of the kV source, 
i.e. x-ray tube, which is similar to those employed for conventional CT 
scanners, and a flat panel detector. The movement of the kV source and 
the detector are controlled by the retractable arms, and a CBCT scan is 
acquired with the kV source and the detector being placed at 90° to the 
treatment source and perpendicular to the axis of the treatment couch. 
The main difference between CT and CBCT scans is the acquisition 
technique. The CT scan reconstructs a 3D image for a patient by scanning 
an area of interest (AOI) slice by slice using a fan beam with a width of ≤40 
mm and a multi-detector array of similar width. The acquisition of CT slices 
is accomplished by using acquisition modes known as axial or helical modes. 
The axial mode scans a patient over the AOI in multiple rotations, each of 
which is acquired with a stationary table but at a different axial position, 
i.e. step and shoot. The helical scan is also obtained with multiple rotations 
but with a table moving at constant speed, so that the x-ray beam scans 
the patient continuously to cover the AOI. The reconstruction of a 3D image 
from a CBCT scan is entirely different from that applied for a CT scan. A 3D 
image for a CBCT scan is formed from a large number of conventional kV 
radiographic images acquired with the 2D flat panel detector and a wide 
beam width usually ~200 mm. Each radiographic image is projected and 
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collected at a different angle, and the number of projections is different 
for each scanning protocol. Unlike conventional CT scans, CBCT scans are 
acquired only using the axial scan mode with a fixed patient table position, 
and the kV source rotates around the patient over arcs of 360° or 200°. 
 
Figure 2.1: The kV system, On Board Imager (OBI), mounted on a Varian TrueBeam 
linear accelerator.  
 
2.2 On Board Imager (OBI) System 
At the present time, several kV systems are commercially available and 
utilized in IGRT procedures to acquire CBCT scans: (1) On Board Imager 
(OBI) by (Varian Medical systems, Palo Alto, CA), (2) Synergy X-ray Volume 
Imager (XVI) by (Elekta, Crawley, UK), and (3) kVision by (Siemens 
Healthcare, Erlangen, Germany), with the first two systems being more 
common. This project was based on using the OBI system mounted on a 
Varian TrueBeam linear accelerator (Figure 2.1). The OBI system can be 
operated in various imaging modes namely radiography, fluoroscopy and 
CBCT mode, and with a tube potential between 40 and 140 kV. In addition, 
two focal spots of size 0.4 mm used for the radiography and fluoroscopy 
modes and 1.0 mm used for the CBCT mode are used. Two different types 
of aluminium bowtie filter, full and half as shown in Figure 2.2, are used to 
improve the quality of the CBCT images by reducing the range of x-ray 
intensities to be recorded.  
Flat panel 
detector 
kV source  
(X-ray tube) 
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Figure 2.2: Half and Full bowtie filters used on the OBI system. 
 
The OBI is manufactured with four collimator blades X1, X2, Y1, and Y2. 
The collimator blades work independently to enable delivery of a 
symmetrical or an asymmetrical field with minimum and maximum field 
sizes of 20 mm × 20 mm and 500 mm × 500 mm at the isocentre. The 
collimator blades X1 and X2 set the lateral extent of the beam that control 
the field of view (FOV) of a scan, while Y1 and Y2 select the length of the 
scan in the axial direction, i.e. beam width of the scan. Therefore, each 
blade can be opened from 10 mm to 250 mm. The maximum image size that 
can be collected by the detector is 400 mm × 300 mm, i.e. the active area 
of the detector. The source-detector distance is set to 150 cm so that the 
distance between the treatment couch and the detector is 50 cm.  
Either of two acquisition modes: the full-fan and the half-fan can be 
employed depending on the size of the scanned target region. For a smaller 
target such as the head, the full-fan mode is employed with the full bowtie 
filter, and for larger regions such as the chest or pelvis, the half-fan mode 
is employed with the half bowtie filter (Figure 2.3). 
1. The full-fan mode: scans the target symmetrically with a diameter 
of 264 mm at the isocentre. The collimator blades X1 and X2 are set 
to 132 mm to give a field of 264 mm at the isocentre, and Y1 and Y2 
to 99 mm to give 198 mm. The flat panel detector is placed at 150 
cm from the kV source and is set so that its centre matches that of 
the region to be imaged. The kV source and the flat panel detector 
7.
7 
cm
 
Full Bowtie Filter 
14 cm 14 cm 
Half Bowtie Filter 
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are rotated simultaneously around a patient lying on a stationary 
table in axial mode to acquire a volumetric image for the target as 
shown in (Figure 2.3 (a - b)). 
 
 
 
 
 
Figure 2.3: Diagrammatic representations of the TrueBeam scanning modes. (a - b) 
The full-fan mode is employed for scanning smaller targets such as the head through 
(a) a partial scan (200°; 90° to 290°) and (b) a full 360° scan. (c - d) The half-fan mode 
is used for scans of the trunk though a full 360° scan, with c and d each covering the 
two halves of the scan. 
 
2. The half-fan mode: allows a larger scan diameter by scanning target 
volumes asymmetrically, where the X1 and X2 blades are set to 25 
mm and 239 mm, respectively, and the Y1 and Y2 ones are set similar 
to those used for the full-fan mode. As the maximum active area of 
the detector is 400 mm for the X blades, 200 mm to each side, setting 
X2 to 239 mm makes the beam width larger than the active length in 
the X2 direction. In order to avoid this issue, the detector is shifted 
laterally by 148 mm to accommodate the beam width in the X2 
direction within the active area as shown in (Figure 2.3 (c - d)), and 
(b) 
100 cm 
kV source 
Full  
bowtie 
filter 
Flat panel 
detector 
X1 X2 
X1 
X2 
(a) 
kV  
source 
Flat panel 
detector 
Full  
bowtie 
filter 
100 cm  
X2 
(c) 
100 cm 
kV source 
Half 
bowtie 
filter 
Flat panel 
detector 
X1 
(d) 
Flat panel 
detector 
100 cm 
kV source 
Half  
bowtie 
filter 
X2 X1 
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hence acquiring a scan with a lateral extent of 478 mm at the 
isocentre.  
Although the reconstructed images for both the modes are different, the 
field size of the head and body scans is similar 264 mm × 198 mm. The full-
fan mode can be acquired with a rotation of 200° or 360°, while only the 
full 360° rotation is used for the half-fan mode. Only a single rotation is 
used for both the modes.  
2.3 Clinical Scanning Protocols 
Several pre-configured scanning protocols such as head, thorax, pelvis and 
pelvis spot light are employed in the clinic for IGRT procedures using the 
OBI system version (V 1.6), with the first three protocols being commonly 
used. The parameters are different for each protocol and are listed in 
Table 2.1. The head scan is different from that used for CT scans, as a 
partial 200° scan is acquired. For the majority of the patients, the head 
scan rotates beneath the patient’s head to minimize the imaging dose and 
to avoid irradiating sensitive organs and tissues directly such as the eye 
lens. The thorax and pelvic scans, however, rotate a full 360° scan, and 
cover the AOI fully. The pelvic spot light scan, which acquires an image for 
a target in the pelvic region posterior of a patient with a partial 200° scan 
mode, is obtained for some patients. Similar to the head scan, the pelvic 
spot light is utilized to minimize the imaging dose delivered to organs and 
tissues lying closer to the anterior surface in the pelvic region, and is 
considered as an alternative scanning protocol for the pelvic scan, which 
requires higher mAs (Table 2.1). The full-fan mode with the full bowtie 
filter is employed for the head and pelvic spot light scans, whereas the 
half-fan mode with the half bowtie filter is used for the thorax and pelvic 
scans.   
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Table 2.1: Parameters of the scanning protocols employed for the OBI system (V 1.6) in IGRT 
procedures.  
(a) Left side-90°, right side-270°. 
 
2.4 CTDI100, CTDIw, and CTDI∞ 
CTDI100 is the main dose index used for CT dosimetry and the basis for other 
CT dosimetry quantities. CTDI100 is defined as: 
𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100  =  1𝑁𝑁 × 𝐶𝐶  � 𝐷𝐷(𝑧𝑧) 𝑑𝑑𝑧𝑧+50 𝑚𝑚𝑚𝑚−50 𝑚𝑚𝑚𝑚  (2.1) 
where 𝐷𝐷(𝑧𝑧) is the dose profile resulting from a single axial scan at a specific 
position at the rotation axis (z-axis), 𝑁𝑁 is the number of slices acquired in 
a single scan, and 𝐶𝐶 is the nominal thickness of a single slice. The product 
of (𝑁𝑁 × 𝐶𝐶) is equal to the nominal beam width involved in the scan. In CBCT 
scans, the region of interest is scanned with a single detector and a single 
rotation. Therefore, the nominal beam width of the scan (𝑊𝑊) is used 
instead of (𝑁𝑁 × 𝐶𝐶) in Eq.(2.1). 
 Head Thorax Pelvis spot light Pelvis 
X-ray tube potential (kV) 100 125 125 125 
X-ray current (mA) 20 20 80 80 
X-ray millisecond (ms) 20 20 25 20 
Exposures (mAs) 147 264 733 1056 
Acquisition mode full-fan half-fan full-fan half-fan 
Scan Arc Gantry rotation 
(degrees) (a) 
200° 360° 200° 360° 
90°-290° 0°-360° 90°-290° 0°-360° 
Bowtie filter Full Half Full Half 
No of Projections 367 660 367 660 
X1 and X2 (mm) 132, 132 25, 239 132 , 132 25, 239 
Y1 and Y2 (mm) 99, 99 
The lateral extent of the 
scan (mm) 264 478 264 478 
The axial extent of the 
scan (mm) 198 
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The CTDI100 measurements are made at the centre of the scan (𝑧𝑧 =0) within the standard head and body PMMA phantoms, which are known as 
CTDI phantoms and shown in Figure 2.4.  
(a) (b) 
  
(c) 
 
Figure 2.4: The standard head and body PMMA phantoms known as CTDI phantoms. 
(a) the head phantom 160 mm in diameter, and (b) the body phantom 320 mm in 
diameter. (c) Both the phantoms are 150 mm in length.  
 
The phantoms are manufactured with removable PMMA plugs at the central 
and four peripheral positions so that a pencil ionization chamber can be 
inserted in these positions. Measurements are performed with the 
phantoms set up at a SID of 100 cm at the middle of the central axis 
(CTDI100,c) and at the four peripheral axes situated 10 mm below the 
phantom surface (CTDI100,p). The weighted CTDI100 known as CTDIw accounts 
for inhomogeneity of the dose distribution over the axial scan plane, and is 
defined as: 
320 mm 160 mm 
150 mm 
150 mm 
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𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100,𝑤𝑤  =  13 𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100,𝑐𝑐  +  23 𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100,𝐸𝐸 (2.2) 
where CTDI100,p is the average of the four dose measurements made at the 
peripheral positions, (𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100,𝐸𝐸  =  1/4 ∑ 𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100,𝐸𝐸𝑝𝑝4𝑝𝑝=1 ). For MSCT scans, 
(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝑣𝑣𝑣𝑣𝑣𝑣  =  𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝑤𝑤 / 𝑝𝑝𝐷𝐷𝑊𝑊𝑛𝑛ℎ) is used to quantify the dose along the scan axis 
to allow for differences in the beam width and pitch of the tube rotation, 
where the pitch is the ratio of the table movement for a single rotation (𝑏𝑏) 
to the nominal beam width (𝑁𝑁 × 𝐶𝐶), i.e. (𝑝𝑝𝐷𝐷𝑊𝑊𝑛𝑛ℎ =  𝑏𝑏/𝑁𝑁 × 𝐶𝐶). In addition, 
(𝐷𝐷𝐿𝐿𝑃𝑃 =  𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝑣𝑣𝑣𝑣𝑣𝑣  ×  𝑠𝑠𝑛𝑛𝑊𝑊𝑛𝑛 𝑙𝑙𝐷𝐷𝑛𝑛𝑙𝑙𝑊𝑊ℎ) is employed in assessment of dose for 
patients undergoing MSCT scans. 
In order to estimate the total amount of radiation to which a patient is 
exposed during a CT scan, the CTDI∞ concept has been proposed (Shope et 
al., 1981, Li et al., 2011). CTDI∞ takes into account all the contributions 
resulting from the primary beam and the scattered radiation by integrating 
the dose from a scan of an infinitely long phantom as: 
𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶∞  =  1𝑁𝑁 × 𝐶𝐶�  𝐷𝐷(𝑧𝑧)𝑑𝑑𝑧𝑧+∞−∞  (2.3) 
and weighed CTDI∞ is defined in manner similar to that for CTDI100,w as: 
𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶∞,𝑤𝑤  =  13 𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶∞,𝑐𝑐  +  23 𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶∞,𝐸𝐸 (2.4) 
 
2.5 CTDI100 for CBCT Dosimetry 
As CTDI100 is evaluated with a chamber and phantoms of arbitrary lengths 
100 mm and 150 mm, respectively, the beam width used for a scan plays a 
major role in determining the CTDI100 measurement values (Eq.(2.1)). The 
ability of CTDI100 in estimating CTDI∞, which is defined as the efficiency of 
CTDI100, has been investigated in a number of studies (Mori et al., 2005, 
Boone, 2007, Dixon and Ballard, 2007, Perisinakis et al., 2007, Kyriakou et 
al., 2008, Ruan et al., 2010, Martin et al., 2011, Li et al., 2011, Li et al., 
2012). Most of these studies were conducted for beams of width (𝑁𝑁 × 𝐶𝐶 ≤
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40 𝑚𝑚𝑚𝑚), which are commonly used for MSCT scans. However, the studies 
conducted by (Mori et al., 2005, Boone, 2007, Kyriakou et al., 2008) have 
been extended to investigate the efficiency of CTDI100 for cone beams. 
Mori et al. (2005) have investigated the efficiency of CTDI100 for five beam 
widths (20, 42, 74, 106 and 138 mm) using a conventional CT scanner. The 
standard 150 mm and 900 mm long head and body PMMA phantoms were 
used to measure dose profiles resulting from the beam widths studied, 
where the length of 900 mm was considered to be a sufficient length to 
measure CTDI∞. Dose profiles of the scans were integrated using pin 
photodiode sensors placed along axes of the short and long phantoms in 
specified intervals. For the long phantoms, the dose profiles were measured 
over a detection length of 900 mm, which was equal to the lengths of the 
phantoms involved, i.e. the chamber and phantoms had the same length. 
Therefore, CTDI∞ was represented by CTDI900 measurements, i.e. CTDI900 ≡ 
CTDI∞. A 300 mm long ionization chamber was also used within the long 
phantoms. It has been found that CTDI100,w underestimated CTDI900,w by 24 
– 40 % in the head and body phantoms for the beam widths studied, with 
the underestimation values being larger in the body phantom. However, 
CTDI300,w measured in a manner similar to those for CTDI100 Eqs.(2.1) and 
(2.2), but over a detection length of 300 mm at the centre and periphery 
of the long phantoms as: 
𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶300  =  1𝑁𝑁 × 𝐶𝐶  � 𝐷𝐷(𝑧𝑧) 𝑑𝑑𝑧𝑧+150 𝑚𝑚𝑚𝑚−150 𝑚𝑚𝑚𝑚  (2.5) 
gave estimates of over 90% of the CTDI∞,w for all beam widths and 
phantoms, i.e. the underestimation values dropped to <10%. Therefore, it 
has been concluded that weighted CTDIL, provides an alternative dose index 
suitable for wide beams, where CTDIL is defined as: 
𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐿𝐿  =  1𝑁𝑁 × 𝐶𝐶  � 𝐷𝐷(𝑧𝑧) 𝑑𝑑𝑧𝑧+𝐿𝐿/2–𝐿𝐿/2  (2.6) 
and CTDIL,w is equal to: 
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𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐿𝐿,𝑤𝑤  =  13 𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐿𝐿,𝑐𝑐  +  23 𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐿𝐿,𝐸𝐸 (2.7) 
where 𝐿𝐿 is the detection length, The detection length needs to be ≥ 300 
mm to minimize the CTDI100,w underestimation for CBCT scans by ~14 – 30%. 
Boone (2007) used Monte Carlo simulations to study the efficiency of CTDI100 
for beam widths up to 400 mm and tube potentials of 80, 100, 120 and 140 
kV. A conventional CT scanner was simulated, and the efficiency values 
were calculated within the standard and 500 mm long head and body PMMA 
phantoms, where CTDI∞ was evaluated within the long phantom. It has been 
found that at 120 kV for beams of width up to 40 mm, the efficiency values 
were approximately constant at 82% and 90% at the centre and periphery 
of the head phantom, respectively, and at 63% and 88% for the centre and 
periphery of the body phantom, respectively. Subsequently, the efficiency 
values declined steadily as beam width increased up to 80 mm, and then 
dropped significantly as the beam width was increased further, reaching 
~25% for a beam of width 400 mm at the central and peripheral axes of 
phantoms. The efficiency values calculated for 120 kV differed only slightly 
from those calculated for the other tube potentials, i.e. the tube potential 
showed a minimal impact on the efficiency values. 
Kyriakou et al. (2008) investigated the efficiency of CTDI100 for a C-arm 
scanner equipped with a flat panel detector using Monte Carlo simulations. 
The efficiency values were investigated for beams of widths ranging from 
20 to 200 mm, and two tube potentials of 70 kV and 125 kV. Two acquisition 
modes partial 200° and full 360° scans, and the standard and 900 mm long 
head and body PMMA phantoms were used. It has been found that the 
relationship between the efficiency and the beam width for the head and 
body phantoms were varying in a manner similar to those reported by 
(Boone, 2007). It has also been shown that the influence of the acquisition 
mode and the tube potential on the efficiency values was minimal, where 
the efficiency values were similar under the different conditions. The 
efficiency values were ~80% and ~85% at the centre and periphery of the 
head phantom, respectively, for a beam of width 20 mm, and declined to 
~50% for a beam of width 200 mm. This also occurred for the body phantom, 
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where the efficiency values declined from ~62% and ~82% to ~42% and ~55% 
at the centre and periphery of the phantom, respectively. 
In addition to investigation of the CTDI100 efficiency, Kyriakou et al. (2008) 
also studied the influence of the detection length on the CTDI100 
measurement using the same scanning parameters, but only for beams of 
width 20 and 200 mm. The influence of the detection length was studied 
by evaluating CTDIL, as given in Eq.(2.6), for the head and body phantoms 
using detection of lengths ranging from 150 to 900 mm with an increment 
of 150 mm, i.e. CTDI150, CTDI300, CTDI450, CTDI600, CTDI750, and CTDI900. The 
phantom length for each CTDIL was similar to the detection length (L). 
CTDI900 was considered to represent CTDI∞, thus all CTDI measured with the 
different detection lengths were normalized by CTDI900. They found that 
the underestimation decreased with increasing detection length, and 
lengths of 600 mm or more, i.e. CTDI600, were needed to assess CTDI∞ within 
±1% for wide beams within the head and body phantoms under different 
conditions. 
2.6 Methods for CBCT Dosimetry 
From the studies conducted by (Mori et al., 2005, Boone, 2007, Kyriakou et 
al., 2008), it has been clearly shown that the CTDI100 has a shortcoming for 
the evaluation of imaging doses for CBCT scans. The total amount of 
radiation delivered to the body is underestimated, and this underestimation 
increases with the beam width used for the scan. To overcome this 
limitation, several methods have been proposed for CBCT dosimetry: 
2.6.1 CTDIL Method 
CTDIL, as given in Eq.(2.6) was proposed by (Mori et al., 2005) and (Kyriakou 
et al., 2008) as an alternative dose index for CTDI100 that is suitable for 
CBCT dosimetry. CTDIL, as illustrated in Figure 2.5, extends the use of the 
CTDI100 concept to provide a better estimate of CTDI∞ for CBCT scans. Mori 
et al. (2005) recommended the detection length to be ≥300 mm, whereas 
Kyriakou et al. (2008) suggested 600 mm. As measurement of CTDIL requires 
different equipment from that used for CTDI100 measurements, i.e. longer 
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chambers and phantoms, which are impractical for routine measurements 
in the clinical environment, Kyriakou et al. (2008) suggested the application 
of correction factors to CTDI100 measurements to allow the assessments.  
 
Figure 2.5: A diagrammatic representation of the experimental configuration used to 
assess CTDIL for a CBCT scan with a beam of width (W). CTDIL is measured using 
infinitely long head and body PMMA phantoms with a diameter of (d) over a detection 
length of (L). CTDIL measurements are made at the centre and periphery of the 
phantom.  
 
2.6.2 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎) Method 
Dixon (2003) has proposed a dosimetric method to replace the CTDI100 
concept for MSCT scans obtained with conventional CT scanners. It is based 
on the cumulative dose concept, and requires measuring cumulative dose 
resulting from a complete MSCT scan. This method involves using a small 
ionization chamber positioned at the middle of a phantom that is long 
enough to provide the scatter equilibrium condition, i.e. further extending 
the length of the phantom will have a negligible effect on the 
measurement. Fahrig et al. (2006) have investigated the use of the 
cumulative dose concept for CBCT scans obtained with a C-arm scanner 
equipped with a flat panel detector. They have adapted the cumulative 
dose concept for CBCT scans, and assumed that the contribution of 
scattered radiation arising from longer phantoms at the central point, at 
which the cumulative dose is measured, is minimal. Therefore, it has been 
proposed that the cumulative dose 𝐷𝐷(0) for a CBCT scan can be measured 
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within the standard PMMA phantoms as illustrated in Figure 2.6 with 
minimal differences from results obtained with longer phantoms. 
 
Figure 2.6: A diagrammatic representation of the experimental configuration used to 
assess 𝑫𝑫(𝟎𝟎) for a CBCT scan with a beam of width (W). The measurements are 
performed using the standard head and body PMMA phantoms with a diameter of (d) 
and a small ionization chamber with an active length of (L) positioned at the centre of 
the scan. 𝑫𝑫(𝟎𝟎) measurements are made at the centre and periphery of the phantoms.  
 
𝐷𝐷(0) can be averaged over the axial plane in a manner similar to that used 
for CTDIw (Eq.(2.2)) as: 
𝐷𝐷(0)𝑤𝑤  =  13 𝐷𝐷(0)𝑐𝑐  +  23 𝐷𝐷(0)𝐸𝐸 (2.8) 
The 𝐷𝐷(0) method has been utilized to evaluate imaging doses from CBCT 
scans in various studies (Song et al., 2008, Kim et al., 2008, Osei et al., 
2009, Kim et al., 2010a, Cheng et al., 2011). 
In order to distinguish between this method and that proposed by AAPM TG-
111, which is discussed in section 2.6.4, the expression 𝑓𝑓(0,150) was used 
in this project, where (0) represents the measurement position at the 
centre of the scan (𝑧𝑧 = 0), and (150) represents the length of the standard 
PMMA phantoms.  
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2.6.3 𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(𝟏𝟏𝟏𝟏𝟎𝟎) Method 
Amer et al. (2007) introduced an alternative dose index called cone beam 
dose index (CBDI). It is based on measurement of the average cumulative 
dose resulting from a CBCT scan using the CTDI100 equipment as illustrated 
in Figure 2.7. The CBDI is slightly different from 𝑓𝑓(0,150) in that a 100 mm 
long chamber is used, and it is defined as: 
𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶 =  1100 � 𝐷𝐷(𝑧𝑧) 𝑑𝑑𝑧𝑧+50𝑚𝑚𝑚𝑚−50𝑚𝑚𝑚𝑚  (2.9) 
 
Although CBDI is not based on the beam width as that for CTDI100 Eq.(2.1), 
partial or full chamber irradiation plays a role in CBDI values. When a beam 
of width < 100 mm is used, the chamber is irradiated partially and that is 
then averaged over length of the chamber. This leads to a minimizing of 
the cumulative dose due to averaging the dose from a given beam over a 
larger detection length. However, when a wider beam > 100 mm is used, 
the chamber is fully irradiated, and the cumulative dose from the scan is 
detected properly. In contrast, CTDI100 depends on the beam width, thus 
the dose is underestimated if a beam > 100 mm is used, i.e. full chamber 
irradiation. This is because the dose measured over the chamber length is 
normalized with respect to a beam that has a nominal width longer than 
the chamber length. However, in the partial chamber irradiation with 
beams < 100 mm, CTDI100 normalizes the dose with respect to the same 
width measured over the chamber. Therefore, based on the CBDI definition 
Eq.(2.9), the full chamber irradiation by using a beam width > 100 mm gives 
the best estimation for the cumulative dose. This has been discussed in 
detail in Chapter 6.   
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Figure 2.7: A diagrammatic representation of the experimental configuration used to 
assess CBDI for a CBCT scan with a beam of width (W). The measurements are 
performed using the standard head and body PMMA phantoms with a diameter of (d) 
and a 100 mm long pencil ionization chamber positioned at the centre of the scan. 
CBDI measurements are made at the centre and periphery of the phantoms.  
 
Amer et al. (2007) used a XVI imaging system mounted on an Elekta linear 
accelerator. CBDI was investigated using three beams of width 160, 210, 
and 260 mm. CBDI was measured at the centre and periphery of the 
standard PMMA phantoms as well as a 290 mm long head PMMA phantom 
and a 440 mm long body PMMA phantom. It has been found that CBDI 
measured within the standard phantoms using the beam of width 260 mm 
underestimated CBDI measured within the longer phantoms by 31% and 8% 
at the centre and periphery, respectively. This underestimation reduced by 
6% and 12% for the weighted CBDI (CBDIw), calculated as for the CTDIw, 
when beams of width 210 and 160 mm, respectively, were used. 
Geleijns et al. (2009) studied five dose indices CTDI100, CTDI300, CTDI600, 
𝐷𝐷100������  and 𝐷𝐷24����� for a conventional CT scanner using a beam of width 160 mm. 
The 𝐷𝐷𝑥𝑥����  forms use chambers that fit within the width of the beam and are 
not normalized with respect to the beam width. CTDI300 and CTDI600 were 
based on the CTDIL method (Eq.(2.6)), and 𝐷𝐷100������ was similar to CBDI 
(Eq.(2.9)). 𝐷𝐷24����� was based on the cumulative dose 𝑓𝑓(0,150) proposed by 
(Fahrig et al., 2006), and was evaluated over a detection length of 24 mm. 
The dose indices were assessed using experimental measurements and 
Monte Carlo simulations. 
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First, CTDI100, CTDI300 and 𝐷𝐷100������ were measured experimentally using 
ionization chambers inserted into head and body PMMA phantoms 150 mm 
long for CTDI100 and 𝐷𝐷100������, and 350 mm for CTDI300 measurements. Beam 
qualities for tube potentials of 80 – 135 kV and head and body bowtie filters 
of different sizes were used. The study found that under different scanning 
conditions, 𝐷𝐷100,𝑤𝑤�������� values were in the range 0.90 – 0.93 of CTDI300,w for the 
head phantom, and 0.93 – 1.02 for the body phantom. Whereas CTDI100,w 
values were only 0.56 – 0.58 of CTDI300,w for the head phantom and 0.58 – 
0.63 for the body phantom.  
Second, Monte Carlo simulations were used to assess all the dose indices at 
120 kV using head and body PMMA phantoms 150, 350, and 700 mm in 
length. CTDI100, 𝐷𝐷100������  and 𝐷𝐷24����� were calculated within all the phantoms of 
different lengths, whereas CTDI300 was only evaluated within the 350 mm 
and 700 mm long phantoms, and CTDI600 was only evaluated within the 700 
mm long phantom. It has been found that CTDI300,w values calculated within 
the 350 mm long phantoms were within 1% of those calculated within the 
700 mm long phantoms. 𝐷𝐷24,𝑤𝑤������� values were in the range of 0.91 – 0.93 of 
CTDI300,w for the head phantom, and 0.99 – 1.02 for the body phantom, 
while 𝐷𝐷100,𝑤𝑤�������� values were in the ranges of 0.89 – 0.91 and 0.95 – 0.99 for the 
head and body phantoms, respectively. CTDI100,w values, however, 
underestimated CTDI300,w values by 43 – 45 % for the head phantoms and 38 
– 41 % for the body phantoms. CTDI600,w values were larger than CTDI300,w 
values by 1% and 4% for the head and body phantoms, respectively.  
The expression 𝑓𝑓100(150) was used in the project for the CBDI concept, 
where (100) and (150) represent the length of the standard pencil ionization 
chamber and the standard PMMA phantoms, respectively.  
2.6.4 𝒇𝒇(𝟎𝟎,∞) Method 
AAPM TG–111 (AAPM, 2010) adapted the cumulative dose concept proposed 
by (Dixon, 2003), and introduced a dosimetric method for measurement in 
MSCT and CBCT scans. For a MSCT scan acquired with the moving table 
mode using the axial or helical modes over a given scan length, the 
cumulative dose 𝐷𝐷𝐿𝐿(0) at the centre of the scan (𝑧𝑧 =  0) is measured using 
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a small ionization chamber placed at the centre of the phantom. 𝐷𝐷𝐿𝐿(0) 
resulting from multiple rotations is assessed as: 
𝐷𝐷𝐿𝐿(𝑧𝑧 = 0) =  1𝑏𝑏  � 𝐷𝐷(𝑧𝑧) 𝑑𝑑𝑧𝑧+𝐿𝐿 2⁄−𝐿𝐿 2⁄  (2.10) 
where the detection length is equal to the scan length, which covers the 
range from – 𝐿𝐿/2 to +𝐿𝐿/2. The small chamber is transferred over the scan 
length L to integrate the dose profile accumulated from the multiple 
rotations. Subsequently, 𝐷𝐷𝐿𝐿(0) is normalized with respect to 𝑏𝑏, which is the 
table increment for a single rotation. This means that 𝐷𝐷𝐿𝐿(0) measures the 
cumulative dose within the (−𝑏𝑏/2 , +𝑏𝑏/2) interval, where 𝑏𝑏 = (𝑁𝑁 × 𝐶𝐶) ×
𝑝𝑝𝐷𝐷𝑊𝑊𝑛𝑛ℎ and 𝑏𝑏 <<  𝐿𝐿. Figure 2.8 shows an example for a dose profile 
accumulated from a scan acquired with five axial scans and pitch = 1, 
i.e. 𝑁𝑁 × 𝐶𝐶 = 𝑏𝑏, within an infinitely long body PMMA phantom. Each axial 
scan is acquired with a beam of width 𝑁𝑁 × 𝐶𝐶 = 40 𝑚𝑚𝑚𝑚, therefore the scan 
length 𝐿𝐿 = 200 𝑚𝑚𝑚𝑚. The small chamber is placed at the centre of the 
phantom, and then the phantom is moved from -100 mm to +100 mm to 
integrate the dose profile. The cumulative dose 𝐷𝐷𝐿𝐿=200𝑚𝑚𝑚𝑚(z = 0), then, is 
normalized with respect to 𝑏𝑏 = 40 𝑚𝑚𝑚𝑚.  
 
Figure 2.8: A dose profile accumulated from five axial scans, each of which is obtained 
with a beam of width 40 mm. The scan is acquired with a pitch of 1, and a scan length 
of 200 mm.  
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However, for scans obtained with the stationary table mode such as those 
employed for CBCT scans, the cumulative dose, which is analogous to that 
for MSCT scans 𝐷𝐷𝐿𝐿(0) obtained with the moving table mode, is evaluated 
as: 
𝐷𝐷𝑁𝑁(𝑧𝑧 = 0)  =  𝑁𝑁𝑓𝑓(0) (2.11) 
where 𝑁𝑁 is the number of rotations involved in a CBCT scan, which is (𝑁𝑁 = 1) in most cases, and 𝑓𝑓(0) is the peak value of a dose profile resulting from 
a single CBCT rotation at the centre of the scan (𝑧𝑧 =  0). 𝑓𝑓(0) is measured 
as a point dose using a small ionization chamber at the middle of an 
infinitely long phantom ≥ 450 mm, which is sufficiently long to create the 
scatter equilibrium condition as illustrated in Figure 2.9 (a). Figure 2.9 (b) 
shows an example of a dose profile for a cumulative dose resulting from a 
CBCT scan obtained with a single rotation and a beam width of 200 mm 
within an infinitely long body PMMA phantom.  
The International Commission on Radiation Units and Measurements (ICRU) 
Report–87 recommended the AAPM method, but proposed a practical 
measurement methodology to avoid the difficulty of using the long 
phantoms (ICRU, 2012). This method is based on the application of a 
function called 𝐺𝐺𝑥𝑥(𝐿𝐿), and is discussed in detail in Chapter 6. 
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(a)  
(b) 
 
Figure 2.9: (a) A diagrammatic representation of the experimental configuration used 
to assess 𝒇𝒇(𝟎𝟎) for a CBCT scan with a beam of width (W). The measurements are 
performed using infinitely long head and body phantoms with a diameter of (d) and a 
small ionization chamber with an active length of L positioned at the centre of the 
scan. 𝒇𝒇(𝟎𝟎) measurements are made at the centre and periphery of the phantoms. (b) 
Dose profile for cumulative dose resulting from a CBCT scan with a single rotation 
and W = 200 mm.   
 
𝐷𝐷𝐿𝐿(0) and 𝑓𝑓(0) measurements can also be performed in infinitely long head 
and body phantoms made of polyethylene or water as shown in Figure 2.10. 
AAPM TG–111 (AAPM, 2010) recommended that the measurements are made 
in a water phantom (Figure 2.10 (a)), 300 mm in diameter and 500 mm in 
length. However, the ICRU in cooperation with the AAPM TG–200 (AAPM, 
2015a) introduced a new cylindrical phantom named the ICRU/AAPM 
phantom, within which the cumulative dose is measured. This phantom is 
shown in Figure 2.10 (b), and is designed to emulate an adult body. The 
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ICRU/AAPM phantom is made of a polyethylene cylinder, 300 mm in 
diameter and 600 mm in length. 
The expression 𝑓𝑓(0,∞) was used in the project for the AAPM method, where 
(0) and (∞) represent the position of the measurement and the infinitely 
long phantom, respectively. 
(a) (b) 
  
Figure 2.10: (a) The water filled phantom recommended by AAPM TG–111. (b) The 
ICRU/AAPM phantom. Both the phantoms represent an adult body. (a) Reprinted with 
a permission of John Boone, (b) reprinted with a permission of AAPM and Robert 
Dixon. 
 
2.6.5 CTDIIEC Method 
The IEC method (CTDIIEC) extends the CTDI100 concept, and is based on the 
use of CTDI100 equipment. Note that the expression IEC has been used with 
CTDI to distinguish this method from the CTDI100 and CTDIL. The CTDIIEC is 
designed to be employed for beams of width > 40 mm and involves the 
application of a correction factor to measurements of CTDI100 for a narrow 
reference CT beam. The correction factor is a ratio of two CTDI 
measurements free in air (FIA) for the beam width of interest (CTDIFIA,N×T) 
and the reference beam width (CTDIFIA,ref). CTDIIEC is defined as follows: 
𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀  =   𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100,𝑊𝑊𝑊𝑊𝑓𝑓  ×  �𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐹𝐹𝐼𝐼𝑃𝑃,𝑁𝑁×𝑇𝑇𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐹𝐹𝐼𝐼𝑃𝑃,𝑊𝑊𝑊𝑊𝑓𝑓 � (2.12) 
where CTDI100,ref is the CTDI100 of a narrow reference beam width (≤ 40 mm) 
measured within the standard PMMA phantoms and CTDIFIA is equal to: 
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𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐹𝐹𝐼𝐼𝑃𝑃  =  1𝑁𝑁 × 𝐶𝐶  � 𝐷𝐷(𝑧𝑧) 𝑑𝑑𝑧𝑧+𝐿𝐿/2–𝐿𝐿/2  (2.13) 
where 𝐿𝐿 is the minimum integration length and depends on (𝑁𝑁 × 𝐶𝐶); (1) if 
𝑁𝑁 × 𝐶𝐶 ≤  60 𝑚𝑚𝑚𝑚 then 𝐿𝐿 =  100 𝑚𝑚𝑚𝑚, or (2) if 𝑁𝑁 × 𝐶𝐶 >  60 𝑚𝑚𝑚𝑚, then 𝐿𝐿 = 𝑁𝑁 × 𝐶𝐶 + 40 𝑚𝑚𝑚𝑚. For the beam widths that fall within the first range, 
measurements of CTDIFIA are made in a manner similar to that for the 
standard CTDI100, but for wider beams, a longer ionization chamber that 
covers 𝐿𝐿 =  𝑁𝑁 × 𝐶𝐶 +  40 𝑚𝑚𝑚𝑚 is required. If a long ionization chamber is not 
available, a standard 100 mm ionization chamber can be used by 
implementing a practical technique (IAEA 2011). This technique involves 
moving the chamber across the entire beam width in 100 mm steps to 
achieve the required length L. Utilizing this technique, integration lengths 
are multiples of 100 mm (i.e. 200, 300, etc). The sum of the dose resulting 
from these steps is then multiplied by the ionization chamber length 100 
mm and divided by the width of the beam of interest to calculate CTDIFIA.  
Therefore, performing measurements for CTDIIEC using CTDI100 equipment 
requires three steps as illustrated in Figure 2.11. Step 1: measuring 
CTDI100,ref using a reference beam width within the standard PMMA 
phantoms. Step 2: measuring CTDIFIA,ref for the same reference beam width 
free in air. Step 3: measuring CTDIFIA,N×T for the beam of interest free in air, 
CTDIFIA,W in the case of CBCT scans. Number of the chamber movement 
required for CTDIFIA,W is mainly based on the beam width W. For example, 
three movements are needed for the clinical beam width W = 198 mm as 
shown in step 3. The measurements within the phantoms in the first step 
are made at the centre and periphery of the phantoms, whereas free in air 
measurements in the second and third steps are only performed at the 
centre, i.e. at the rotation axis. 
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Figure 2.11: Diagrammatic representations of the experimental configuration used to 
assess CTDIIEC through three different steps for a CBCT scan with a beam of width (W 
= 198 mm). The measurements are performed with the standard head and body PMMA 
phantoms with a diameter of (d) (step 1) and free in air (steps 2 and 3) using a 100 mm 
long pencil ionization chamber positioned at the centre of the scan in steps 1 and 2, 
and moved over the scan range in step 3.  
 
2.7 Organ Doses from CBCT Scans 
Organ doses resulting from CBCT scans utilized in IGRT procedures using the 
different CBCT systems under different conditions have been investigated 
extensively in many studies in the literature. Table 2.2 shows a summary 
for some of these studies. Although all these studies investigated imaging 
and organ doses from CBCT scans, the aims and methods were different in 
each study. For example, some studies estimated organ doses from the 
scans, while other studies assessed imaging doses at the patient surface, 
i.e. skin dose, and the dose distribution within the patient body. The early 
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studies, which were conducted at the time of implementation of the CBCT 
systems in the clinic such as those published by (Ding et al., 2007, Wen et 
al., 2007, Walter et al., 2007, Amer et al., 2007, Ding et al., 2008a), aimed 
to characterize and assess imaging and organ doses from the scans. Organ 
doses outside the scans field were also investigated (Perks et al., 2008), 
and some studies conducted to evaluate imaging and organ doses for 
paediatric patients (Ding and Coffey, 2009, Kim et al., 2010b, Zhang et al., 
2012b, Deng et al., 2012). The dose distribution within the body from the 
scans was also investigated (Tomic et al., 2010, Nobah et al., 2014). 
2.7.1 Methods for Organ Dose Evaluation 
From Table 2.2, it can be seen that the majority of the studies were 
conducted experimentally using anthropomorphic phantoms and dosimeters 
or by using Monte Carlo simulations on CT images of adult and paediatric 
patients or computational phantoms. The Monte Carlo method is discussed 
in Chapters 3 and 9. However, for experimental measurements, different 
dosimeters placed inside or at the surface of an anthropomorphic phantom 
are utilized to measure organ doses. Thermoluminescent dosimeters 
(TLDs), which were involved in most of the experimental studies 
(Table 2.2), are considered as the standard dosimeter used to measure 
organ doses. Some studies, however, utilized different dosimeters such as 
metal oxide semiconductor field effect transistors (MOSFETs) (Kim et al., 
2010b), and Gafchromic film to measure the dose distribution within the 
phantom, i.e. the dose profile (Tomic et al., 2010, Nobah et al., 2014). 
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Table 2.2: A summary of studies conducted for patients dosimetry from CBCT scans. 
Investigators Methodology CBCT system Results 
(Wen et al., 2007) 
- TLDs on prostate cancer patients’ skin 
- An adult anthropomorphic phantom with 
TLDs  
OBI Skin and in vivo doses from prostate scans 
(Amer et al., 2007) 
- An adult anthropomorphic phantom with 
TLDs  
- TLDs on patients’ skin  
- ImPACT calculator 
XVI Organ doses from head, lung, and pelvic scans 
(Walter et al., 2007) - Ionization chambers at the surface and inside of five patients (rectum) XVI 
Dose for rectum and at the patients 
surface from MV EPID images and pelvic 
CBCT scans  
(Kan et al., 2008) - An adult anthropomorphic phantom with TLDs OBI 
Effective dose and organ doses from head 
and neck, chest, and pelvic scans 
(Gu et al., 2008) - MC on an adult phantom Not mentioned 
Effective dose and organ doses for kV and 
MV CBCT head and prostate scans 
(Ding et al., 2008a) - MC on CT images of adult patients OBI Organ doses from head and neck, lung, prostate, and pelvic scans 
(Perks et al., 2008) - An adult anthropomorphic phantom with TLDs  XVI 
Imaging doses outside the scan field from 
pelvic scans 
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(Osei et al., 2009) 
- An adult anthropomorphic phantom with 
TLDs 
- TLDs on patients’ skin 
OBI Imaging doses and skin doses from head and body scans  
(Downes et al., 2009) - MC on CT images of adult patients XVI Organ doses from head and neck, lung, and pelvic scans 
(Ding and Coffey, 
2009) 
- MC on CT images of paediatric and adult 
patients OBI 
Organ doses from head and neck, chest, 
and abdominal scans 
(Walters et al., 2009) - MC on adult phantoms OBI 
Red bone marrow and bone surface cells 
doses from head and neck, chest, and 
pelvic scans 
(Chow, 2009) - MC on anthropomorphic phantoms XVI Organ doses from head and neck, chest, and pelvic scans 
(Ding et al., 2010a) - MC on CT images of adult patients OBI Organ doses from CBCT and MSCT scans from prostate scans 
(Hyer et al., 2010) - An adult anthropomorphic phantom with fibre-optic coupled dosimetry system OBI and XVI 
Effective dose and organ doses from head, 
chest and pelvic scans 
(Hyer and Hintenlang, 
2010) 
- ImPACT calculator and comparison with 
measurements obtained with an adult 
anthropomorphic phantom 
OBI and XVI Organ doses from head, chest and pelvic scans 
(Kim et al., 2010b) - A paediatric anthropomorphic phantom with MOSFETs OBI 
Effective dose and organ doses from 
abdominal scans 
 35 
 
(Palm et al., 2010) - An adult anthropomorphic phantom with TLDs  OBI 
Imaging doses from head, thorax and 
pelvic scans using two different versions 
of OBI 
(Tomic et al., 2010) - An adult anthropomorphic phantom with Gafchromic film  OBI 
Skin and imaging doses from head, thorax 
and pelvic scans 
(Alaei et al., 2010) 
- An adult anthropomorphic phantom with 
TLDs 
- A treatment planning system  
XVI Imaging doses from pelvic scan 
(Ding et al., 2010b) - MC on CT images of paediatric and adult patients OBI 
Organ doses from head, thorax, and pelvic 
scans using two different versions of OBI 
(Dufek et al., 2011) - An adult anthropomorphic phantom with TLDs  OBI and XVI 
Effective dose and organ doses from head 
and neck and pelvic scans using (1) two 
different versions of OBI, (2) MV EPID, and 
(3) kV images 
(Cheng et al., 2011) - An adult anthropomorphic phantom with TLDs OBI 
Effective dose and organ doses from head 
and neck and pelvic scans using two 
different versions of OBI 
(Qiu et al., 2012) - MC on CT images of adult patients OBI Equivalent doses from pelvic scans 
(Shah et al., 2012) - An adult anthropomorphic phantom with TLDs OBI and XVI 
Imaging and organ doses from thorax and 
pelvic scans using (1) two different CBCT 
systems and (2) MVCT 
(Zhang et al., 2012b) - MC on CT images of paediatric patients OBI Organ doses from head and neck, and pelvic scans 
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(Spezi et al., 2012) - MC on CT images of adult patients XVI Organ doses from head and neck, chest, and pelvic scans 
(Deng et al., 2012) - MC on CT images of paediatric patients OBI Organ doses from head and pelvic scans 
(Alaei and Spezi, 2012) 
- A treatment planning system and MC on 
anthropomorphic phantoms 
- An adult anthropomorphic phantom with 
TLDs 
XVI Imaging doses from head and neck, chest, and pelvic scans 
(Stock et al., 2012) - An adult anthropomorphic phantom with TLDs XVI 
Imaging doses from MV EPID images, kV 
radiographic images, MSCT, and CBCT 
using from head and neck and pelvic 
scans. 
(Ding and Malcolm, 
2013) 
- An anthropomorphic phantom with and 
OSLDs 
- MC on CT images of adult patients 
OBI Skin and imaging doses from head and neck, thorax and pelvic scans 
(Giaddui et al., 2013) - An anthropomorphic phantom with Gafchromic film and OSLDs OBI and XVI 
Imaging doses from head and neck, thorax 
and pelvic scans 
(Ding and Munro, 2013) - MC on CT images of adult patients OBI 
Organ doses from MV EPID images, kV 
radiographic images and CBCT using from 
head, thorax and pelvic scans 
(Montanari et al., 
2014) - MC on CT images of adult patients OBI Organ doses from head and pelvic scans 
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(Son et al., 2014) - MC on adult phantoms OBI Organ doses from head and neck, chest, abdomen, and pelvic scans 
(Nelson and Ding, 
2014) 
- MC on CT images of paediatric and adult 
patients OBI 
Organ doses from head and neck, chest, 
abdomen, and pelvic scans 
(Nobah et al., 2014) - An anthropomorphic phantom with Gafchromic film OBI 
Skin and imaging doses from head and 
neck, lung and prostate scans using (1) 
two different OBI systems, (2) MVCT, and 
(3) kV images 
(Dzierma et al., 2014) 
- An adult anthropomorphic phantom with 
TLDs 
- A treatment planning system  
kVision Organ doses from head and neck, thorax, and pelvic scans 
(Alaei et al., 2014) - A treatment planning system XVI Organ doses from head and neck, and pelvic scans 
(Brochu et al., 2014) - MC on CT images of adult patients XVI Imaging doses from chest scans 
(Wood et al., 2015) 
- An adult anthropomorphic phantom with 
TLDs 
- PCXMC program 
OBI Organ doses from pelvic scans 
OBI: Varian On Board Imager, XVI: Elekta X-ray Volume Imager, kVision: Siemens imaging system, TLDs: Thermoluminescent Dosimeters, MC: Monte Carlo 
simulations, MOSFETs: Metal Oxide Semiconductor Field Effect Transistors, OSLDs: Optically Stimulated Luminescence Dosimeters, ImPACT: Imaging 
Performance and Assessment of CT, PCXMC: PC-based Monte Carlo program. 
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In addition, Ding and Malcolm (2013) investigated the suitability of using 
optically stimulated luminescence dosimeters (OSLDs), which are a 
relatively recent alternative dosimeter to TLDs. OSLDs were used to 
measure CBCT scans doses from the OBI system at the surface and selected 
points inside an anthropomorphic phantom. The experimental 
measurements were then compared against values calculated with Monte 
Carlo simulations. They found that OSLDs can be used as an alternative 
dosimeter for TLDs, but correction factors are required for the photon 
energy distribution. For the OBI system used in their study, the correction 
factors were in the range 0.88 – 1.13 for tube potentials of 60 – 125 kV.  
2.7.2 Programs for Organ Dose Calculations 
Various dose calculation programs have been developed to estimate organ 
doses for x-ray procedures. A dose calculator known as Imaging 
Performance and Assessment of CT (ImPACT) is commonly used to calculate 
organ doses from conventional CT scans. Hyer and Hintenlang (2010) 
studied the suitability of utilizing ImPACT to estimate organ doses from 
CBCT scans. Organ doses calculated with ImPACT for the head, chest and 
pelvic scans were compared to experimental measurements with an 
anthropomorphic phantom and TLDs using the OBI and XVI systems. They 
found significant differences between the measurements and the 
calculated values within ±551% and ±101% for the OBI and XVI systems, 
respectively. 
Another dose calculation program developed to assess organ doses from x-
ray examinations is known as PC-based Monte Carlo (PCXMC) (Tapiovaara 
and Siiskonen, 2008). Wood et al. (2015) investigated the use of this 
program to estimate organ doses from pelvic scans using the OBI system. 
Organ doses calculated with PCXMC program were found to differ by 1% to 
-80% from those measured experimentally using an anthropomorphic 
phantom and TLDs. The suitability of using TPS for evaluating organ doses 
from CBCT scans have also been studied by (Alaei et al., 2010, Alaei and 
Spezi, 2012, Dzierma et al., 2014), and they found differences between 
experimental measurements and those from TPS as discussed in the 
introduction chapter. 
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Recently, Montanari et al. (2014) showed that organ doses from CBCT scans 
can be estimated efficiently for each patient, i.e. patient-specific, by a 
dose calculation package named gCTD. This package is based on Monte 
Carlo simulations and uses a graphics processing unit (GPU), which 
decreases the time required for the simulations significantly. This allowed 
accurate calculation of organ doses for each patient within less than five 
minutes. This approach is still in the early stage of development and 
associated with some challenges such as the possibility of contouring the 
organs of interest automatically. This approach, however, might provide a 
practical solution to evaluating organ doses from CBCT scans easily as it is 
more practical in the clinical environment. Also it may give a solution to 
overcome the TPS limitation in the kV range. 
2.7.3 Development of Hardware and Software for the OBI System 
Since introduction of the CBCT systems, the hardware and software have 
been developed over time. For example, the Varian OBI system was 
upgraded from version of 1.0 to 1.6, and recently, a new version of 2.0 and 
2.5 were released. For some new upgraded versions, new scanning 
protocols with different parameters from the early versions are configured 
by Varian. Therefore, some studies have investigated the differences 
between old and new scanning protocols, .i.e. different system versions 
(Ding et al., 2010b, Palm et al., 2010, Dufek et al., 2011, Cheng et al., 
2011). Generally, the studies showed that more optimisation of radiation 
protection has been introduced in new scanning protocols, which has 
reduced imaging doses delivered to the patents. For example, Palm et al. 
(2010) found that imaging doses for head, thorax, pelvic spot light and 
pelvic scans of the OBI system with a version of 1.3 were reduced 
significantly to less than half when a version of 1.4 with different 
parameters was used. Moreover, Cheng et al. (2011) compared between 
organ doses and effective dose resulting from two different versions 
V1.4.11 and V1.4.13 of the OBI system. They also found that, overall, doses 
reduced significantly to less than half. 
In addition, the hardware of the OBI system was changed slightly for new 
machines such as those integrated in TrueBeam linac. The main difference 
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between hardware of the OBI systems was the introduction of a filter made 
of titanium in addition to an internal aluminium filter. This was found to 
reduce organ doses from the head, thorax and pelvic scans to about the 
half compared to the scans acquired without the filter, as well as it 
enhanced the image quality for the scans (Ding and Munro, 2013). For 
instance, doses to heart and lung resulting from a thorax scan declined from 
4.2 mGy and 5.2 mGy to 2.0 mGy and 2.7 mGy, respectively. 
2.7.4 Differences between Imaging Modalities Used in IGRT 
As various imaging modalities are used in IGRT procedures, some studies 
compared doses resulting from the different modalities (Gu et al., 2008, 
Ding et al., 2010a, Dufek et al., 2011, Shah et al., 2012, Ding and Munro, 
2013, Nobah et al., 2014). For example, Ding and Munro (2013) evaluated 
organ doses from conventional radiographic kV images, CBCT scans, and MV 
images obtained with Electronic Portal Imaging Devices (EPID) using 6 MV 
for head, thorax and pelvic scans. Doses from CBCT scans were found to be 
lower than those delivered by MV EPID images, but higher than kV images. 
Doses to the brain stem, for instance, resulting from a head scan using MV 
EPID images, CBCT scans without the titanium filter and with the filter, and 
radiographic kV images were 37 mGy, 2.4 mGy, 1.6 mGy and 0.3 mGy, 
respectively. These findings were in agreement with other studies 
conducted by (Walter et al., 2007, Dufek et al., 2011, Stock et al., 2012). 
Nobah et al. (2014) also compared doses from CBCT scans, kV images from 
a kV system mounted on a CyberKnife unit, and MVCT from TomoTherapy 
linac. It has been found that, generally, doses from head, thorax, and pelvic 
CBCT scans were lower than those of the other modalities, followed by 
MVCT scans and kV images from the CyberKnife unit. 
2.7.5 Organ Doses from OBI and XVI Systems 
The differences between the OBI and XVI CBCT systems that are commonly 
used in the clinic have also been investigated in various studies (Hyer et 
al., 2010, Shah et al., 2012, Giaddui et al., 2013). Hyer et al. (2010) found 
that organ doses from the head scan obtained with the XVI system were 
about half of those for the OBI system, but larger for the thorax scan. Organ 
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doses from the pelvic scan were found to be comparable for both the 
systems. Shah et al. (2012) also found organ doses from the XVI system were 
larger than those for the OBI system for the thorax scan, but organ doses 
were comparable for the pelvic scan as shown in Table 2.3. Giaddui et al. 
(2013) used Gafchromic film and optically stimulated luminescence 
dosimeters (OSLDs) to estimate imaging doses at the surface and inside the 
patients delivered from both the systems. They found that the surface and 
internal doses from the head scan of the OBI system were higher than those 
from the XVI system, but doses from the thorax scan delivered by the XVI 
system were larger. Doses from the pelvic scans were found to be 
comparable for both the systems. These findings were in agreement with 
organ doses measurements conducted by (Hyer et al., 2010, Shah et al., 
2012). 
Table 2.3: Results for organ doses resulting from thorax and pelvic scans using the 
OBI and XVI systems. Organ doses were measured experimentally by (Shah et al., 
2012) using anthropomorphic phantoms and TLDs. 
 OBI XVI 
Organ Thorax scan (mGy) 
Breast 6.8 (6.4–7.4) 20.1 (18.6–23.2) 
Breast surface 6.4 (6.3–6.5) 19.4 (18.8–19.4) 
Heart 7.4 (6.9–7.9) 20.6 (19.6–21.6) 
Lung 5.8 (1.7–8.4) 14.4 (3.0–22.8) 
Abdomen 5.3 (3.8–7.0) 9.9 (3.6–16.5) 
Sternum 14.7 (4.3–22.8) 33.2 (5.1–54.5) 
Rib 13.9 (9.2–16.2) 35 (8.2–48.6) 
Thyroid 0.9  1.0  
 Pelvic scan (mGy) 
Prostate 21.9 (21.0–22.8) 25.5 (24.3–26.5) 
Bladder 23.2 (19.3–29.5) 25.4 (21.2–31.1) 
Rectum 20.7 (19.4–21.6) 23.9 (22.9–25.6) 
Sigmoid 17.9 (17.6–18.1) 19 (17.3–20.7) 
Left femoral head 37.9 (36.8–39.1) 42 (40.4–43.5) 
Right femoral head 37.2 (36.7–37.7) 50.6 (49.7–51.4) 
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2.7.6 Daily CBCT Scan  
Spezi et al. (2012) used Monte Carlo simulations to simulate the XVI system 
and investigate the influence of using CBCT scans on a daily basis during a 
treatment course of 40 fractions. They calculated organ doses resulting 
from head and neck, chest and pelvic scans for 6 adult patients. They found 
that mean doses to organs within the imaging field from daily head and 
neck scans taken throughout treatment were in the range of 0.07 – 0.12 Gy. 
This range, however, increased to 0.79 - 1.90 Gy and 0.45 – 1.27 Gy, for the 
chest and pelvic scans, respectively. They suggested that the doses to the 
target tissues are significant and should be taken into account if daily scans 
are acquired. The doses accumulated during the course of treatment might 
also increase the risk of developing a secondary cancer in adjacent tissues 
for the patients. In addition, Nelson and Ding (2014) also used Monte Carlo 
simulations to simulate the OBI system. They calculated organ doses 
resulting from head and neck, thorax and pelvic scans for 30 paediatric and 
adult patients. For 40 fractions, organ doses from daily head and neck scans 
were in the range of 0.01 – 0.44 Gy. This range also increased in the OBI 
system for the thorax and pelvic scans to 0.11 – 0.69 Gy and 0.47 – 1.58 Gy, 
respectively. 
2.7.7 Organ Doses and Scan Isocentre 
In most cases, the isocentre of CBCT scans is set at the centre of the area 
of interest, i.e. (0, 0, 0). However, some of CBCT scanning protocols are 
based on using the treatment isocentre, i.e. the centre of the tumour. The 
arrangement varies between cancer centres, and in the Beatson Centre the 
practice adopted is to use the centre of the patient as the isocentre for the 
scan. Chow (2009) used the XVI system to investigate the influence of 
movement of the scan isocentre on the imaging doses. It has been shown 
that the imaging doses varied by up to 15% for the head scans when the 
isocentre was shifted across the x-y plan by up to 6 cm compared to those 
acquired at the centre of the patient. The difference increased by up to 
19% and 22% for the thorax and pelvic scans, respectively, when shifts of 
up to 10 cm were applied. Moreover, Nelson and Ding (2014) used the OBI 
system and showed that the shift of the scan isocentre by 5 cm led to 
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differences in organ dose of less than 1 mGy for the head scan, and in the 
range of -7.7 to 4.7 mGy for the pelvic scan when the isocentre was shifted 
by 8 cm. 
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Chapter 3  
The Monte Carlo Technique 
3.1 Introduction 
The Monte Carlo (MC) technique was used in this project as the main 
method to conduct different dosimetric studies by simulating the OBI 
system. The MC technique enables a wide range of studies that would be 
more difficult and time-consuming to investigate experimentally. It also 
allows simulating a system with a high level of accuracy, and hence 
obtaining accurate results. This chapter gives a general background for the 
MC technique and the basic concept behind the technique. It also presents 
an overview of the codes used in this project. This chapter is mainly based 
on descriptions and explanations given in the references (Hirayama et al., 
2005, AAPM, 2007b, Dunn and Shultis, 2011, Seco and Verhaegen, 2013), 
and the manuals of the codes involved in this project (Rogers et al., 2013a, 
Rogers et al., 2013b, Walters et al., 2013). 
3.2 Monte Carlo Technique 
The MC technique is utilized in a wide range of applications such as medical 
and particle physics, astrophysics, and financial applications. The main 
concept used in all of them is the same, but the way of employing the MC 
technique is different in each science. Therefore, the definition of the MC 
technique can be divided into a general definition describing the main 
concept of the technique and a specific definition based on the application, 
for which the MC technique is used. In the literature, different general 
definitions for the MC technique have been given. All these definitions try 
to encompass the essence of the technique, and some examples are: 
“The MC technique is a statistical method for performing numerical 
integrations.” (AAPM, 2007b), 
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“The analysis technique called Monte Carlo is, in essence, a methodology 
to use sample means to estimate population means.” (Dunn and Shultis, 
2011), 
“Monte Carlo is a numerical method to solve equations or to calculate 
integrals based on random number sampling.” (Seco and Verhaegen, 2013). 
The technique was called ‘Monte Carlo’ by Stanislaw Ulam and John von 
Neumann in 1947 during the development of thermonuclear weapons in the 
Manhattan project, from which the atomic bomb was produced during the 
Second World War. The MC technique was employed in this project by using 
the first electronic computers, ENIAC, to calculate neutron transport 
accurately, which was one of the essential steps in the project. Since then, 
the term of Monte Carlo became common, and the interest of using the MC 
technique increased, especially with the improvement and developments 
in computer technology in 1950’s and 1960’s. However, for a long time 
before 1940’s, in which the name of Monte Carlo was used, the concept of 
the MC technique was known as statistical sampling. The first experiment, 
which used the statistical sampling concept, was conducted by Comte de 
Buffon in 1777, and his experiment is known as Buffon’s needle experiment. 
This experiment is designed as shown in Figure 3.1, and consists of a plane 
of a given dimension of (x, y) and has parallel lines spaced equally over the 
plane with a separation distance of (D). This experiment is based on tossing 
needles on the plane randomly, where all the needles have an equal length 
of (L) and 𝐿𝐿 < 𝐷𝐷. The aim of the experiment was to find the probability of 
a needle dropped randomly crossing one of the parallel lines 𝑃𝑃𝑐𝑐, which is 
evaluated as: 
𝑃𝑃𝑐𝑐 = 𝑁𝑁𝑐𝑐𝑁𝑁𝑊𝑊𝑣𝑣𝑊𝑊 (3.1) 
where 𝑁𝑁𝑐𝑐 is the number of needles crossing one of the lines, and 𝑁𝑁𝑊𝑊𝑣𝑣𝑊𝑊 is the 
total number of needles dropped randomly on the plane.  
Buffon found that 𝑃𝑃𝑐𝑐 can be expressed as: 
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𝑃𝑃𝑐𝑐 = 2𝐿𝐿𝜋𝜋𝐷𝐷 (3.2) 
In 1886, Laplace suggested that Buffon’s needle experiment could be used 
to estimate the value of 𝜋𝜋. As 𝐿𝐿 and 𝐷𝐷 in Eq.(3.2) are known, the 𝜋𝜋 value, 
can be calculated as: 
𝜋𝜋 = 2𝐿𝐿
𝑃𝑃𝑐𝑐𝐷𝐷
= 2𝐿𝐿(𝑁𝑁𝑐𝑐 𝑁𝑁𝑊𝑊𝑣𝑣𝑊𝑊)⁄ 𝐷𝐷 (3.3) 
For example, if the needles shown in Figure 3.1 have a length of 𝐿𝐿 =  0.5 𝐷𝐷, 
and 10 needles are dropped randomly on the plane, and 4 of them are found 
to cross the lines, then: 
𝜋𝜋 = 2 × 0.5𝐷𝐷(4 10)⁄ 𝐷𝐷 = 2.5 (3.4) 
which does not give a good estimation for 𝜋𝜋 = 3.1415929. Thus, in order to 
overcome this difference, a large number of needles, i.e. samples or trials, 
are required to be dropped randomly.  
 
   
Figure 3.1: A schematic representation of Buffon’s needle experiment.  
 
Moreover, another experiment, which is used to estimate the value of 𝜋𝜋 by 
using the random sampling concept, is shown in Figure 3.2. Assume we have 
a circle with a radius of (r) placed inside a square with a length of (2r). If 
several points located inside the square area are selected randomly, then 
D 
L 
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the probability of these points to be inside the circle as well (𝑃𝑃𝑖𝑖𝑝𝑝) is 
estimated by: 
𝑃𝑃𝑖𝑖𝑝𝑝 = 𝑁𝑁𝑖𝑖𝑝𝑝𝑁𝑁𝑊𝑊𝑣𝑣𝑊𝑊 (3.5) 
where 𝑁𝑁𝑖𝑖𝑝𝑝 is the number of the random points located inside both the circle 
and the square, and 𝑁𝑁𝑊𝑊𝑣𝑣𝑊𝑊 is the total number of random points selected. 
Theoretically, the probability of a random point (x,y) being inside the circle 
is calculated as:  
𝑃𝑃𝑖𝑖𝑝𝑝 = 𝑃𝑃𝐷𝐷𝐷𝐷𝑊𝑊 𝑜𝑜𝑓𝑓 𝑛𝑛𝐷𝐷𝐷𝐷𝑛𝑛𝑙𝑙𝐷𝐷𝑃𝑃𝐷𝐷𝐷𝐷𝑊𝑊 𝑜𝑜𝑓𝑓 𝑠𝑠𝑠𝑠𝑠𝑠𝑊𝑊𝐷𝐷𝐷𝐷 = 𝜋𝜋𝐷𝐷24𝐷𝐷2 = 𝜋𝜋4 (3.6) 
Thus, Eqs.(3.5) and (3.6) can be used to estimate the value of 𝜋𝜋 as follows: 
𝜋𝜋 = 4𝑃𝑃𝑖𝑖𝑝𝑝 = 4 × 𝑁𝑁𝑖𝑖𝑝𝑝𝑁𝑁𝑊𝑊𝑣𝑣𝑊𝑊 (3.7) 
 
  
  
Figure 3.2: A schematic representation of an experiment used to estimate the (𝝅𝝅) 
value by using the random sampling concept, which is similar to the MC concept. 
 
For example, if 10 points are selected randomly, and 7 of these points are 
found to be inside the circle, i.e. 𝑃𝑃𝑖𝑖𝑝𝑝 = 0.7, then, 
r 
2r 
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𝜋𝜋 = 4𝑃𝑃𝑖𝑖𝑝𝑝 = 4 × 0.7 = 2.8 (3.8) 
This underestimation is also affected by the total number of points 
selected, and the differences can be minimized by using a large number of 
points.  
Kawrakow (2006) showed that the underestimation associated with 
estimation of the value of  𝜋𝜋 decreased with increasing number of trials for 
both the experiments. 1 × 109 tossing needles and 1 × 1010 random points 
were required to estimate 𝜋𝜋 value accurately.  
3.3 Monte Carlo Technique for Medical Physics 
Applications 
The two experiments described in the previous section are considered to 
be good examples to illustrate the main concept behind the MC technique. 
The MC technique plays a vital role in predicting output of an experiment 
with a stochastic output, such as a random point being inside or outside the 
circle. This predication is based on sampling random numbers, i.e. points 
in our example, repeatedly a large number of times until a reasonable 
estimation for the result is achieved. Therefore, one of the main bases of 
using the MC technique is to perform a larger number of trials. The larger 
number of trials we take; the closer we approach the true value. This is 
also the case for medical physics applications. When a particle is incident 
on a bulk of a given medium such as a water phantom, the behaviour of the 
particle inside the medium is not known as this behaviour is governed by 
stochastic events. For example, the distance that a particle travels inside 
the medium before the first interaction takes place, the trajectory of the 
particle inside the medium, the energy loss, the type of the interaction 
that a particle undergoes, the scattering angle, and so on. Such information 
that describes the random trajectories of individual particles is difficult to 
determine experimentally or analytically. Thus, the MC technique is a 
powerful tool and a suitable approach to solve such complex problems. The 
MC technique provides an average value for outputs of these stochastic 
events by tracking the trajectories of a large number of particles using 
probability distribution functions, as will be discussed in next section. The 
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MC output is, then, unitized to predicate the behaviour of the particles 
inside the medium, and hence determine the quantity of interest. Thus, 
the specific definition for the MC technique used for medical physics 
applications is defined as: 
“The Monte Carlo method provides a numerical solution to a problem that 
can be described as a temporal evolution (“translation / reflection/ 
mutation”) of objects (“quantum particles” [photons, electrons, neutrons, 
protons, charged nuclei, atoms, and molecules] in the case of medical 
physics) interacting with other objects based upon object−object 
interaction relationships (“cross sections”)” (Seco and Verhaegen, 2013). 
3.4 Transport Photons and Electrons using the Monte 
Carlo Technique 
Although the main concept of the MC technique is simple as shown in the 
two experiments presented in section 3.2, simulating a trajectory of a 
particle travelling in a medium in three-dimensions (3D) is a complex 
process compared to a 2D experiment. In order to evaluate the quantity of 
interest such as estimation of the absorbed dose value at a specific depth 
within a medium, MC simulations known as analog simulations are 
employed. As this project was based on simulating photons and charged 
particles (electron and positron), the discussion only focuses on 
transporting these particles. 
3.4.1 Analog Simulations 
The analog simulations method is the standard approach for transporting 
particles inside a medium using the MC technique, and similar steps are 
followed for most MC codes. This method is also known as event-by-event 
or interaction-by-interaction simulations. To illustrate the method, assume 
a photon is incident on a phantom of a given medium. The analog 
simulations method transports this photon through the medium using four 
steps: 
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Step 1: Determination of a distance that the photon travels inside the 
medium before an interaction takes place. The probability of the photon 
travelling distance (𝑑𝑑𝐷𝐷) to reach the interaction site at (𝐷𝐷) is governed by a 
continuous probability distribution function (PDF). This PDF is based on the 
linear attenuation coefficient 𝜇𝜇(𝑃𝑃) of the medium and the photon energy (𝑃𝑃), as follows: 
𝑝𝑝(𝐷𝐷)𝑑𝑑𝐷𝐷 = 𝐷𝐷−𝜇𝜇(𝑃𝑃)𝑊𝑊𝜇𝜇(𝑃𝑃)𝑑𝑑𝐷𝐷 (3.9) 
To estimate the position (𝐷𝐷), sampling from the PDF using random numbers 
is the essential step. In MC simulations, the random numbers are produced 
by a generator known as a pseudo-random number generator. This 
generator distributes random numbers in the range (0 - 1) uniformly. Thus, 
direct sampling from the PDF in Eq.(3.9) using these random numbers is 
invalid as 𝐷𝐷 value can be any value ≥ 0. In order to avoid this, and since the 
(PDF) is known, a method known as the inverse-transform method or the 
inverse cumulative distribution function (CDF) method is utilized. This 
method is based on using the CDF for the known PDF. Values for the CDF 
are in the range (0 - 1), which are in the same range for the random 
numbers distributed by the generator. Thus, CDF values can be equated to 
the random numbers 𝜉𝜉1 values as:  
𝑃𝑃𝐷𝐷𝐹𝐹 = 𝑝𝑝(𝐷𝐷)𝑑𝑑𝐷𝐷 →  𝐶𝐶𝐷𝐷𝐹𝐹 = 𝑃𝑃(𝐷𝐷′)𝑑𝑑𝐷𝐷′ (3.10) 
so, 
𝜉𝜉1 = 𝐶𝐶𝐷𝐷𝐹𝐹 = 𝑃𝑃(𝐷𝐷′)𝑑𝑑𝐷𝐷′ (3.11) 
For a given position (𝐷𝐷): 
𝜉𝜉1 = � 𝑃𝑃(𝐷𝐷′)𝑑𝑑𝐷𝐷′𝑊𝑊
0
= � 𝐷𝐷−𝜇𝜇(𝑃𝑃)𝑊𝑊′𝜇𝜇(𝑃𝑃)𝑑𝑑𝐷𝐷′𝑊𝑊
0
= 1 − 𝐷𝐷−𝜇𝜇(𝑃𝑃)𝑊𝑊 (3.12) 
This leads to  
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𝐷𝐷 = − ln (1 − 𝜉𝜉1)
𝜇𝜇(𝑃𝑃)  (3.13) 
Thus, the 𝐷𝐷 value for the particle is estimated from this equation using the 
random number. 
Step 2: Transporting the photon for a distance 𝑑𝑑𝐷𝐷, which is estimated in 
the first step, to the interaction site at 𝐷𝐷. If this site is located inside the 
geometry of interest, for example a phantom, then the simulation moves 
to the third step. If this site, however, is outside the geometry, i.e. the 
photon leaves the phantom, then tracking of the photon is terminated. 
Step 3: Determination of the interaction type that the photon undergoes 
at the interaction site. This step is similar to the first step in terms of 
sampling from a CDF based on a known PDF using random numbers. 
However, when a photon enters a medium, one of four interactions is likely 
to occur: (1) photoelectric absorption, (2) Rayleigh (coherent) scattering, 
(3) Compton (incoherent) scattering, or (4) pair production. Therefore, the 
probability of occurrence for one of these interactions is governed by a 
discrete PDF. This PDF is based on the cross-section values (𝜎𝜎) of these 
interactions, which give the probability of occurrence a certain interaction 
for a photon with energy of 𝑃𝑃 travelling inside a medium. If 𝜎𝜎𝑊𝑊𝑣𝑣𝑊𝑊 is the total 
cross-section value for all the potential interactions for the photon: 
𝜎𝜎𝑊𝑊𝑣𝑣𝑊𝑊 = 𝜎𝜎𝑃𝑃𝑃𝑃 + 𝜎𝜎𝑅𝑅𝑅𝑅 + 𝜎𝜎𝑀𝑀𝑅𝑅 + 𝜎𝜎𝑃𝑃𝑃𝑃 (3.14) 
then the probability of occurrence for the photoelectric absorption 
interaction is (𝜎𝜎𝑃𝑃𝑃𝑃 𝜎𝜎𝑊𝑊𝑣𝑣𝑊𝑊)⁄ , and (𝜎𝜎𝑅𝑅𝑅𝑅 𝜎𝜎𝑊𝑊𝑣𝑣𝑊𝑊)⁄ , (𝜎𝜎𝑀𝑀𝑅𝑅 𝜎𝜎𝑊𝑊𝑣𝑣𝑊𝑊)⁄ , and (𝜎𝜎𝑃𝑃𝑃𝑃 𝜎𝜎𝑊𝑊𝑣𝑣𝑊𝑊)⁄  for the 
Rayleigh scattering, Compton scattering and pair production interactions, 
respectively. Subsequently, different random numbers 𝜉𝜉2 from those used 
for the first step 𝜉𝜉1 are generated, and are used with the CDF as follows: 
Let 𝐷𝐷 = 1, 2, 3, 4 represent the different interactions, if (𝜉𝜉2 ≤ 𝜎𝜎1 𝜎𝜎𝑊𝑊𝑣𝑣𝑊𝑊)⁄  
then the first interaction is likely to occur, if (𝜉𝜉2 ≤ 𝜎𝜎1 + 𝜎𝜎2 𝜎𝜎𝑊𝑊𝑣𝑣𝑊𝑊)⁄  then the 
second interaction, if (𝜉𝜉2 ≤ 𝜎𝜎1 + 𝜎𝜎2 + 𝜎𝜎3 𝜎𝜎𝑊𝑊𝑣𝑣𝑊𝑊)⁄  then the third interaction, 
and the fourth interaction for the larger values. 
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Step 4: Performing the interaction determined in the third step. If the 
interaction type determined produces secondary particles, the four steps 
are, then, repeated for all the secondary particles and so on. 
The four steps are repeated for a large number of primary and secondary 
particles using different random numbers 𝜉𝜉1 and 𝜉𝜉2 in the first and third 
steps, respectively. The random numbers are changed for each particle, 
thus a long cycle for the random number generator is needed to obtain 
unique random numbers for each particle. The use of many particles and 
different random numbers helps to approach the true value for the 
interaction position and the interaction type for a given experiment in a 
manner similar to the two experiments presented earlier. The simulation 
keeps tracking all primary and secondary particles using the four steps until 
(1) the particle leaves the geometry, (2) the particle is absorbed, or (3) the 
energy of the particle becomes lower than a user-defined cut-off energy 
known as PCUT and ECUT for the photon and electron, respectively. In the 
latter case, the MC simulation terminates tracking the particle trajectory, 
and its energy is absorbed locally at the site at which its energy becomes 
lower than PCUT and ECUT values. 
The initial incident particle and all its secondary particles resulted from 
the different interactions are called ‘a particle history’ or ‘history’. This 
term is commonly used in the MC simulations to indicate the number of the 
initial particles used in a simulation, i.e. similar to the number of needles 
tossed and random points used for the two experiments. 
 
3.4.2 Condensed History Technique 
As only a few photons are transported during a given simulation, the analog 
simulations (event-by-event) method is practical for photons. However, this 
method is impractical for electrons due to the large number of interactions 
- the order of 106 - that electrons undergo during their travels in a medium. 
Such numbers of interactions leads to a significant increase in the time 
required for a MC simulation using the analog simulations method. 
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Therefore, in order to avoid this difficulty, another technique known as the 
condensed history (CH) technique has been introduced by Berger in 1963. 
Electrons interact with a medium through either elastic (soft) collisions or 
inelastic (hard) collisions. The majority of electrons undergo the elastic 
collisions, through which a very small change in direction and energy of the 
electrons occurs. Based on this fact, the CH technique transports electrons 
by grouping, i.e. condensing and combining, small effect interactions, in 
the order of 103 - 105, into a single large effect interaction, also known as 
a large step. This step accounts for the effects resulting from the 
interactions condensed by sampling from PDFs covering the physical process 
involved for transporting grouped interactions. This technique decreases 
the time required for MC simulations significantly, by factors of hundreds. 
Thus, it plays a major role in MC simulations, and is considered as one of 
the essential techniques for implementation in almost all MC codes used at 
the present time. 
The use of the CH technique is divided into two classes: (1) In the first class, 
all electrons undergoing elastic or inelastic collisions are transported by the 
CH technique. (2) In the second class, however, electrons undergoing 
elastic collisions are transported by the CH technique, but the analog 
simulations method is used for transporting electrons undergoing inelastic 
collisions. Figure 3.3 shows an example for using the CH technique. A 
photon is incident on the geometry of interest of a given medium. It is 
transported using the analog simulations method and the second class of 
the CH technique. First, the photon is transported using the analog 
simulations method. It begins when the photon reaches the surface of the 
medium geometry, where the first step is performed to calculate the 𝐷𝐷 
value. This step is followed by the second and the third steps to move the 
photon to the interaction site and determine the interaction type. In this 
example, the photon undergoes a Compton scattering interaction in the 
fourth step, which results in a photon and an electron: (1) For the photon 
resulting from the interaction, the four steps for the analog simulations 
method are repeated. This leads to another interaction, such as a pair 
production interaction. The simulation, then, continues running for the 
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secondary particles (electron and positron) until one of the four things 
mentioned earlier occurs. (2) For the electron, on the other hand, the CH 
technique is employed to transport the electron. Then, an inelastic collision 
(radiative interaction) with the atomic nucleus occurs, at which point the 
analog simulations method is used. Subsequently, the secondary particles 
(electron and bremsstrahlung photon) resulting from the inelastic collision 
are simulated in a manner similar to that for the secondary particles in (1). 
It should be noted that the particle trajectory shown in Figure 3.3 is an 
example given for an illustration purpose. However, the real particle 
trajectory is predicted by simulating a large number of histories, and is 
affected by various factors, mainly the particle type and energy and the 
medium of the interest. 
 
Figure 3.3: An example for the trajectory of a particle transported inside a medium 
using the analog simulations method and the second class of the CH technique. (r: 
the interaction site, ph: photon, CS: Compton scattering interaction, PP: pair 
production interaction, CH-technique: condensed history technique, brem ph: 
bremsstrahlung photon, and In-collision: Inelastic collision) 
 
3.5 Selection of a Monte Carlo Code to Simulate the OBI 
System  
With the evolution of computer technology, many general purpose MC codes 
have been developed for particles transport. One of the earliest codes 
written to transport particles using the MC technique was called SHOWER1 
code. This code was written by Nagel at Stanford Linear Accelerator Centre 
(SLAC) at Stanford University in the early-to-mid 1960s to transport high 
energy electrons. In addition, another code named ETRAN code was written 
by Berger and Seltzer in 1968 to transport electrons and photons. 
ph ph 
ph 
brem. ph 
(2) dr → r (1) (3) 
(4) 
e- 
e- 
e+ 
e- 
CS 
PP 
In-collision 
(4) 
Repeat 1-4 
Repeat 1-4 
CH-technique 
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Performance of the different codes written in the early days has improved 
remarkably over time, which has led to the use of the MC technique 
extensively to conduct accurate studies in various aspects of many different 
fields. Some of the general purpose codes were developed for a wide range 
of applications including medical physics for interactions of both low and 
high energies of different particles. 
At the present time, there are a number of codes that can be utilized for 
medical physics applications. For example, Electron Gamma Shower 
(EGSnrc) code from the National Research Council of Canada (NRC) 
(Kawrakow, 2000a, Kawrakow et al., 2013), Monte Carlo N-Particle (MCNP), 
which was originated from ETRAN code, and the extended version of MCNP 
(MCNPX) codes from Los Alamos National Laboratory (Team, 2008, Pelowitz, 
2008), GEANT4 code from an international collaboration (Agostinelli et al., 
2003), and Penetration and Energy Loss of Positrons and Electrons 
(Penelope) code from University of Barcelona (Salvat et al., 2011). The 
main difference between MCNP and MCNPX codes is in the type of particles 
they transport, where MCNPX has the ability to transport particles of all 
types. Many studies investigated the differences between these codes such 
as those conducted by (Faddegon et al., 2009, Maigne et al., 2011, 
Koivunoro et al., 2012, Archambault and Mainegra-Hing, 2015). 
As shown in Chapter 2 Table 2.2, MC played a major role in conducting many 
studies carried out with the OBI system. EGSnrc code was found to be the 
most popular code, where the majority of these studies employed EGSnrc 
code. This is due to the user codes based on EGSnrc such as BEAMnrc (Rogers 
et al., 1995) and DOSXYZnrc (Walters et al., 2013) codes, which were 
developed to be utilized in various areas of medical physics and are 
common in radiotherapy applications. Moreover, EGSnrc showed a good 
accuracy at low and high energies (Kawrakow, 2000b, Mainegra-Hing and 
Kawrakow, 2006, Ali and Rogers, 2007, Ali and Rogers, 2008). The other 
codes were also utilized for simulating the OBI system such as GEANT4 
(Brochu et al., 2014), and GATE code (Son et al., 2014), where GATE is a 
user code based on GEANT4 and commonly used for nuclear medicine 
applications (Jan et al., 2004, Jan et al., 2011, Sarrut et al., 2014). 
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Additionally, McMillan et al. (2013) and Poirier et al. (2014) used MCNPX 
and MCNP, respectively, for the OBI system. All the studies have shown 
good accuracy in evaluating results for the different codes at low energies. 
Therefore, any of the codes available can be utilized for simulating the OBI 
system. In this project, EGSnrc was used by utilizing different user codes 
based on EGSnrc (see section 3.7). 
3.6 EGSnrc 
As mentioned previously, SHOWER1 code was one of the first codes 
developed in the early 1960s by Nagel. Subsequently, Nicoli improved the 
code in 1966 and called it SHOWER2 code. This was followed by other 
improved versions SHOWER3/PREPRO code in 1972 and SHOWER4/SHINP 
code in 1974. Ford and Nelson continued to develop the code at SALC, and 
they re-named the code as Electron Gamma Shower (EGS1) in the mid 
1970s. This was followed by further improvements, and the new versions of 
the code were called EGS2 in 1975, and EGS3 in 1978 (Ford and Nelson, 
1978 ). In 1985, another version of EGS code (EGS4) was released in 
collaboration between Nelson from SALC, Rogers from NRC, and Hirayama 
from the High Energy Accelerator Research Organization in Japan (KEK) 
(Nelson et al., 1985). EGS4 code was then used extensively for a relatively 
long time. In 2000, Kawrakow at NRC developed EGS4 code and re-named 
it as EGSnrc code (Kawrakow, 2000a, Kawrakow, 2000b). Since then, EGSnrc 
code has been improved by NRC, and the last version of the code was 
EGSnrc V4 2.4.0 released in 2013, which was used in this project. Figure 3.4 
shows a summary for the development of EGSnrc code. 
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Figure 3.4: The development of EGSnrc code (Hirayama et al., 2005). 
 
SHOWER codes and subsequently EGS have been improved significantly over 
the time to transport electrons and photons in the range of a few keV up to 
several hundreds of GeV with a high level of accuracy (Kawrakow et al., 
2013). Initially, the different versions of SHOWER code and the early 
versions of EGS code were developed for shielding design for high energy 
particles. However, since 1985, the use of EGS4 code and after that EGSnrc 
code became more popular for medical physics applications. This is mainly 
due to the release of user codes used for medical physics applications such 
as studying an ionization chamber dosimetry and simulating a linear 
accelerator head (Rogers, 2006). 
SHOWER1 in early 1960s
SHOWER2 in 1966
SHOWER3/PREPRO in 1972
SHOWER4/SHINP in 1974
EGS1 in mid 1970s
EGS2 in 1975
EGS3 in 1978
EGS4 in 1985
EGSnrc in 2000
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3.7 EGSnrc-Based User Codes 
A number of user codes have been developed based on EGSnrc, each 
designed for a specific purpose. These codes have played a vital role in 
simplifying the use of the MC technique, by providing pre-coded routines. 
There has been further simplification in the development of friendly 
graphical user interfaces for some user codes, by which one can model a 
given geometry accurately. As a result, the use of EGSnrc-based user codes 
has increased and allowed large numbers of studies to be conducted based 
on simulations using the MC technique (Rogers, 2006). EGSnrc is a flexible 
code that allows a user to modify the user codes provided, if necessary, as 
well as creating a new user code if needed. In this project, three different 
user codes were used, namely BEAMnrc (Rogers et al., 1995, Rogers et al., 
2013b), DOSXYZnrc (Walters et al., 2013) and CAVRZnrc (Rogers et al., 
2013a).  
3.7.1 BEAMnrc 
BEAMnrc is considered to be one of the main user codes distributed with 
EGSnrc code. Originally, BEAMnrc was developed in collaboration between 
NRC and the University of Wisconsin in the early-mid 1990s in a 
collaborative project named Ottawa Madison Electron Gamma Algorithm 
(OMEGA) (Rogers et al., 1995). The aim of the project was to develop a 3D 
treatment planning system based on the MC technique using EGS4. Thus, 
the code was initially developed to model a linear accelerator head and to 
calculate 3D absorbed doses for patients undergoing radiotherapy 
treatment. Beside BEAMnrc, other codes were also developed such as 
DOSXYZnrc. These codes were made available publically for research and 
educational purposes. This has given medical physics researchers worldwide 
the opportunity to utilize the codes, and hence the increase of MC studies, 
especially in the radiotherapy field (Seco and Verhaegen, 2013). Currently, 
the user codes are based on EGSnrc, and are being improved continuously 
at NRC. 
The steps of running a simulation in BEAMnrc can be divided into three main 
steps: 
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Step1: Specifying the geometry, i.e. designing the system of interest. This 
step is the essential step, upon which the accuracy of the simulation is 
largely based. It requires the geometrical specifications of each component 
of the system to be obtained accurately. This includes material, dimensions 
in (x, y, z) directions, the position of each component inside the system, 
and so on. In most cases, such information can be obtained from the 
manufacturer. More than 20 pre-coded components known as component 
modules (CMs) were implemented in BEAMnrc to simplify modelling 
components of the system of interest with a high degree of accuracy. Each 
CM is utilized for a specific purpose, for example, CMs known as XTUBE and 
SLABS are used to simulate an x-ray target (anode) and a filter of a specific 
thickness and material, respectively. Also some CMs are used to model 
complex geometries such as DYNJAWS, which is utilized to simulate the 
dynamic jaws used during a radiotherapy treatment. 
All the geometrical data used for designing the system are then listed in an 
input file in (.egsinp) extension to be involved in the second step. This input 
file also contains information and parameters specified by the user for the 
simulation. For example, it includes the number of histories to be 
simulated, parameters of the variance reduction techniques (see 
section 3.8), values for PCUT and ECUT, and database names from which 
cross-section data are obtained. For instance, bremsstrahlung cross-section 
data can be obtained from Bethe-Heitler, the National Institute of 
Standards and Technology (NIST), or NRC.  
Step 2: Running the simulation. In this step, a set of files including the 
input file prepared by the user in the first step, the code files, and the data 
file in (.pegs4dat) extension containing the cross-section date, densities, 
mediums compositions, etc. for the system materials used in the first step 
are compiled. The data file is created from a stand-alone code PEGS4 
distributed with EGSnrc code (Kawrakow et al., 2006). This code allows the 
user to create a data file for all the materials involved in the simulation 
over a range of energies for photons and electrons. This range starts from 
the lower energy thresholds for creation of secondary electrons (AE) and 
photons (AP), and ends at the upper thresholds (UE) and (UP). These 
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thresholds are determined by the user, and typically AE and AP values are 
equated to ECUT and PCUT values, respectively. When all the files required 
are compiled successfully, the simulation begins to run.  
The simulation runs in BEAMnrc using one of more than 15 per-coded 
sources called source routines (ISOURCE). These sources are employed to 
determine the parameters of the incident beam, and it depends on the 
simulation type. For example, (ISOURCE = 10: Parallel Circular Beam 
Incident from Side), which was used in this project, is employed for x-ray 
tube simulations such as those used to simulate CT and CBCT scanners. This 
ISOURCE allows an electron beam with a given energy and diameter to hit 
the anode of the x-ray tube from the side at a specific angle. The ISOURCE 
is selected by the user in the first step, and is incorporated into the input 
file. The simulation could be run as a single job using a single computer, or 
it could be split into N jobs running in parallel, where each job is run by a 
separate computer simultaneously.  
Step 3: Collecting the simulation results. In most cases, outputs from the 
simulation are stored in a file called a phase space (PHSP) file. The PHSP 
file records information related to all the particles resulting from the 
simulation and passing a plane defined by the user at a specific distance 
from the source. This information includes the charge, the total energy, 
the position and the direction, the statistical weigh for each particle, and 
the position of the last interaction site for photons and creation of electrons 
by a photon moving in the z direction towards the target. Subsequently, 
the particles stored in the PHSP file are used as a source in another code 
to run another simulation such as DOSXYZnrc to calculate 3D absorbed dose. 
The PHSP file can also be analyzed by another code called BEAMDP to 
extract information from the PHSP file such as obtaining the spectrum 
resulting from the simulation (Ma and Rogers, 2013). 
Usually, the PHSP file has a large size, the order of Gigabytes, and this size 
depends on factors such as the number of histories, the beam diameter and 
energy, and geometry of the system. This means that the PHSP file requires 
a relatively large disk storage space in most cases. In the case of a lack of 
storage capacity, a shared library from BEAMnrc code is created. The shared 
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library allows making BEAMnrc the source for the simulation, and running 
another code such as DOSXYZnrc simultaneously without a need to record 
an intermediate PHSP file. However, this needs longer simulation time 
(Kawrakow and Walters, 2006, Bazalova et al., 2009), and it requires 
running a new simulation from BEAMnrc, if the simulation with the second 
code, DOSXYZnrc in this example, needs to be repeated. This is different 
from the use of a PHSP file, where the simulation is only repeated for the 
second code. Moreover, in some cases, the same PHSP file is used 
repeatedly in anther code under different conditions, such as for different 
phantoms in DOSXYZnrc for the same PHSP file. The differences between 
doses calculated with PHSP files and BEAMnrc (shared library) as sources 
were minimal at high energies (Kawrakow and Walters, 2006), but the use 
of PHSP files was 54 -1.6 times more efficient than using BEAMnrc as a 
source at low energies (Bazalova et al., 2009). Thus, recording a PHSP file 
is recommended, as this can overcome the need to run the same simulation 
in BEAMnrc each time, hence minimizing the time required for all 
simulations. Also, it increases the efficiency of the simulation. Therefore, 
the method of using the PHSP file as a source was employed in this project. 
For some simulations, however, neither a PHSP file nor using another code 
are required such as obtaining a depth dose curve in BEAMnrc using the CM 
CHAMBER. In this case, the simulation results are listed in a file in (.egslst) 
extension. Figure 3.5 shows the main steps used in this project to run a 
simulation in BEAMnrc. 
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  Specify a system   
     
  Compile and build the model   
     
-Input file (.egsinp) 
-Cross-section data 
file (.pegs4dat) 
 Run simulation   
     
  Simulation output  
-PHSP file 
-Output listing 
(.egslst) 
     
Figure 3.5: The main steps used in this project to run a simulation in BEAMnrc. 
 
3.7.2 DOSXYZnrc 
Beside BEAMnrc, DOSXYZnrc is also considered to be one the main user 
codes distributed with EGSnrc code. DOSXYZnrc calculates 3D absorbed 
dose in phantoms of simple geometries designed in the code or in complex 
geometries extracted from CT images. The geometries are obtained from 
CT images by converting the format (DICOM) to DOSXYZnrc format. This 
conversion is accomplished by using another code called CTCREATE 
(Walters et al., 2013). The geometry of a phantom designed in DOSXYZnrc 
or converted from CT images is divided into voxels of specific size. This 
means that DOSXYZnrc format is based on voxels. Subsequently, the 
absorbed dose at an area of interest is calculated from the voxels of this 
area. 
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The steps required for DOSXYZnrc simulations are similar to those followed 
in BEAMnrc (section 3.7.1). Figure 3.6 shows the main steps used in this 
project to run a simulation in DOSXYZnrc. 
     
-Input file (.egsinp) 
-Cross-section data 
file (.pegs4dat) 
   Source (PHSP file) 
     
  Compile the code files   
     
  Run simulation   
     
  Simulation output  
-Voxels values 
(.3ddose) 
-Output listing 
(.egslst) 
-Graphics 
(.egsphant) 
     
Figure 3.6: The main steps used in this project to run a simulation in DOSXYZnrc. 
 
In the first step, the input file is created by the user, and this file includes 
the geometry of the phantom including the size of the voxels. It also 
includes the source of the particles such as the PHSP file or BEAMnrc (shared 
library), and other parameters such as the number of histories and 
parameters of the variance reduction techniques (see section 3.8). In the 
second step, all files required for the simulation are compiled and the 
simulation begins to run using one of more than 10 pre-coded sources 
(ISOURCE). Similar to BEAMnrc, each ISOURCE works differently and 
depends on the simulation. For example, (ISOURCE = 2: Phase-Space Source 
Incident from Any Direction) delivers the particles from a PHSP file to a 
phantom from a specific direction and angle determined by the user, 
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whereas (ISOURCE = 8: Phase-Space Source Incident from Multiple 
Directions) delivers the particles from various directions at different angles 
determined by the user. In this step, the cross-section data for the phantom 
materials are also obtained from the data file. In the third step, DOSXYZnrc 
outputs are given in a file in (.3ddose) extension. The results can also be 
listed in the (.egslst) file. The (.3ddose) file is, then, analyzed by a code 
called STATDOSE (McGowan et al., 2013) or a specific code developed by 
the user such as a MATLAB code. DOSXYZnrc allows the user to output the 
phantom geometry in a file in (.egsphant) extension. This file can then be 
used with the (.3ddose) file to show the dose distribution inside the 
phantom using dosxyz_show code (Kawrakow, 2013).  
3.7.3 CAVRZnrc 
Simulations in CAVRZnrc code are run in a manner similar to those for 
DOSXYZnrc. CAVRZnrc is used to calculate various factors of interest related 
to an ionization chamber dosimetry such as the chamber response and 
correction factors for a chamber wall. CAVRZnrc simulates the cavity of an 
ionization chamber with a diameter of (r) and a length of (z) as well as the 
wall and electrode of the chamber. More than 15 pre-coded sources are 
implemented in CAVRZnrc, and they are used to simulate the source. 
Outputs of the simulations are given in a (.egslst) file. 
3.8 Variance Reduction Techniques 
As mentioned previously, the use of a large number of histories for a 
simulation assists in approaching the true value for the quantity of interest. 
This leads to a reduction in the statistical variance of the simulation, also 
known as the statistical uncertainty, and is estimated by: 
𝑆𝑆(𝑁𝑁) = �〈𝑓𝑓2(𝑁𝑁)〉 − 〈𝑓𝑓(𝑁𝑁)〉2
𝑁𝑁 − 1  (3.15) 
where 𝑁𝑁 is number of histories simulated, 𝑓𝑓 is value of the quantity of 
interest, and 〈𝑓𝑓(𝑁𝑁)〉 and 〈𝑓𝑓2(𝑁𝑁)〉 are mean values, calculated by using a 
method called “history-by-history” as: 
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 (3.16) 
where 𝑓𝑓𝑖𝑖 is calculated for each history (𝐷𝐷). 
The 𝑆𝑆(𝑁𝑁) value becomes virtually constant as the number of histories 
increases, where any increase above a specific number of histories leads to 
a very small change in 𝑆𝑆(𝑁𝑁). Such a value is desirable for any simulation. 
However, this comes at the cost of increasing the time required for the 
simulation. 
The efficiency (𝜀𝜀) for a given simulation is estimated by: 
𝜀𝜀 = 1
𝑆𝑆(𝑁𝑁)2 𝐶𝐶(𝑁𝑁) (3.17) 
where 𝐶𝐶(𝑁𝑁) is the time required to simulate 𝑁𝑁 histories. Thus, obtaining a 
small value for the statistical uncertainty 𝑆𝑆(𝑁𝑁) and minimizing the 
simulation time 𝐶𝐶(𝑁𝑁) are required to improve the efficiency of the 
simulation. Besides the use of ECUT and PCUT values, techniques called the 
variance reduction techniques (VRTs) are employed to speed up the 
simulation, and hence achieve a high efficiency for a simulation. Various 
VRTs were implemented in EGSnrc-based user codes. For example, four 
different VRTs are available in BEAMnrc code. One of these VRTs is called 
bremsstrahlung splitting, upon which three different techniques are based: 
uniform bremsstrahlung splitting (UBS), selective bremsstrahlung splitting 
(SBS), and directional bremsstrahlung splitting (DBS). Each VRT works 
differently. In this project, three VRTs were used namely DBS, photon 
splitting, and HOWFARLESS.  
3.8.1 Directional Bremsstrahlung Splitting 
The main concept behind the bremsstrahlung (brem) splitting technique is 
to increase the number of photons in the field of interest in order to 
minimize the 𝑆𝑆(𝑁𝑁) value and complete the simulation within a shorter time. 
To illustrate this technique, assume an electron is incident on the target of 
a system, and this electron interacts in the target and produces several 
brem photons, one of which is able to reach the field of interest and 
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contribute to the quantity of interest. This means that, approximately, 𝑋𝑋 
numbers of electrons are required to be simulated to produce 𝑋𝑋 number of 
brem photons that reach the field of interest. However, the electron may 
or may not produce brem photons. Moreover, the brem photon produced 
may or may not reach the field of interest. In the range of kV energies, only 
a relatively small number of brem photons are produced by the electrons. 
This is due to the low probability of brem photon emission in the kV range, 
being less than 10% and 5% for tungsten and molybdenum targets, 
respectively, at 100 keV, and less than 20% at 250 keV (Ali and Rogers, 
2007). Therefore, simulating a large number of electrons to increase the 
number of brem photons at the field on interest is required to gain a small 
𝑆𝑆(𝑁𝑁) value, which increases the simulation time. The splitting technique 
saves the time required for these transports by splitting brem photons 
produced by fewer electrons into many photons. This splitting can be made 
using one of three different techniques implemented in BEAMnrc UBS, SBS, 
or DBS. Comparison of these techniques has shown DBS to be the efficient 
technique at low and high energies (Kawrakow et al., 2004, Mainegra-Hing 
and Kawrakow, 2006). Mainegra-Hing and Kawrakow (2006) showed that 
DBS technique increases the efficiency of an x-ray simulation at kV energies 
up to 5 - 6 times compared to that for a simulation without a splitting 
technique and 60 times higher than a simulation with the UBS technique. 
Therefore, the DBS technique was employed in this project. DBS is not only 
employed for brem photons, but also used to split photons resulting from 
other interactions such as annihilation (Mainegra-Hing and Kawrakow, 
2006). 
In order to utilize the DBS technique for photon splitting, three main 
parameters should be provided by the user: (1) the splitting number 
(NBRSPL), (2) the radius of the field of splitting (FS), i.e. the field of 
interest, and (3) the source to surface distance (SSD) at the FS. When a 
photon is produced, DBS splits it into NBRSPL photons each of which is given 
a statistical weight of (𝑤𝑤 = 1/𝑁𝑁𝐶𝐶𝑁𝑁𝑆𝑆𝑃𝑃𝐿𝐿) in the final result. DBS, then, 
examines the split photons individually, and determines whether the 
photon is aiming inside or outside the FS specified by the user. If it is inside, 
the photon is kept and simulated with the given weight, and this photon is 
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called (non-fat) photon. However, for photons aiming outside the FS, a 
technique called Russian roulette is employed. This technique is considered 
as the opposite of the splitting technique. It is based on using a value known 
as a survival threshold, or a survival probability, equal to (1/𝑁𝑁𝐶𝐶𝑁𝑁𝑆𝑆𝑃𝑃𝐿𝐿), and 
a random number (𝜉𝜉) distributed uniformly in the range (0 - 1). If (𝜉𝜉 <1/𝑁𝑁𝐶𝐶𝑁𝑁𝑆𝑆𝑃𝑃𝐿𝐿), then the photon is kept and its weight is multiplied by NBRSPL 
to be (𝑤𝑤 = 1), and it is called a (fat) photon. However, If (𝜉𝜉 > 1/𝑁𝑁𝐶𝐶𝑁𝑁𝑆𝑆𝑃𝑃𝐿𝐿), 
the photon is terminated. If the surviving (fat) photons undergo interactions 
and produce secondary photons, the DBS technique is repeated for the 
secondary photons, and so on. By the end of the simulation, all the split 
photons reaching the field of interest are non-fat photons and have similar 
weight (𝑤𝑤 = 1/𝑁𝑁𝐶𝐶𝑁𝑁𝑆𝑆𝑃𝑃𝐿𝐿). The use of this technique means that the majority 
of the simulation time is spent on tracking the particles that contribute to 
the quantity of interest, and avoids wasting time in simulating the other 
particles. So the splitting technique saves the time required to simulate a 
large number of electrons to obtain many photons. Thus, the use of a VRT 
improves the efficiency of a simulation significantly. 
Figure 3.7 shows an example to illustrate the DBS technique and to show 
importance of the technique. In Figure 3.7 (a), four electrons are incident 
on a target. Two photons are resulted from these electrons, where one of 
the photons is aiming inside the FS, thus it contributes to the quantity of 
interest. This means that only a single photon is resulted from four 
electrons, which requires a long simulation time. However, if the DBS 
technique is used, larger number of photons are reaching the FS, and hence 
contribute to the quantity of interest within a shorter time and lower 
number of electros as shown in Figure 3.7 (b), where each photon is split 
to five photons (𝑁𝑁𝐶𝐶𝑁𝑁𝑆𝑆𝑃𝑃𝐿𝐿 = 5). 
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(a) (b) 
  
Figure 3.7: An example for a simulation (a) without and (b) with the DBS technique. 
(Ph: photon). 
 
3.8.2 Photon Splitting 
Photon splitting technique was implemented in DOSXYZnrc and CAVRZnrc 
codes. This technique has the same concept as that for the DBS technique. 
A user-defined splitting number (𝑛𝑛_𝑠𝑠𝑝𝑝𝑙𝑙𝐷𝐷𝑊𝑊) is used to split the photon 𝑛𝑛_𝑠𝑠𝑝𝑝𝑙𝑙𝐷𝐷𝑊𝑊 
times when it enters the DOSXYZnrc or CAVRZnrc geometry. Thus, split 
photons are given a weight of (𝑤𝑤 = 1/𝑛𝑛_𝑠𝑠𝑝𝑝𝑙𝑙𝐷𝐷𝑊𝑊). The use of DBS in BEAMnrc 
and photon splitting in DOSXYZnrc was found to increase the simulation 
efficiency by a factor of up to 6.5 and ~2 for high and low energies, 
respectively (Kawrakow and Walters, 2006, Bazalova et al., 2009). The 
encashment in the simulation efficiency showed dependencies on various 
factors such as beam energy and diameter, field size, and voxel size.  
3.8.3 HOWFARLESS 
The HOWFARLESS technique is only used in DOSXYZnrc code, and it is 
utilized for simulations carried out with phantoms made of a homogeneous 
medium (Walters and Kawrakow, 2007). As mentioned previously, phantoms 
used in DOSXYZnrc are formed of voxels of specific sizes. The phantom 
consists of outer boundaries, i.e. the phantom size, and inner boundaries, 
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i.e. the voxel size. When a charged particle is transported inside the 
phantom, its step is restricted to the inner boundaries. The charged particle 
is stopped at each boundary to calculate the dose deposited inside the voxel 
during its transport, and this increases the time required for the simulation 
remarkably. In order to overcome this, the HOWFARLESS technique is used. 
It is based on transporting the charged particle without a restriction to the 
inner boundaries, i.e. ignoring the voxels boundaries, and only considering 
the outer boundaries. Thus, the charged particle is transported in steps 
freely without the need to stop at each inner boundary. Subsequently, the 
dose deposited at each voxel is calculated by the HOWFARLESS algorithm 
using the total curved path, through which the charged particle travels 
inside the phantom. The HOWFARLESS technique is only used for charged 
particles and not employed for photons. This is because no dose is deposited 
as photons cross over voxels. Thus, the photon step is not restricted to the 
voxel boundaries. The HOWFARLESS technique has been shown to be 
dependent on different factors such as beam energy and the boundary 
crossing algorithm (BCA), which is used in EGSnrc-based user codes to 
control the transport of electrons. The simulation efficiency was found to 
increase by a factor of 2.9 – 5.4 when the HOWFARLESS technique was used 
with a BCA called EXACT, and by 51% – 89% with PRESTA-I BCA (Walters and 
Kawrakow, 2007).  
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Chapter 4  
Monte Carlo Modelling, Validation, and Calibration 
4.1 Introduction 
In the previous chapter, the theoretical aspects of the MC technique were 
discussed. The MC user codes used in this project and parameters employed 
for these codes were also presented. This chapter discusses the practical 
aspects concerning the use of the MC technique followed in this project. 
The chapter is divided into three main parts: (1) Modelling: this part 
discusses the method and component modules employed to model the OBI 
system. (2) Validation: this part presents the measurements carried out to 
validate the MC model designed in the first part. The validation tasks were 
(a) to validate the geometrical and beam properties of the model and (b) 
to validate dose calculations reported by the MC simulation for the 
quantities of interest. (3) Calibration: in this part, calibration factors were 
obtained to convert outputs of the MC results from Gy/incident particle to 
Gy. These factors were required for the study related to organ doses 
calculations reported in Chapter 9. 
4.2 Modelling of the OBI System 
The components of the OBI system were modelled in detail using BEAMnrc. 
The geometrical specifications of the system were obtained from the 
manufacturer under a non-disclosure agreement. Five component modules 
implemented in BEAMnrc, listed in Table 4.1, were utilized to model the 
system. Figures 4.1 - 4.2 show the model designed for the full-fan and half-
fan modes, respectively. 
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Table 4.1: Component modules and materials used to model the OBI system involved 
in this project. 
CM 
order 
Component modules 
of BEAMnrc 
Component of the 
OBI system Material 
1 XTUBE x-ray target (anode) 95% Tungsten and 5% Rhodium 
2 CONESTAK Tube window and inherent filter 
Beryllium and 
Aluminium 
3 PYRAMIDS Port Lead 
4 PYRAMIDS Primary collimator Lead 
5 JAWS Blades Lead and Steel 
6 SLABS Beam hardening filter Titanium 
7 PYRAMIDS Half and Full bowtie filters Aluminium 
8 SLABS Housing window Polycarbonate 
 
 
Figure 4.1: The MC model for the OBI system representing the full-fan mode with full 
bowtie filter. The model was designed using the CMs listed in Table 4.1. The 
dimensions are in cm. 
(1) 
(2) 
(3) 
(4) 
(5) 
(6) 
(7) 
(8) 
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Figure 4.2: The MC model for the OBI system representing the half-fan mode with half 
bowtie filter. The model was designed using the CMs listed in Table 4.1. The 
dimensions are in cm. 
 
4.3 Validation of the OBI System Model 
In order to validate the geometrical and beam properties of the MC models 
designed in BEAMnrc, shown in Figures 4.1 - 4.2, five experimental 
measurements namely (1) x-ray spectra, (2) half value layer (HVL), (3) 
lateral (in-plane), (4) axial (cross-plane) and (5) depth dose profiles were 
performed. Subsequently, results of these experiments were compared 
against MC results calculated under the same conditions. All the materials 
and cross sectional data used in the simulations were obtained from PEGS4 
code. 
(1) 
(2) 
(3) 
(4) 
(5) 
(6) 
(7) 
(8) 
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4.3.1 Experimental Measurements 
4.3.1.1 X-ray Spectra 
X-ray spectra were obtained from a MATLAB-based code SPEKTR (V2.1) 
(Siewerdsen et al., 2004). The SPEKTR code is based on experimental 
measurements obtained with parameters almost similar to those used for 
the OBI system. The code allows the user to generate an x-ray spectrum for 
a wide range of keV energies using filters of different materials and 
thicknesses. The x-ray spectra were generated for tube potentials 100 kV 
and 125 kV, which are used for the OBI scanning protocols listed in Table 2.1 
Chapter 2. The x-ray spectra were obtained with all the internal filters, 
except the bowtie filters, which cannot be model in SPEKTR due to their 
shapes (see Chapter 2 Figure 2.2). 
4.3.1.2 Measurements of HVL  
To examine the beam quality for the designed MC model, the HVL 
measurements were made in terms of air kerma using two tube potentials 
100 kV and 125 kV. The radiographic mode which allows the system to be 
operated with a stationary source was used to deliver a beam with a field 
of size 5 × 5 cm2 without a bowtie filter at a source-isocentre-distance (SID) 
of 100 cm. Different thicknesses of aluminium (Al) layers ranging from 0.5 
– 5.5 mm were applied to filter the beam. The Al thicknesses were 
incremented in steps of 0.5 mm over the full range studied, and by 0.1 mm 
or 0.2 mm in the region of the expected HVL. To minimize the effect of 
scattered radiation arising from the Al layers and the kV system housing, 
the Al layers were set up at a source-to-surface distance (SSD) of 65 cm. A 
plane parallel ionization chamber (Fluke model 96020C (150 CC), US) with 
a calibration traceable to a standard dosimetry laboratory was involved and 
placed at an SID of 100 cm as shown in Figure 4.3. An exponential curve 
from the measurements for each tube potential was, then, obtained, from 
which the HVL was estimated. 
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Figure 4.3: The experimental set up used for HVL measurements. 
 
4.3.1.3 Measurements of Dose Profiles 
Measurements for the lateral, axial, and depth dose profiles were used to 
validate the geometric design of the MC model. The dose profiles were 
measured by using two settings: 100 kV with the full bowtie filter and 125 
kV with the half bowtie filter. The measurements were made within a 30 × 
30 × 30 cm3 solid water phantom (Gammex, Middleton, WI, US) using sheets 
of Gafchromic film (International Specialty Products—Advanced Materials, 
New Jersey, US) XR-QA model (lot No. 10121202). The dose profiles 
measurements were completed in two stages:  
Stage 1: Calibration of the Gafchromic film. XR-QA model is manufactured 
to be used at low energies in the range of 20 – 200 kV. It consists of a 25 
μm thick active layer with sensitivity ranges from 1 – 200 mGy. The film 
was calibrated using a local calibration protocol, which was described in 
(Martin et al., 2011). A Gulmay superficial x-ray therapy unit operated at 
110 kV was used to calibrate the film. This tube potential gives a calibration 
curve almost similar to those for 100 kV and 125 kV (Giaddui et al., 2012). 
At the beginning, a number of measurements were made to determine the 
SID = 100 cm 
Chamber 
Al holder 
65 cm 
35 cm 
kV source 
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dose values corresponding to the monitor unit (MU) settings at the position 
used for the film exposure as shown in Figure 4.4. 20 pieces of the film with 
a size of 2 x 2 cm2 were exposed to doses ranging from 0.27 to 197.6 mGy. 
The film pieces were left for 24 hours after the exposure process to allow 
the optical density (OD) of the film to reach equilibrium status. 
 
Figure 4.4: The experimental set up used to calibrate the Gafchromic film. 
 
Subsequently, an Epson V700 flatbed colour scanner was employed to scan 
the 20 exposed pieces and a single unexposed piece using the reflection 
mode at 72 dpi resolution as shown in Figure 4.5. Images of the scanned 
pieces were saved in (.tiff) format so that they could be analyzed using 
ImageJ software. The red channel of the software was selected, and a 
macro built in house was used to automatically select a region of interest 
(ROI) with a size of 1 x 1 cm2 at the centre of each piece of film. The ROIs 
selected were, then, analysed to obtain the red pixel value (RPV) for each 
piece. 
  
Chamber Film pieces 
kV source 
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0.27 1.60 4.23 7.78 12.73 
6 7 8 9 10 
 
18.89 28.41 41.08 44.42 50.59 
11 12 13 14 15 
 
60.06 72.66 89.41 102.13 121.13 
16 17 18 19 20 
 
146.59 159.7 178.80 191.38 197.60 
  Unexposed   
  
 
  
  0   
Figure 4.5: The 21 film pieces scanned with Epson V700 flatbed colour scanner. Doses 
used to calibrate the film ranged from 0.27 - 197.6 mGy.  
 
The RPV values were used to calculate the OD for each piece as follows: 
𝑂𝑂𝐷𝐷 = 𝑙𝑙𝑜𝑜𝑙𝑙10 �𝑁𝑁𝑃𝑃𝑅𝑅𝑢𝑢𝑝𝑝𝑊𝑊𝑥𝑥𝐸𝐸𝑣𝑣𝑢𝑢𝑊𝑊𝑢𝑢𝑁𝑁𝑃𝑃𝑅𝑅𝑊𝑊𝑥𝑥𝐸𝐸𝑣𝑣𝑢𝑢𝑊𝑊𝑢𝑢 � (4.1) 
ImageJ was used to obtain a curve fit for the dose values used in Gulmay 
and the corresponding OD values calculated in Eq.(4.1). The curve was 
fitted using the Rodbard function, which is defined as: 
𝑦𝑦 = 𝑑𝑑 + (𝑊𝑊 − 𝑑𝑑)/ �1 + �𝑥𝑥
𝑛𝑛
�
𝑏𝑏
� (4.2) 
where a, b, c, and d are parameters of the fitted curve. Thus: 
77 
 
 
𝑂𝑂𝐷𝐷 = 𝑑𝑑 + (𝑊𝑊 − 𝑑𝑑)/�1 + �𝐷𝐷𝑜𝑜𝑠𝑠𝐷𝐷
𝑛𝑛
�
𝑏𝑏
� (4.3) 
which leads to 
𝐷𝐷𝑜𝑜𝑠𝑠𝐷𝐷 = 𝑛𝑛 × �� 𝑊𝑊 − 𝑑𝑑
𝑂𝑂𝐷𝐷 − 𝑑𝑑
� − 1�1 𝑏𝑏�  (4.4) 
 
Stage 2: Performing dose profile measurements. Once the film was 
calibrated, a sheet of film was cut into strips of size 3 × 30 cm2 and 3 × 15 
cm2. The fluoroscopy mode was employed for all the measurements to 
deliver a continuous beam for 5 - 6 minutes to minimize fluctuations that 
may arise from the different responses of film from low exposure times. 
For the lateral and axial dose profiles, the solid water phantom was set up 
at an SSD of 100 cm, and the strips were placed at a depth of 0.5 cm inside 
the phantom along the x-axis for the lateral profiles and along the y-axis 
for the axial profiles as shown in Figure 4.6 (a - b). In order to ensure that 
the beam widths used in the MC calculations were set up properly by the 
MC model, a lateral dose profile and four axial dose profiles of different 
beam widths were measured for each setting. A field of size 280 × 280 mm2 
was used for the lateral dose profile, while 280 × 20 mm2, 280 × 100 mm2, 
280 × 198 mm2, and 280 × 280 mm2 were used for the axial dose profiles. 
The film strips of size 3 × 15 cm2 were employed for the beams of width 20 
mm and 100 mm, and the strips 3 × 30 cm2 for 198 mm and 280 mm. 
For the depth dose profiles, the kV source was moved 90°, and a film strip 
with a size of 3 × 30cm2 was placed parallel to the beam at a depth of 15 
cm inside the phantom along the z-axis. The film strip was centred within 
a field of size 280 × 280 mm2 at an SSD of 100 cm as shown in Figure 4.6 (c 
- d) (Fletcher and Mills, 2008). After the exposure, all the strips were left 
for more than 24 hours to reach the equilibrium status. The strips were, 
then, analyzed in a manner similar to that described in the first stage. Once 
the OD values were obtained, dose profiles for the strips were calculated 
using the calibration curve as in Eq.(4.4). 
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(a) (b) 
 
 
(c) (d) 
 
 
Figure 4.6: The experimental set up for (a - b) axial and lateral dose profiles 
measurements, and (c - d) for depth dose profiles. 
 
4.3.2 Monte Carlo Simulations 
The five measurements described in the previous section were calculated 
in MC through two steps: First, PHSP files were generated from BEAMnrc, 
and second, the files generated were utilized to obtain x-ray spectra using 
BEAMDP, HVL values using CAVRZnrc, and lateral, axial, and depth dose 
profiles using DOSXYZnrc. All these quantities were calculated using the 
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same parameters and set up used for the experimental measurements. In 
this project, almost all the MC simulations were run in the Scottish Grid 
Service (ScotGrid) at the University of Glasgow. 
4.3.2.1 PHSP Files from BEAMnrc 
The parameters used to generate the PHSP files from BEAMnrc were the 
same for all the different experiments, apart from three parameters: the 
number of histories, the SSD, at which the PHSP file is stored, and the field 
size for the beam. These parameters depended on the experiment type, 
thus they are given in the relevant sections. The DBS technique with a 
splitting number NBRSP of 1 - 2 × 104 were employed for all simulations 
(Ding and Coffey, 2010). ISOURCE = 10 of BEAMnrc (Parallel Circular Beam 
Incident from Side) was selected to allow an electron beam with a diameter 
of 0.4 mm or 1 mm to hit the anode of the OBI system from the side at an 
angle of  14⁰. The electron beam was specified as a mono-energetic beam 
of energies either 100 keV or 125 keV. The low energy thresholds for 
creation of secondary electrons (AE) and photons (AP) were set to 0.516 
MeV and 0.001 MeV, respectively, and these values were also set to the cut-
off energies for transport of electrons (ECUT) and photons (PCUT) (Ding and 
Munro, 2013). The default boundary crossing algorithm (EXACT) and 
electron step algorithm (PRESTA-II) were used. Spin effect, the electron 
impact ionization, Rayleigh scattering, and atomic relaxations were 
included in the simulations (Ding and Coffey, 2010). The cross-section data 
of the National Institute of Standards and Technology (NIST) was used for 
bremsstrahlung cross sections, Koch–Motz for bremsstrahlung angular 
sampling, and NIST XCOM for photon cross sections (Mainegra-Hing and 
Kawrakow, 2006). The default cross-section data for all other interactions 
were used. 
4.3.2.2 Calculations of X-ray Spectra  
8 × 108 histories were run in BEAMnrc with a field of size 50 × 50 cm2 without 
the bowtie filters and with the presence of the internal filters. Two PHSP 
files for energies 100 kV and 125 kV were recorded at an SID of 100 cm. 
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These files were, then, analyzed by BEAMDP to acquire x-ray spectra for 
the two simulations. 
4.3.2.3 Calculations of HVL  
The HVL calculation for the MC model was accomplished by calculating the 
dose in an air cavity using CAVRZnrc (Ding et al., 2007, Kim et al., 2012). 
First, 1 × 109 histories with a field of size 5 × 5 cm2 were run in BEAMnrc for 
tube potentials 100 kV and 125 kV. PHSP files for the simulations were 
recorded at an SSD of 65 cm, similar to the experimental set up. Second, 
the plane parallel ionization chamber used in the experimental 
measurements was modelled in CAVRZnrc using specifications of the 
chamber obtained from the manufacturer. The PHSP files were used to run 
2 - 3 × 107 histories using a photon splitting number 100 and source No. 22 
of CAVRZnrc (Full Beam Phase-Space Beam Data from Any Angle, Inside or 
Outside). Al layers of thicknesses 0.5 – 6 mm with an increment of 0.5 mm 
were utilized. The designed chamber was placed at an SID of 100 cm, and 
the dose for each Al thickness was calculated with a statistical uncertainty 
of less than 1%. The HVL value for each tube potential was estimated by 
fitting the resulting values obtained from CAVRZnrcn to exponential curves. 
4.3.2.4 Calculations of Dose Profiles 
The MC dose profiles were derived by DOSXYZnrc using the experimental 
set up shown in Figure 4.6. First, 8 PHSP files (four for each setting 
described in section 4.3.1.3) were recorded in BEAMnrc at an SID of 100 cm 
using 1 × 109 histories. Second, the PHSP files were used as sources in 
DOSXYZnrc to calculate the absorbed dose inside the phantom by using 
ISOURCE = 2 of DOSXYZnrc (Phase-Space Source Incident from Any 
Direction). The solid water phantom used in the experimental 
measurements was designed in DOSXYZnrc as a cube of size 30 × 30 × 30 
cm3 and consisted of voxels of size 0.5 × 0.5 × 0.5 cm3. 5 × 108 histories 
with a photon splitting number 50 - 300 were used for all simulations to 
achieve a statistical uncertainty of less than 2% in the voxels of interest 
(Bazalova et al., 2009). The same ECUT and PCUT values used in BEAMnrc 
were also involved in DOSXYZnrc. The HOWFARLESS technique together 
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with the default boundary crossing algorithm (PRESTA-I) were utilized to 
enhance the efficiency of the simulations. The output files were in 
(.3ddose) format, which were analyzed subsequently by STATDOSE. 
4.3.3 Results 
4.3.3.1 Comparison of X-ray Spectra 
Figure 4.7 shows a comparison between x-ray spectra for 100 kV and 125 
kV generated by the MC model, which were obtained at an SID of 100 cm 
with a field of size 50 × 50 cm2, and those generated by Spektr code. For 
all spectra, the number of photons at each tube potential was normalized 
with respect to the number of photons at the characteristic energy. The 
comparisons show good agreement between the spectra. 
(a) 
 
(b) 
 
Figure 4.7: A comparison between the x-ray spectra of the MC model and Spektr 
normalized with respect to the number of photons at the characteristic energy. (a) 100 
kV and (b) 125 kV. 
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4.3.3.2 Comparison of HVL Values 
Figure 4.8 shows a comparison between the MC and the experimental 
results for the HVL experiment. The HVL values calculated in MC were 3.84 
mm Al and 4.89 mm Al for 100 kV and 125 kV, respectively. These values 
were within 0.05 mm of the respective experimental measurements 3.79 
mm Al and 4.90 mm Al, respectively. The HVL values for the MC model 
agreed with the experimental measurements to within 1.3% for 100 kV and 
0.41% for 125 kV. 
 
Figure 4.8: A comparison between the ratios of the dose in the air cavity with Al 
thicknesses (0.5 – 6.0) mm to the dose in the air cavity without a filter calculated with 
CAVRZnrc and those measured experimentally (Exp) at tube potentials 100 kV and 
125 kV. 
 
4.3.3.3 Comparison of Dose Profiles 
Figure 4.9 shows the calibration curve for the Gafchromic film. The lateral, 
axial, and depth dose profiles obtained from the MC in terms of absorbed 
dose to the phantom showed good agreement with the experimental 
measurements as shown in Figures 4.10 - 4.11. The dose values for the 
profiles were normalized with respect to the central value, while those for 
the depth dose profiles were normalised to the dose at a depth of 1 cm. 
The lateral dose profiles (Figures 4.10 (a) - 4.11 (a)) were used to validate 
the geometrical design of the full and half bowtie filters, respectively. The 
lateral dose profiles of the MC for both settings matched to the 
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experimental measurements to within ±2.3%. Figures 4.10 (b) - 4.11 (b) 
show the comparison between the axial dose profiles for different beam 
widths. The MC and the experimental axial profiles agreed within 3 – 5%, 
on average, for both settings, but a larger variation was found at the tails 
of the narrower beam width (20 mm) profiles. Such variations are likely to 
be caused by the accuracy of blade collimation for narrower beam widths 
(Varian, 2010). The depth dose profiles for the energies 100 kV and 125 kV 
obtained from the MC model (Figures 4.10 (c) - 4.11 (c)) were within ±2.2% 
and ±2.9% of the experimental measurements, respectively. 
 
 
Figure 4.9: The calibration curve for the Gafchromic film used in this project calibrated 
at tube potential of 110 kV. 
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(a) 
 
(b) 
 
(c) 
 
Figure 4.10: A comparison between dose profiles of the MC and the experimental 
measurements made within a solid water phantom with film using 100 kV and the full 
bowtie filter (FBF). (a) The lateral dose profiles, (b) the axial dose profiles for the 
beams of width 20, 100, 198, and 280 mm, and (c) the depth dose profiles. 
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(a) 
 
(b) 
 
(c) 
 
Figure 4.11: A comparison between dose profiles of the MC and the experimental 
measurements made within a solid water phantom with film using 125 kV and the half 
bowtie filter (HBF). (a) The lateral dose profiles, (b) the axial dose profiles for the 
beams of width 20, 100, 198, and 280 mm, and (c) the depth dose profiles. 
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4.4 Validation of Monte Carlo Dose Calculations 
The previous section shows the measurements made to validate the 
geometrical and beam properties for the MC model. In this section, further 
validations for four dose measurements were performed. These 
measurements were made to ensure accuracy of the dose calculations 
reported by the MC for the quantities of interest. The four dose 
measurements (1) CTDI100, (2) 𝑓𝑓(0,150), and (3) dose distributions within 
the standard PMMA phantoms, and (4) CTDIFIA free in air were performed 
experimentally using pencil and small ionization chambers and Gafchromic 
film. Results of these measurements were subsequently compared to the 
MC results calculated under the same conditions and parameters. All the 
measurements performed experimentally and results calculated in the MC 
were obtained using the clinical beam width of 198 mm. 
4.4.1 Experimental Measurements 
4.4.1.1 Measurements of CTDI100 
Two scanning protocols (head and body) were used to measure CTDI100 
within the standard PMMA phantoms: (1) The head protocol called (Head-
200): 100 kV, full bowtie filter, and 200° rotation, and (2) the body protocol 
called (Body-360): 125 kV, half bowtie filter, and 360° rotation. The 
measurements were carried out with a 100 mm pencil ionization chamber 
(Radcal, 20X6-3CT, US) with a calibration traceable to a standard dosimetry 
laboratory. The CTDI100 values were measured at the middle of each 
phantom in the central and peripheral positions, with the phantoms placed 
at an SID of 100 cm. As measurement of CTDI100 and 𝑓𝑓100(150) are obtained 
in a similar manner, the CTDI100 validation was used to cover the validation 
required for 𝑓𝑓100(150). 
4.4.1.2 Measurements of CTDIFIA 
The CTDIFIA measurements were made free in air using the same scanning 
protocols used for CTDI100 measurements Head-200 and Body-360. 
Moreover, the CTDIFIA measurements were obtained using the same pencil 
chamber. The practical technique described in Chapter 2 section 2.6.5, 
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which requires stepping the chamber across the beam width in specific 
intervals, was employed. An integration of length 300 mm was required to 
cover the beam width 198 mm, thus the chamber was moved in three steps 
at the isocentre (IAEA, 2011). Additional experimental measurements for 
CTDIFIA were made at the peripheral positions free in air to validate the MC 
calculations. The 100 mm ionization chamber was set up at 15 cm away 
from the isocentre for the body protocol and at 7 cm for the head protocol. 
It should be noted that these measurements are not required for the QA 
procedure using the IEC method, but they have been performed for the 
purpose of the validation. 
4.4.1.3 Measurements of 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎) 
Fours scanning protocols were used for 𝑓𝑓(0,150) measurements: (1) Head-
200 and (2) Body-360, which are similar to those used for CTDI100 
measurements, additionally (3) Head-360: 100 kV, full bowtie filter, and 
360° rotation, and (4) Body-200: 125 kV, full bowtie filter, and 200° 
rotation. Measurements for 𝑓𝑓(0,150) were taken with a 0.6 cm3 Farmer-
type ionization chamber (10X5-0.6CT, Radcal Corporation, US) with a 
calibration traceable to a standard dosimetry laboratory within the 
standard PMMA phantoms set up at an SID of 100 cm. 𝑓𝑓(0,150) 
measurements were made at the middle of each phantom on the central 
and four peripheral axes. 
4.4.1.4 Measurements of Dose Distributions 
The experimental measurements for dose distributions at the centre of the 
standard PMMA phantoms were obtained for all the four scanning protocols 
employed for 𝑓𝑓(0,150) measurements. The phantoms were set up at an SID 
of 100 cm, and four film strips of size 1 × 15 cm2 (i.e. a film strip for each 
scanning protocol) were inserted into the central hole of the phantom. In 
order to avoid an air gap resulting from removal of the central PMMA rod 
from the phantoms, a PMMA rod was cut in half along its length so that the 
film strips could be inserted in a PMMA sandwich during the measurements 
as shown in Figure 4.12. The resulting profiles were, then, compared 
against MC profiles derived within PMMA phantoms. 
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Figure 4.12: A PMMA rod 15 cm in length was used to measure dose distributions at 
the centre of the standard PMMA head and body phantoms using film strips of size 1 
× 15 cm2.  
 
4.4.2 Monte Carlo Simulations 
MC results for the four experiments were calculated in a manner similar to 
that used for validation of the MC modelling presented in section 4.3.2. 
PHSP files were generated from BEAMnrc using the same parameters given 
in section 4.3.2.1. All the experiments were calculated by DOSXYZnrc using 
the PHSP files. For all the simulations, the same ECUT and PCUT values used 
in BEAMnrc were also involved in DOSXYZnrc. Additionally, the HOWFARLESS 
transport algorithm and the PRESTA-I boundary crossing algorithm were 
used to enhance the efficiency of the dose calculation. The PHSP files were 
recorded at an SSD of 75 cm, which were run subsequently using ISOURCE 
= 8 (Phase-Space Source Incident from Multiple Directions) of DOSXYZnrc. 
The distance between the source, i.e. the PHSP files, and the isocentre was 
set to 25 cm as shown in Figure 4.13. The steps and parameters used in MC 
to calculate results of the four experiments were similar in all the 
simulations. 
  
PMMA rod 15 cm 
Film strip 
1 × 15 cm2 
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(a) (b) 
 
 
Figure 4.13: An illustration of the steps used to calculate the absorbed dose within 
the PMMA head and body phantoms using BEAMnrc and DOSXYZnrc. (a) Represents 
the steps employed to simulate scanning protocols with a 360° rotation and (b) 200° 
rotation. 
 
4.4.2.1 Calculations of CTDI100, 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎), and Dose Distributions 
1 × 109 histories were run in BEAMnrc for the four scanning protocols Head-
200, Head-360, Body-200, and Body-360 using the same parameters 
employed for experimental measurements to generate PHSP files. This step 
was followed by designing two PMMA phantoms with a density of 
(ρ = 1.19  g/cm3) in DOSXYZnrc to calculate CTDI100 and 𝑓𝑓(0,150) values, 
and to derive the dose distributions along the central axes of the phantoms. 
The phantoms were simulated using voxels of different sizes 0.5 × 0.5 × 0.5 
cm3 at the centre and periphery of the phantoms and larger voxels at the 
different sites. The use of this technique results in minimizing the time for 
the simulations carried out with a homogenous phantom by more than a 
factor of three without affecting the dose accuracy (Babcock et al., 2008). 
2.4 - 3 × 108 histories with a photon splitting number set to 100 - 300 were 
run in DOSXYZnrc to obtain a statistical uncertainty of less than 2%.  
4.4.2.2 Calculations of CTDIFIA 
Parameters used to calculate CTDIFIA values in DOSXYZnrc were similar to 
those used for dose calculations within the phantoms (section 4.4.2.1). 
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However, CTDIFIA values were calculated free in air by simulating a pencil 
chamber with a length of 300 mm instead of the phantoms shown in 
Figure 4.13. In addition to calculations at the isocentre, CTDIFIA values were 
also calculated at 15 cm away from the isocentre for the body protocol and 
at 7 cm for the head protocol in a manner similar to those obtained 
experimentally. 
4.4.3 Results 
4.4.3.1 Comparison of CTDI100 and CTDIFIA 
Table 4.2 shows a comparison between CTDI100 and CTDIFIA values measured 
experimentally using a beam of width 198 mm against those obtained from 
the MC. The results were normalised with respect to the CTDIFIA value at 
the isocentre for each protocol. The average variations between the MC 
and experimental values using the scanning protocols Body-360 and Head-
200 were ±2.9% and ±5.8%, respectively.  
Table 4.2: A comparison between the MC values and experimental measurements 
(Exp) for CTDI100 and CTDIFIA for the scanning protocols Body-360 and Head-200 
normalised with respect to the CTDIFIA at the isocentre. (p) indicates measurements at 
the periphery as shown in Figure 4.13. 
 Body-360 Head-200 
 CTDIFIA CTDI100 CTDIFIA CTDI100 CTDIFIA CTDI100 CTDIFIA CTDI100 
 Exp MC Exp MC 
Centre 1.00 0.099 1.00 0.091 1.00 0.297 1.00 0.256 
p 0° 0.307 0.143 0.316 0.142 0.608 0.113 0.589 0.117 
p 90° 0.312 0.144 0.319 0.142 0.663 0.273 0.665 0.244 
p 180° 0.296 0.141 0.315 0.142 0.616 0.433 0.615 0.384 
p 270° 0.297 0.144 0.318 0.144 0.663 0.317 0.661 0.301 
Avg. p 0.302 0.143 0.317 0.143 0.637 0.284 0.632 0.261 
CTDIw 0.535 0.129 0.545 0.125 0.758 0.292 0.755 0.258 
 
The larger differences in the head protocol are thought to occur because 
the LINAC couch was not included in the simulations. This omission may 
have a greater impact on the results for the lower attenuation head 
phantom, and the differences between the experimental and MC results 
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will be enhanced by the lower tube potential (100 kV) employed for head 
scans. 
4.4.3.2 Comparison of 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎) 
Table 4.3 shows a comparison between 𝑓𝑓(0,150) values measured 
experimentally and those obtained from the MC simulations. The values for 
the body protocols (Body-200 and Body-360) were normalized with respect 
to the central value of Body-200, and values for the head protocols were 
normalized with the respect to the central value of Head-200. The MC 
values for the body phantom were in good agreement with the experimental 
measurements, where the average differences for Body-200 and Body-360 
were ±0.9% and ±0.8%, respectively. However, larger variations were also 
observed for the head protocols, for which the average differences were 
±1.1% for Head-200 and ±4.1% for Head-360.  
Table 4.3: A comparison between the MC results for 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎) and experimental 
measurements (Exp) made within the standard PMMA phantoms using the scanning 
protocols Body-200, Body-360, Head-200, and Head-360, and a beam of width 198 mm. 
p indicates measurements at the periphery as shown in Figure 4.13. 
 Body-200 Body-360 Head-200 Head-360 
 Exp MC Exp MC Exp MC Exp MC 
Centre 1.00 1.00 0.86 0.85 1.00 1.00 1.06 1.10 
p 0° 0.10 0.10 1.20 1.22 0.38 0.34 0.99 1.01 
p 90° 1.30 1.30 1.20 1.20 0.87 0.84 0.96 1.01 
p 180° 2.38 2.43 1.19 1.22 1.36 1.41 0.95 0.99 
p 270° 1.95 1.98 1.21 1.22 1.04 1.07 0.96 1.01 
Avg. p 1.43 1.45 1.20 1.21 0.91 0.90 0.96 1.01 
𝑓𝑓(0,150)𝑤𝑤 1.29 1.30 1.09 1.10 0.94 0.94 0.99 1.03 
 
4.4.3.3 Comparison of Dose Distributions 
Figures 4.14 - 4.15 compare dose distributions derived from the MC model 
and experimental measurements performed at the centre of the standard 
PMMA phantoms set up at an SID of 100 cm. The dose values for all the 
profiles were normalized with respect to the central value at (𝑧𝑧 = 0). The 
dose distributions obtained with Head-200 and Head-360 (Figure 4.14) were 
within ±1.7% and ±2.4% of the experimental profiles, respectively, while 
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Body-200 and Body-360 (Figure 4.15) were within ±2.1% and ±2.5%, 
respectively. 
(a) 
 
(b) 
 
Figure 4.14: A comparison between dose distributions derived from MC simulations 
and those measured experimentally for the scanning protocols: (a) Head-200 and (b) 
Head-360. 
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(a) 
 
(b) 
 
Figure 4.15: A comparison between dose distributions derived from MC simulations 
and those measured experimentally for the scanning protocols: (a) Body-200 and (b) 
Body-360. 
 
4.5 Calibration of the Monte Carlo 
The majority of the studies conducted in this project used relative dose 
values. However, absolute absorbed dose values were necessary for organ 
doses calculations. The MC user codes utilized in this project report dose 
values in (Gy/incident particle). Therefore in order to evaluate the 
absorbed dose for each organ and tissue in (Gy), the MC model developed 
in section 4.2 was calibrated to obtain a calibration factor (𝐹𝐹𝑃𝑃𝑀𝑀), which 
converts the MC output to (Gy). The calibration method followed in this 
project was described by (Qiu et al., 2012) as: 
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𝐹𝐹𝑃𝑃𝑀𝑀  =  𝐷𝐷𝑃𝑃𝑥𝑥𝐸𝐸𝐷𝐷𝑃𝑃𝑀𝑀 × 𝑚𝑚𝑃𝑃𝑠𝑠 (4.5) 
where 𝐷𝐷𝑃𝑃𝑀𝑀 is absorbed dose calculated in MC, and 𝐷𝐷𝑃𝑃𝑥𝑥𝐸𝐸/𝑚𝑚𝑃𝑃𝑠𝑠 is absorbed 
dose measured experimentally in Gy per 1 mAs, thus 𝐹𝐹𝑃𝑃𝑀𝑀 is defined in 
(incident particle/mAs). 𝐷𝐷𝑃𝑃𝑥𝑥𝐸𝐸  and 𝐷𝐷𝑃𝑃𝑀𝑀 are required to be determined using 
the same parameters and conditions. 
4.5.1 Experimental Measurements 
Experimental measurements for 𝐷𝐷𝑃𝑃𝑥𝑥𝐸𝐸 were made in terms of absorbed dose 
to water based on the Institute of Physics and Engineering in Medicine 
(IPEM) code of practice (Klevenhagen et al., 1996, Aukett et al., 2005) as: 
𝐷𝐷𝑤𝑤,𝑧𝑧=2 = 𝑃𝑃 𝑁𝑁𝑘𝑘  𝑘𝑘𝑐𝑐ℎ  ��𝜇𝜇𝑊𝑊𝑝𝑝�����𝜌𝜌 �𝑤𝑤/𝑊𝑊𝑖𝑖𝑊𝑊�𝑧𝑧=2,𝜑𝜑 (4.6) 
where 𝐷𝐷𝑤𝑤,𝑧𝑧=2 is the absorbed dose to water at a depth of 2 cm, 𝑃𝑃 is the 
chamber response in coulombs (C) corrected for air temperature and 
pressure, 𝑁𝑁𝑘𝑘 is the air kerma calibration factor for the chamber employed 
in (Gy/C), 𝑘𝑘𝑐𝑐ℎ is a correction factor which accounts for the difference 
between the chamber response in air and inside the water phantom, and 
��
μen�����
ρ
�
w/air
�
z=2,φ
 is the mass energy absorption coefficient ratio water to air 
averaged over the photon spectrum at a depth of 2 cm within the water 
phantom using a field of diameter 𝜑𝜑. 𝐷𝐷𝑃𝑃𝑥𝑥𝐸𝐸  was measured at a depth of 2 
cm within a 30 × 30 × 20 cm3 solid water phantom (Gammex, Middleton, 
WI, US) set up at an SSD of 100 cm using a Farmer ionization chamber 
NE2611A calibrated at the National Physical Laboratory (NPL) in the UK for 
energies in the kV range. The measurements were performed with a 
stationary kV source using a field of size 10 × 10 cm2 at an SSD of 100 cm. 
Two protocols were used (Head: 100 kV and full bowtie filter) and (Body: 
125 kV and half bowtie filter). The measurements were repeated three 
times using 1000 mAs/reading for each protocol, and the average reading (𝑃𝑃) was subsequently normalized with the respect to the mAs used for the 
measurements to obtain (C/mAs). 𝑁𝑁𝑘𝑘 values were provided in the 
calibration certificate for the beam qualities specified in terms of half 
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value layer (HVL), whereas values for 𝑘𝑘𝑐𝑐ℎ and the mass energy absorption 
coefficient ratio were obtained from the code of practice (Klevenhagen et 
al., 1996). 
4.5.2 Monte Carlo Simulations 
The same parameters and conditions, under which 𝐷𝐷𝑃𝑃𝑥𝑥𝐸𝐸  values were 
measured, were used in the MC calculations to calculate 𝐷𝐷𝑃𝑃𝑀𝑀 values. First, 
the validated BEAMnrc model was used to run two simulations for the two 
protocols used for 𝐷𝐷𝑃𝑃𝑥𝑥𝐸𝐸  with 1 × 109 histories using the same MC parameter 
given in section 4.3.2.1. Outputs of the simulations were recorded in PHSP 
files at an SSD of 100 cm. The resulting PHSP files were, then, employed as 
sources in DOSXYZnrc using ISOURCE = 2 of the code. The same solid water 
phantom was designed in DOSXYZnrc, and 3 × 108 histories with a photon 
splitting number set to 100 were run to calculate 𝐷𝐷𝑃𝑃𝑀𝑀 values at a depth of 
2 cm with a statistical uncertainty of ≤ 0.2%. The HOWFARLESS transport 
algorithm and the default boundary crossing algorithm (PRESTA-I) were 
utilized 
4.5.3 Results 
Table 4.4 shows the values for the average 𝐷𝐷𝑃𝑃𝑥𝑥𝐸𝐸 measured experimentally 
and 𝐷𝐷𝑃𝑃𝑀𝑀 calculated in MC under the same conditions for the head and body 
protocols. Once 𝐷𝐷𝑃𝑃𝑥𝑥𝐸𝐸  and 𝐷𝐷𝑃𝑃𝑀𝑀 had been determined, values of 𝐹𝐹𝑃𝑃𝑀𝑀 were 
calculated for 1 mAs as in Eq.(4.5). Subsequently, 𝐹𝐹𝑃𝑃𝑀𝑀 was utilized to 
evaluate absolute absorbed dose for organ doses calculations in (Gy). 
Table 4.4: Values for 𝑫𝑫𝑴𝑴𝑴𝑴 and the average 𝑫𝑫𝑬𝑬𝑬𝑬𝑬𝑬  of three readings measured 
experimentally using 1000 mAs and a field size of 10 × 10 cm2. The values were 
normalized with respect to 1 mAs, and 𝑭𝑭𝑴𝑴𝑴𝑴 is calculated as in Eq.(4.5). 
Absorbed dose Head Body 
𝐷𝐷𝑃𝑃𝑀𝑀 [𝐺𝐺𝑦𝑦/𝐷𝐷𝑛𝑛𝑛𝑛𝐷𝐷𝑑𝑑𝐷𝐷𝑛𝑛𝑊𝑊 𝑝𝑝𝑊𝑊𝐷𝐷𝑊𝑊𝐷𝐷𝑛𝑛𝑙𝑙𝐷𝐷] 7.9680×10-21 1.4921×10-20 
𝐷𝐷𝑃𝑃𝑥𝑥𝐸𝐸 [𝐺𝐺𝑦𝑦/𝑚𝑚𝑃𝑃𝑠𝑠] 7.9751×10-05 1.5273×10-04 
𝐹𝐹𝑃𝑃𝑀𝑀[𝐷𝐷𝑛𝑛𝑛𝑛𝐷𝐷𝑑𝑑𝐷𝐷𝑛𝑛𝑊𝑊 𝑝𝑝𝑊𝑊𝐷𝐷𝑊𝑊𝐷𝐷𝑛𝑛𝑙𝑙𝐷𝐷/𝑚𝑚𝑃𝑃𝑠𝑠] 1.0009×10+16 1.0235×1016 
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4.6 Conclusion 
Specifications of the OBI system were obtained from the manufacturer 
Varian, which were subsequently used to model the system using BEAMnrc. 
A set of experiments were then used to validate the model. First, different 
experiments relating to x-ray spectra, HVL measurements, and lateral, 
axial, and depth dose profiles were used to validate the geometrical 
specifications and the beam properties of the model. Results of these 
experiments were found to be in good agreement with those obtained from 
the MC model. Second, results of different experimental measurements for 
the quantities of interest CTDI100, CTDIFIA, 𝑓𝑓(0,150), and the dose 
distribution within the standard PMMA phantoms were compared with those 
from the MC model. The comparison again showed good agreement, which 
gave an indication of the validity of the model. The MC model was also 
calibrated to convert output of the MC from (Gy/incident particle) to (Gy) 
by using calibration factors 𝐹𝐹𝑃𝑃𝑀𝑀 for the head and body scanning protocols, 
which are used to calculate organ doses in Chapter 9.  
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Chapter 5  
The Efficiency of CTDI100 and CTDIIEC 
5.1 Introduction 
The efficiency of the CTDI100 is assessed as the ratio of the CTDI100 
measurement in a standard phantom to that recorded by an infinitely long 
chamber within an infinitely long PMMA phantom CTDI∞, which is close to 
the dose received by body tissues near the middle of a scan. The efficiency 
defined here should not be confused with the efficiency of the MC 
simulation discussed in Chapter 3 section 3.8. As mentioned previously, the 
efficiency of the CTDI100 is approximately constant for beams of width ≤ 40 
mm at ~75% and ~60% at the centre of the standard PMMA head and body 
phantoms, respectively, and at ~84% at the periphery of the phantoms. 
However, the values decrease with increasing beam width reaching ~25% of 
CTDI∞ for wide beams for both the phantoms. The efficiency is considered 
to be a good indicator for the ability of the CTDI100 to estimate the actual 
tissue dose absorbed by the patient near the middle of a scan. This chapter 
presents an investigation conducted to evaluate the efficiency of the new 
IEC dosimetry arrangement described in Chapter 2 section 2.6.5 using the 
MC technique and compare it to the efficiency of the CTDI100. The influence 
of the reference beam width on the efficiency calculation was also 
investigated. Results were analysed and compared with experimental 
measurements for three scanning protocols (head, thorax, and pelvis) 
frequently used in the clinic. 
5.2 Materials and Methods 
5.2.1 The Scanning Protocols 
Four scanning protocols employed for validation of the MC dose calculations 
in Chapter 4 section 4.4 were used to investigate the efficiency of CTDI100 
and CTDIIEC. The protocols were Head-200, Head-360, Body-200, and Body-
360. Parameters of these protocols are listed in Table 5.1, which were 
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defined as they cover all scanning parameters used in the clinic. Head-200 
and Head-360 are used for head scans, Body-200 covers the pelvic spot light 
scan, and Body-360 covers thorax and pelvic scans (Chapter 2 section 2.3). 
Table 5.1: The scanning protocols employed in this study. Body-360 is used with 20 
mA, 264 mAs for thorax scans and with 80 mA, 1056 mAs for pelvic scans.  
 Head-200 Head-360 Body-200 Body-360 
x-ray tube potential (kV) 100 100 125 125 
x-ray current (mA) 20 20 80 20, 80 
x-ray millisecond (ms) 20 20 25 20 
Exposures (mAs) 147 264 733 264, 1056 
Acquisition mode Full-Fan Full-Fan Full-Fan Half-Fan 
Scan Arc Gantry rotation 
(degrees)(a) 
200° 
90°-290° 
360° 
0°-360° 
200° 
90°-290° 
360° 
0°-360° 
Bowtie filter Full Full Full Half 
No of Projections 367 660 367 660 
Longitudinal extent of 
beam (mm) 20 -300 
Lateral collimator blade 
positions at the isocentre 
X1 and X2 (mm) 
132, 132 132, 132 132 , 132 25, 239 
Axial collimator blade 
positions at the isocentre 
Y1 and Y2 (mm) 
(10 – 150), (10 – 150) 
(a) Left side-90°and right side-270°. The angles are shown in Figure 4.13 of Chapter 4. 
 
5.2.2 Monte Carlo Calculations for the Efficiency: 
The efficiency (𝜀𝜀) is evaluated as follows (Boone, 2007, Li et al., 2011): 
𝜀𝜀 =  𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100
𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶∞
 (5.1) 
where CTDI100 and CTDI∞ are defined in Chapter 2 section 2.4. 
BEAMnrc and DOSXYZnrc codes were involved for the efficiency 
calculations. The efficiency of CTDI100 was assessed at the centre (𝜀𝜀𝑐𝑐) and 
periphery �𝜀𝜀𝐸𝐸� of the phantom, and for CTDIw (𝜀𝜀𝑤𝑤)as follows: 
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𝜀𝜀𝑐𝑐(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100) =   𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100,𝑐𝑐𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶 ∞,𝑐𝑐  
 
𝜀𝜀𝐸𝐸(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100) =  𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100,𝐸𝐸𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶 ∞,𝐸𝐸  
 
𝜀𝜀𝑤𝑤(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100)  =  𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝑤𝑤𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶 ∞,𝑤𝑤 
(5.2) 
 
Similarly, the efficiency values for CTDIIEC were assessed as follows: 
𝜀𝜀𝑐𝑐(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀)  =  𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀,𝑐𝑐 𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶 ∞,𝑐𝑐  
  𝜀𝜀𝐸𝐸(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀)  =  𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀,𝐸𝐸 𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶∞,𝐸𝐸  
    𝜀𝜀𝑤𝑤(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀)  =  𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀,𝑤𝑤 𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶∞,𝑤𝑤  
(5.3) 
 
The scanning protocols listed in Table 5.1 were used to generate PHSP files 
using BEAMnrc and then run in DOSXYZnrc as described in Chapter 4 
section 4.4.2 to calculate values for CTDI100, CTDIIEC and CTDI∞. Mori et al. 
(2005) and Kim et al. (2011) have shown that the PMMA head and body 
phantoms of length 600 and 900 mm, respectively, are sufficient to provide 
the full scatter condition, thus these lengths were designed in DOSXYZnrc 
and used to represent the infinite lengths for the head phantom as: 
𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶∞(ℎ𝐷𝐷𝑊𝑊𝑑𝑑)  =  1𝑊𝑊�  𝐷𝐷(𝑧𝑧)𝑑𝑑𝑧𝑧+300−300  (5.4) 
and  
𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶∞(𝑏𝑏𝑜𝑜𝑑𝑑𝑦𝑦)  =  1𝑊𝑊�  𝐷𝐷(𝑧𝑧)𝑑𝑑𝑧𝑧+450−450  (5.5) 
thus, three lengths of the phantoms were used 150, 600, and 900 mm, 
where 150 mm represented the standard length for the standard PMMA head 
and body phantoms, and the latter two were used for CTDI∞. 
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The beam widths (20 – 300) mm and (40 – 300) mm with an increment of 20 
mm were applied to assess 𝜀𝜀(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100) and 𝜀𝜀(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀), respectively. A beam 
of width 20 mm was used as the reference beam width for evaluating 
𝜀𝜀(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀). 
To indicate the influence of the reference beam width on 𝜀𝜀(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀), the 
efficiency values were calculated using another reference beam of width 
40 mm. The influence was estimated at the centre and periphery of the 
phantoms and for the weighted efficiency as the ratio of 𝜀𝜀(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀) values 
calculated with 20 mm to those of 40 mm as follow: 
𝑁𝑁𝑊𝑊𝑊𝑊𝐷𝐷𝑜𝑜 =   𝜀𝜀(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀)20
𝜀𝜀(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀)40 (5.6) 
 
5.2.3 CTDI Measurements 
CTDI100 and CTDIIEC were assessed experimentally for three clinical scanning 
protocols (head, thorax, and pelvis). The clinical beam width 198 mm was 
used, and the protocol Head-200 was employed for the head scan, while 
Body-360 was used for the thorax and pelvic scans. Values for CTDI∞ for 
these protocols were estimated by the application of correction factors 
derived from the MC calculations.  
5.3 Results and Discussion 
5.3.1 Efficiency CTDI100 and CTDIIEC Calculations 
Figures 5.1 - 5.2 show the efficiency values for the scanning protocols used 
in this study (Table 5.1). 𝜀𝜀(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100) values for all protocols were 
approximately stable for the beam widths (20 – 40) mm. For Head-200 
(Figure 5.1 (a)), values of 𝜀𝜀𝑐𝑐(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100), 𝜀𝜀𝐸𝐸(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100), and 𝜀𝜀𝑤𝑤(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100) for the 
beam widths (20 – 40) mm were 74.7 ± 0.6%, 84.6 ± 0.3%, and 80.9 ± 0.4%, 
respectively, whereas for Head-360 (Figure 5.1 (b)) the values were 74.3 ± 
0.5%, 84.5 ± 0.3%, and 80.7 ± 0.4%, respectively. The efficiency values for 
the same beam widths for Body-200 (Figure 5.2 (a)) were 58.5 ± 0.3%, 82.1 
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± 0.1%, and 74.7 ± 0.2%, and for Body-360 (Figure 5.2 (b)) the values were 
59.7 ± 0.3%, 82.1 ± 0.3%, and 74.9 ± 0.3%, respectively. When the beam 
width increased beyond 40 mm, the efficiency of all protocols fell steadily 
reaching values between ~30% and ~40% at a beam width of 300 mm. 
(a) 
 
(b) 
 
Figure 5.1: The efficiency values for CTDI100 and CTDIIEC calculated with MC using (a) 
Head-200 and (b) Head-360. Beam widths 20 – 300 mm were used for CTDI100, while 40 
– 300 mm were used for CTDIIEC. The reference beam width was 20 mm. 
 
However, 𝜀𝜀(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀) values for all the scanning protocols were within ±1.0% 
over all the beam widths (Table 5.2). The beam width was found to play a 
minimal role in determining the efficiency values for the IEC approach 
(Figures 5.1 - 5.2). Differences between the efficiency values calculated 
with a 200°scan (Figure 5.1 (a)) and a 360°scan (Figure 5.1 (b)), and full-
fan with the full bowtie filter (Figure 5.2 (a)) and half-fan with the half 
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bowtie filter (Figure 5.2 (b)) were within 1%. Therefore, 𝜀𝜀(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀) values 
were not affected by the type of scan or the bowtie filter significantly. 
Table 5.2 gives 𝜀𝜀(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀) values calculated with reference beams of width 
20 and 40 mm. Differences were within ±1% for head scanning protocols, 
and ±0.7% for body protocols. 
(a) 
 
(b) 
 
Figure 5.2: The efficiency values for CTDI100 and CTDIIEC calculated with MC using (a) 
Body-200 and (b) Body-360. Beam widths 20 – 300 mm were used for CTDI100, while 40 
– 300 mm were used for CTDIIEC. The reference beam width was 20 mm. 
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Table 5.2: The percentage 𝜺𝜺(𝑴𝑴𝑪𝑪𝑫𝑫𝑪𝑪𝑪𝑪𝑬𝑬𝑴𝑴) values at centre and periphery of the head and 
body phantoms, and for the weighted efficiency using the four scanning protocols 
and reference beams of width 20 and 40 mm. 
 Head-200 (%) 
Head-360 
(%) 
Body-200 
(%) 
Body-360 
(%) 
𝜀𝜀𝑐𝑐(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀)20 76.1 ± 0.9 75.7 ± 0.9 59.5 ± 0.8 60.6 ± 0.7 
𝜀𝜀𝐸𝐸(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀)20 85.9 ± 1.0 85.7 ± 1.0 83.1 ± 1.0 82.8 ± 0.8 
𝜀𝜀𝑤𝑤(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀)20 82.2 ± 0.9 81.9 ± 1.0 75.6 ± 0.9 75.8 ± 0.7 
𝜀𝜀𝑐𝑐(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀)40 75.5 ± 0.9 75.2 ± 0.9 59.4 ± 0.8 60.3 ± 0.6 
𝜀𝜀𝐸𝐸(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀)40 85.7 ± 1.0 85.6 ± 1.0 83.5 ± 1.0 82.9 ± 0.8 
𝜀𝜀𝑤𝑤(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀)40 81.8 ± 0.9 81.7 ± 0.9 75.9 ± 0.9 75.8 ± 0.7 
 
5.3.2 CTDI100 and CTDIIEC Measurements 
The experimental values for CTDI100 were, as expected, lower than those of 
CTDIIEC for all protocols (Table 5.3), and agreed with the MC findings 
(Figures 5.1 - 5.2). CTDI∞ values for the protocols in Table 5.3 were 
estimated by application of correction factors (𝐶𝐶𝑓𝑓) derived from 
𝜀𝜀(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀)20 values (Table 5.2). Moreover, these correction factors were 
used to estimate the efficiency of CTDI100 values measured experimentally 
(Table 5.3) using Eq.(5.2). 𝜀𝜀𝑐𝑐(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100), 𝜀𝜀𝐸𝐸(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100) and 𝜀𝜀𝑤𝑤(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100) for the 
head scan were 42.9%, 48.8%, and 46.6%, respectively. These values agreed 
to within ±1.7% with the values derived from MC calculations of 41.5%, 
47.1%, and 45.1%, respectively, using Head-200 (Figure 5.1 (a)). Similarly, 
the thorax and pelvic scans were within ±0.9% of the MC calculations, where 
𝜀𝜀𝑐𝑐(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100), 𝜀𝜀𝐸𝐸(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100) and 𝜀𝜀𝑤𝑤(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100) were 36.0%, 48.4%, and 44.6%, 
respectively, for the thorax scan, and 35.8%, 48.0% and 44.6%, respectively, 
for the pelvic scan, and the MC calculations were 35.2%, 48.9%, and 44.5%, 
respectively, using Body-360 (Figure 5.2 (b)). 
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Table 5.3: Experimental measurements for CTDI100 and CTDIIEC for the head, thorax, 
and pelvic scans using a beam of width 198 mm. The scanning protocol Head-200 with 
(20 mA, 147 mAs) was used for head scan, whereas Body-360 with (20 mA, 264 mAs) 
and (80 mA, 1056 mAs) was used for thorax and pelvic scans, respectively. The 
correction factors (𝑴𝑴𝒇𝒇) within parentheses can be used to derive (𝑴𝑴𝑪𝑪𝑫𝑫𝑪𝑪∞  =  𝑴𝑴𝒇𝒇  × 𝑴𝑴𝑪𝑪𝑫𝑫𝑪𝑪𝑪𝑪𝑬𝑬𝑴𝑴). 
 CTDI100 CTDIIEC CTDI∞ 
 Head (mGy) 
Centre 1.72 3.06 (1.31) 4.01 
Average periphery 1.62 2.84 (1.17) 3.32 
CTDIw 1.66 2.92 (1.22) 3.56 
 Thorax (mGy) 
Centre 1.73 2.95 (1.63) 4.81 
Average periphery 2.47 4.24 (1.20) 5.1 
CTDIw 2.21 3.81 (1.30) 4.95 
 Pelvis (mGy) 
Centre 6.87 11.79 (1.63) 19.21 
Average periphery 9.80 16.97 (1.20) 20.40 
CTDIw 8.84 15.25 (1.30) 19.82 
 
5.3.3 The Use of CTDI100 and CTDIIEC for CBCT Dosimetry 
The efficiency of the CTID100 in providing a measure that collects all the 
radiation to which a patient is exposed has become a more important issue 
since the introduction of advanced CT scanners using wider beams and 
CBCT. The efficiency of the CTID100 has been studied extensively using a 
variety of techniques, beam widths and CT scanners (Table 5.4). The MC 
results from the present study are in good agreement with other studies, 
and show that CTID100,w underestimates the CTID∞,w by ~ 18% and ~24% for 
the head and body phantoms, respectively, using narrow beam widths ≤ 40 
mm. This underestimation increases for wider beams, where the primary 
beam extends beyond the length of the chamber and phantoms (Figures 5.1 
- 5.2). The variation of 𝜀𝜀(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100) with beam width found in the present 
study is similar to that reported for a CT scanner (Boone, 2007) and a C-
arm interventional CBCT scanner (Kyriakou et al., 2008). 
The IEC approach (CTDIIEC) addresses the dependency of the efficiency on 
beam width successfully, with 𝜀𝜀(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀) values being essentially 
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independent of beam width. Moreover, 𝜀𝜀(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀) values for the beam 
widths 40 – 300 mm were nearly identical to 𝜀𝜀(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100) values for narrow 
beam widths (Figures 5.1 - 5.2, and Tables 5.2 and 5.4). Thus, the CTDIIEC 
successfully extends the application of the CTID100 approach to CBCT scans 
and provides a practical solution for the use of CTID100 dosimetry equipment 
that are widely available in medical imaging and therapy departments for 
CBCT dosimetry. 
The IAEA has recommended using a reference beam with a width of about 
20 mm (IAEA, 2011). Results from this study have shown that the difference 
between using 20 and 40 mm as the reference beam was not significant 
(Table 5.2). However, the use of a 40 mm beam rather than 20 mm one is 
recommended for CBCT scanners as these systems are manufactured for 
use with wide beams and use of a narrower beam width may lead to 
uncertainty due to the accuracy of blade collimation at narrow beams 
(Varian, 2010). 
Although maintaining the CTDI100 concept and equipment, the CTDIIEC 
approach does not include all the radiation contributing to the patient 
exposure. This is inevitable with this approach unless a much longer 
phantom is used, which is less practical for routine measurement because 
of the requirement to handle the larger weight. Moreover, using a standard 
100 mm ionization chamber requires the acquisition of a relatively large 
number of scans (nine for 198 mm) to measure CTDIIEC,w for one protocol 
using the practical technique described earlier. Moving the 100 mm 
ionization chamber using the practical technique over two or three 
positions increases the uncertainty of the measurements, which with three 
steps for a beam of width 160 mm was found to be 2% (Platten et al., 2013). 
Therefore, use of a longer ionization chamber should be considered to 
minimize the number of scans and to reduce the uncertainty, and these are 
now becoming more readily available.  
 106 
 
Table 5.4: Comparisons between 𝜺𝜺(𝑴𝑴𝑪𝑪𝑫𝑫𝑪𝑪𝟏𝟏𝟎𝟎𝟎𝟎) values in the present study obtained from the MC simulations and those from studies conducted with 
different techniques, beam widths, and CT scanners. 
Investigator 
Beam 
width 
(mm) 
Phantom 
X-ray 
voltage 
(kV) 
Scanner Technique 𝜺𝜺𝒄𝒄(𝑴𝑴𝑪𝑪𝑫𝑫𝑪𝑪𝟏𝟏𝟎𝟎𝟎𝟎) 𝜺𝜺𝑬𝑬(𝑴𝑴𝑪𝑪𝑫𝑫𝑪𝑪𝟏𝟏𝟎𝟎𝟎𝟎) 𝜺𝜺𝒘𝒘(𝑴𝑴𝑪𝑪𝑫𝑫𝑪𝑪𝟏𝟏𝟎𝟎𝟎𝟎) 
(Li et al., 2011) 18 Head 100 Siemens SOMATOM MC 0.76 0.87 0.83 
This study 20 Head 100 OBI MC 0.75 0.85 0.81 
(Li et al., 2011) 40 Head 100 Siemens SOMATOM MC 0.76 0.87 0.83 
(Ruan et al., 2010) 40 Head 100 GE LS VCT OSL 0.73 0.86  
This study 40 Head 100 OBI MC 0.74 0.84 0.80 
(Li et al., 2011) 18 Body 120 Siemens SOMATOM MC 0.55 0.84 0.74 
(Perisinakis et al., 
2007) 18 Body 120 Siemens 16 TLD 0.63 0.78  
(Martin et al., 2011) 20 Body 120 
GE 
Lightspeed 
16 
Gaf. film 0.57 0.83  
(Martin et al., 2011) 20 Body 120 
GE 
Lightspeed 
16 
Gaf. film 0.55 0.81  
(Martin et al., 2011) 20 Body 120 
GE 
Lightspeed 
16 
20 mm IC 0.60 0.85  
(Ruan et al., 2010) 20 Body 120 GE LS VCT OSL 0.58 0.83  
(Boone, 2007) 20 Body 120 GE LS MC 0.63 0.88  
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(Dixon and Ballard, 
2007) 20 Body 120 GE LS-16 Farmer 0.61 0.86  
(Dixon and Ballard, 
2007) 20 Body 120 GE VCT-64 Farmer 0.61 0.83  
(Mori et al., 2005) 20 Body 120 Prototype 256 Photodiode   0.76 
This study 20 Body 125 OBI MC 0.59 0.82 0.75 
(Mori et al., 2005) 42 Body 120 Prototype 256 Photodiode   0.74 
(Martin et al., 2011) 40 Body 120 Philips Brilliance Gaf. film 0.58 0.82  
(Li et al., 2011) 40 Body 120 Siemens SOMATOM MC 0.55 0.83 0.74 
(Ruan et al., 2010) 40 Body 120 GE LS VCT OSL 0.56 0.81  
(Dixon and Ballard, 
2007) 40 Body 120 GE VCT-64 Farmer 0.61 0.81  
(Boone, 2007) 40 Body 120 GE LS MC 0.62 0.87  
This study 40 Body 125 OBI MC 0.59 0.82 0.74 
(Mori et al., 2005) 138 Body 120 Prototype 256 Photodiode   0.60 
This study 140 Body 125 OBI    0.61 
(Geleijns et al., 
2009) 160 Body 120 
Aquilion 
ONE MC   0.59 
This study 160 Body 125 OBI MC   0.56 
MC: Monte Carlo, OSL: Optically Stimulated Luminescence, TLD: Thermoluminescent Dosimeter, Gaf. film: Gafchromic film, 20 mm IC: A Farmer type 
ionization chamber with an active length of 20 mm. 
108 
 
 
In addition to the underestimation associated with the IEC approach, the 
number of measurements required to complete a quality assurance (QA) 
procedure (i.e. extra time and effort) and the expected uncertainty, which 
may arise from the accuracy of blade collimation at a narrower beam and 
moving the ionization chamber over several steps, may limit the 
acceptability of this method.  
Our results together with other studies (Mori et al., 2005, Boone, 2007) 
(Kyriakou et al., 2008, Geleijns et al., 2009) show that the CTDI100 
underestimates CTDI∞ significantly. For the clinical beam width 198 mm 
used in this study, CTDI100,w underestimates CTDI∞,w by ~55% for head and 
by ~56% for body (Figures 5.1 - 5.2). Therefore, the continued use of the 
standard CTDI100 concept for CBCT scans does not provide a good reflection 
of the relative doses involved in the CBCT imaging procedures, as only half 
of the scan dose received by a patient is measured. The efficiency, 
maintaining the use of the CTDI100 equipment, and the simplicity (i.e. more 
practical for regular use in the medical environment) may be the more 
important aspects for the majority of medical physicists. Moreover, the 
technique is used to give a measure that can be related to patient doses, 
rather than being used as an absolute measurement of patient dose. The 
IEC approach provides a practical solution for the CBCT dosimetry that 
overcomes some of the CTDI100 limitations for CBCT. The efficiency of the 
CTDIIEC,w is only ~82% for head and ~76% for body, but since CTDIIEC is 
independent of beam width (Figures 5.1 - 5.2), this could be addressed by 
use of appropriate correction factors. 
5.4 Conclusion 
The MC BEAMnrc and DOSXYZnrc codes have been used to evaluate the 
efficiency of the CTDI100 and CTDIIEC for the OBI imaging system on a 
TrueBeam linear accelerator for different scanning protocols and beam 
widths. The IEC approach successfully extends the application of the CTDI100 
to CBCT scans and provides a practical solution using existing CTDI100 
dosimetry equipment. The simulations demonstrate that the efficiency 
𝜀𝜀𝑤𝑤(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀) is essentially independent of beam width, with values of ~82% 
for head and ~76% for body, approximately equal to those for 𝜀𝜀𝑤𝑤(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100) 
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at narrower beam widths. Differences in values for CTDIIEC derived using 
beams with widths 20 mm and 40 mm as the reference were only ±1%. 
Therefore the use of a 40 mm reference beam is recommended to reduce 
the uncertainty associated with the accuracy of blade collimation. 
CTDIIEC,w has the same disadvantage as the CTDI100,w in that CTDI∞,w is 
underestimated by ~18% for head scans and ~24% for body scans, but unlike 
the CTDI100,w, the underestimation is independent of beam width. If use of 
the CTDI approach, which is well established for multi-slice CT, is 
considered to be the best way forward for CBCT dosimetry, then use of the 
CTDIIEC method with correction factors applied to overcome the 
underestimation of CTDI∞ would be appropriate. The results of this study 
have been published in (Abuhaimed et al., 2014). 
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Chapter 6  
The Efficiency of Cumulative Dose Indices 
6.1 Introduction 
The previous chapter presents the study that investigated the efficiency of 
CTDI100 and CTDIIEC. This chapter describes an investigation into four 
approaches based on the alternative concept for CBCT dosimetry proposed 
by AAPM and other studies as discussed in Chapter 2 section 2.6, namely 
the cumulative dose, using different scanning protocols and a range of 
beam widths. Monte Carlo simulations were used to study the four 
approaches: the cumulative dose (1) 𝑓𝑓(0,150) (section 2.6.2) and (2) 
𝑓𝑓(0,∞) (section 2.6.4) with a small ionization chamber 20 mm long, and 
the cumulative dose (3) 𝑓𝑓100(150) (section 2.6.3) and (4) 𝑓𝑓100(∞) (defined 
in this study) with a standard 100 mm pencil ionization chamber. The 
𝑓𝑓(0,150) and 𝑓𝑓100(150) were studied within the standard PMMA phantoms, 
while 𝑓𝑓(0,∞) and 𝑓𝑓100(∞) were within infinitely long head and body 
phantoms. In addition, the influence of using the 20 mm and 100 chambers 
on the cumulative dose measurements was investigated. Contributions to 
the cumulative dose measurements resulting from the primary beam and 
scattered radiation created under a scatter equilibrium condition were 
investigated. The imaging doses involved in CBCT scans for head and body 
scanning protocols were evaluated experimentally using the three 
approaches 𝑓𝑓(0,150), 𝑓𝑓100(150), and 𝑓𝑓(0,∞), and the results were 
compared with those from other methodologies (CTDI100 and CTDIIEC) 
investigated in the previous chapter. 
6.2 Materials and Methods 
6.2.1  The Scanning Protocols 
The scanning protocols presented in Chapter 5 and listed in Table 5.1, 
namely Head-200, Head-360, Body-200, and Body-360, which were used to 
calculate the efficiency of CTDI100 and CTDIIEC, were employed. The only 
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difference was in the beam width involved. In the previous chapter, the 
beam width (W) used in the study ranged from 20 mm to 300 mm for CTDI100, 
whereas W in this study ranged from 40 – 300 mm with an increment of 20 
mm for the all dose indices.  
6.2.2 Monte Carlo Calculation for the Efficiency 
𝑓𝑓100(∞) defined in this study was identical to 𝑓𝑓100(150), which is defined 
as: 
𝑓𝑓100(150) =  1100 � 𝐷𝐷(𝑧𝑧) 𝑑𝑑𝑧𝑧+50𝑚𝑚𝑚𝑚−50𝑚𝑚𝑚𝑚  (6.1) 
The only difference between these dose indices is in the length of the 
phantom involved. 𝑓𝑓100(150) is measured within the standard PMMA 
phantoms, whereas 𝑓𝑓100(∞) is within infinitely long phantoms. 
The efficiency values for the four dose indices were calculated using 
BEAMnrc and DOSXYZnrc in a manner similar to that used for 𝜀𝜀(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100) and 
𝜀𝜀(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀). The efficiency values were calculated at the centre and 
periphery of the phantom and for the weighted value as: 
𝜀𝜀𝑐𝑐(𝑓𝑓(0,150)) =   𝑓𝑓(0,150)𝑐𝑐𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶 ∞,𝑐𝑐  
 
𝜀𝜀𝐸𝐸(𝑓𝑓(0,150)) =  𝑓𝑓(0,150)𝐸𝐸𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶 ∞,𝐸𝐸  
 
𝜀𝜀𝑤𝑤(𝑓𝑓(0,150))  =  𝑓𝑓(0,150)𝑤𝑤𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶 ∞,𝑤𝑤  
(6.2) 
Similarly, �𝑓𝑓100(150)�, 𝜀𝜀(𝑓𝑓(0,∞)), and 𝜀𝜀�𝑓𝑓100(∞)� were calculated in a 
similar manner. PMMA head and body phantoms with lengths similar to 
those used for the 𝜀𝜀(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100) and 𝜀𝜀(𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝐼𝐼𝑃𝑃𝑀𝑀) study were used, and these 
are listed in Table 6.1. 
The scanning protocols listed in Chapter 5 Table 5.1 were used to generate 
PHSP files using BEAMnrc. The PHSP files were, then, run in DOSXYZnrc as 
described in Chapter 4 section 4.4.2 to calculate values for 𝑓𝑓(0,150), 
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𝑓𝑓100(150), 𝑓𝑓(0,∞), 𝑓𝑓100(∞), and CTDI∞. Figure 6.1 shows the configurations 
used to assess the five dose indices. 
Table 6.1: The head and body PMMA phantoms used in this study. 
Phantom Diameter (d) (mm) Length (mm) Used for 
Standard head 160 150 𝑓𝑓(0,150), 𝑓𝑓100(150) 
Standard body 320 150 𝑓𝑓(0,150), 𝑓𝑓100(150) 
Infinitely long head 160 600 𝑓𝑓(0,∞), 𝑓𝑓100(∞), CTDI∞ 
Infinitely long body 320 900 𝑓𝑓(0,∞), 𝑓𝑓100(∞), CTDI∞ 
 
 (a) (b) 
  
(c) (d) 
  
Figure 6.1: Diagrammatic representations of the configurations used to assess (a) 
𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎), (b) 𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(𝟏𝟏𝟏𝟏𝟎𝟎), for both head and body PMMA phantoms, (c) CTDI∞ within the 
infinitely long head PMMA phantom, and (d) CTDI∞ within the infinitely long body 
PMMA phantom. The phantoms shown in (c) and (d) were also used for 𝒇𝒇(𝟎𝟎,∞) and 
𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(∞), but with detection lengths similar to those in (a) and (b). 
40 – 300 mm 
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6.2.3 Experimental Measurements for Dose Indices 
Experimental measurements of 𝑓𝑓(0,150), 𝑓𝑓100(150), and 𝑓𝑓(0,∞) for the 
CBCT scans for head and body scanning protocols used in the clinic were 
performed. The measurements were carried out with the clinical beam 
width of 198 mm. Head-200 protocol in Table 5.1 was used for the head 
scan, and Body-360 was employed for the body scan. 𝑓𝑓(0,150) 
measurements were obtained as described in Chapter 4 section 4.4.1.3 , 
and 𝑓𝑓100(150) were measured in the same manner as that used for 𝑓𝑓(0,150), 
but with the standard 100 mm pencil ionization chamber employed in 
Chapter 4 section 4.4.1.1. 𝑓𝑓(0,∞) measurements were obtained within 
head and body phantoms of length 450 mm. This length is considered 
sufficiently long to provide a full scatter condition for a beam width of 198 
mm (AAPM, 2010). Three standard PMMA phantoms were combined together 
by attaching the ends to form one long phantom as shown in Figure 6.2. 
The phantoms were set up at an SID of 100 cm and the 0.6 cm3 Farmer–type 
ionization chamber (10X5-0.6CT, Radcal Corporation, US) was placed at the 
middle of the central axis and the four peripheral axes to measure 𝑓𝑓(0,∞). 
The experimental measurements of 𝑓𝑓(0,150), 𝑓𝑓100(150), and 𝑓𝑓(0,∞) were, 
then, compared with values derived from Monte Carlo simulation and with 
different dosimetry approaches CTDI100 and CTDIIEC. 
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Figure 6.2: Combining three standard 150 mm long phantoms to perform 𝒇𝒇(𝟎𝟎,∞) 
measurements. 
 
6.3 Results and Discussion 
6.3.1 The Efficiency for Dose Indices 
The efficiency values for 𝑓𝑓(0,150), 𝑓𝑓100(150), 𝑓𝑓(0,∞), and 𝑓𝑓100(∞), 
calculated at the centre of the standard and infinitely long phantoms using 
Head-200, Head-360, Body-200, and Body-360 protocols are shown in 
Figures 6.3 - 6.6 (a), respectively. 𝜀𝜀𝑐𝑐(𝑓𝑓(0,150)) and 𝜀𝜀𝑐𝑐(𝑓𝑓100(150)) values 
within the standard head and body phantoms increased with the beam 
width (W) until ~150 mm at which point the primary beam began to extend 
beyond the length of the standard phantoms (150 mm), thus the values for 
𝜀𝜀𝑐𝑐(𝑓𝑓(0,150)) and 𝜀𝜀𝑐𝑐(𝑓𝑓100(150)) remained virtually constant for W > 150 mm 
(Figures 6.3 - 6.6 (a)).The differences between 𝜀𝜀𝑐𝑐(𝑓𝑓(0,150)) and 
𝜀𝜀𝑐𝑐(𝑓𝑓100(150)) values for W = 160 mm and those obtained for W = 300 mm 
were all within 3%. The long phantoms within which 𝜀𝜀𝑐𝑐(𝑓𝑓(0,∞)) and 
𝜀𝜀𝑐𝑐(𝑓𝑓100(∞)) calculations were performed, provided a full scatter condition 
accommodating the whole primary beam and all scattered radiation for W 
= 40 – 300 mm, and as a result, values of 𝜀𝜀𝑐𝑐(𝑓𝑓(0,∞)) and 𝜀𝜀𝑐𝑐(𝑓𝑓100(∞)) 
continued to increase with W. 
450 mm 
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At a narrow beam width W = 40 mm, 𝜀𝜀𝑐𝑐(𝑓𝑓(0,150)) values were larger by 20% 
and 13% than those for 𝜀𝜀𝑐𝑐(𝑓𝑓100(150)) calculated within the standard head 
and body phantoms, respectively (Figures 6.3 - 6.6 (a)). The magnitudes of 
these differences declined as the beam width increased until W = 100 mm, 
after which the difference stabilized at ~5% for the head phantom and ~4% 
for the body phantom. However, the differences between 𝜀𝜀𝑐𝑐(𝑓𝑓(0,∞)) and 
𝜀𝜀𝑐𝑐(𝑓𝑓100(∞)) were similar to those found between 𝜀𝜀𝑐𝑐(𝑓𝑓(0,150)) and 
𝜀𝜀𝑐𝑐(𝑓𝑓100(150)) for W = 40 mm, and continued to decline with W reaching 1% 
and 2% for the head and body phantoms, respectively, for W = 300 mm. In 
general, the differences between 𝜀𝜀𝑐𝑐(𝑓𝑓(0,150)) and 𝜀𝜀𝑐𝑐(𝑓𝑓100(150)) and 
between 𝜀𝜀𝑐𝑐(𝑓𝑓(0,∞)) and 𝜀𝜀𝑐𝑐(𝑓𝑓100(∞)) in the head phantom were higher than 
those for the body phantom (Figures 6.3 - 6.6 (a)). 
Figures 6.3 - 6.6 (a), also show the differences between contributions 
resulting from the primary beam and scattered radiation to the cumulative 
dose measurements under scatter equilibrium and non-equilibrium 
conditions. For W ≤ 140 mm, the differences were not as significant, but 
the differences rose steadily as W increased beyond the length of the 
standard phantom to be 11% between 𝜀𝜀𝑐𝑐(𝑓𝑓(0,150)) and 𝜀𝜀𝑐𝑐(𝑓𝑓(0,∞)), and 15% 
between 𝜀𝜀𝑐𝑐(𝑓𝑓100(150)) and 𝜀𝜀𝑐𝑐(𝑓𝑓100(∞)) for the head phantoms (Figures 6.3 
- 6.4 (a)), and 24% and 25% respectively, for the body phantom at W = 300 
mm (Figures 6.5 - 6.6 (a)). 
 
  
116 
 
  
(a) 
 
(b) 
 
(c) 
 
Figure 6.3: The efficiency values for 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎), 𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(𝟏𝟏𝟏𝟏𝟎𝟎), 𝒇𝒇(𝟎𝟎,∞), and 𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(∞) 
calculated at the (a) centre and (b) periphery of the head phantom, and for (c) the 
weighted values using Head-200 protocol derived by MC simulations. 
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(a) 
 
(b) 
 
(c) 
 
Figure 6.4: The efficiency values for 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎), 𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(𝟏𝟏𝟏𝟏𝟎𝟎), 𝒇𝒇(𝟎𝟎,∞), and 𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(∞) 
calculated at the (a) centre and (b) periphery of the head phantom, and for (c) the 
weighted values using Head-360 protocol derived by MC simulations. 
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Figures 6.3 - 6.6 (b) show 𝜀𝜀𝐸𝐸(𝑓𝑓(0,150)), 𝜀𝜀𝐸𝐸(𝑓𝑓100(150)), 𝜀𝜀𝐸𝐸(𝑓𝑓(0,∞)), and 
𝜀𝜀𝐸𝐸(𝑓𝑓100(∞)) values calculated at the periphery of the simulated phantoms 
using Head-200, Head-360, Body-200, and Body-360 protocols, respectively. 
In a similar manner to that at the centre of the phantoms, 𝜀𝜀𝐸𝐸(𝑓𝑓(0,150)) and 
𝜀𝜀𝐸𝐸(𝑓𝑓100(150)) values remained constant when the beams extended beyond 
the edges of the phantoms at 4% and 3% for the standard head and body 
phantoms, respectively. As at the centre, 𝜀𝜀𝐸𝐸(𝑓𝑓(0,∞)) and 𝜀𝜀𝐸𝐸(𝑓𝑓100(∞)) 
values increased with W within all phantoms. 𝑓𝑓(0,150)𝐸𝐸 and 𝑓𝑓100(∞)𝐸𝐸 
exceeded CTDI∞,p values by up to 2% for W ≥ 180 mm within the standard 
body phantom, whereas values for the head phantom were lower than 
CTDI∞,p values for all beam widths. CTDI∞,p values were overestimated by 
𝑓𝑓(0,∞)𝐸𝐸 and 𝑓𝑓100(∞)𝐸𝐸 by up to 5% for the head and 11% for the body 
phantom. 
The differences between 𝜀𝜀𝐸𝐸(𝑓𝑓(0,150)) and 𝜀𝜀𝐸𝐸(𝑓𝑓100(150)) and between 
𝜀𝜀𝐸𝐸(𝑓𝑓(0,∞)) and 𝜀𝜀𝐸𝐸(𝑓𝑓100(∞)) for W ≤ 100 mm at the periphery of the 
phantoms were much larger than those at the centre. For W = 40 mm, 
𝜀𝜀𝐸𝐸(𝑓𝑓(0,150)) was 44% higher than 𝜀𝜀𝐸𝐸(𝑓𝑓100(150)) for the head and body 
phantoms, and the difference between 𝜀𝜀𝐸𝐸(𝑓𝑓(0,∞)) and 𝜀𝜀𝐸𝐸(𝑓𝑓100(∞))  was 43% 
for both the phantoms (Figures 6.3 - 6.6 (b)). These differences fell with 
increasing W reaching 2% between 𝜀𝜀𝐸𝐸(𝑓𝑓(0,150)) and 𝜀𝜀𝐸𝐸(𝑓𝑓100(150)), and 1% 
between 𝜀𝜀𝐸𝐸(𝑓𝑓(0,∞)) and 𝜀𝜀𝐸𝐸(𝑓𝑓100(∞)) for W = 300 mm. The diameter of the 
phantoms influenced the differences at the centres of the phantoms, but 
had little effect at the periphery (Figures 6.3 - 6.6 (a - b)). 
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(a) 
 
(b) 
 
(c) 
 
Figure 6.5: The efficiency values for 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎), 𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(𝟏𝟏𝟏𝟏𝟎𝟎), 𝒇𝒇(𝟎𝟎,∞), and 𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(∞) 
calculated at the (a) centre and (b) periphery of the body phantom, and for (c) the 
weighted values using Body-200 protocol derived by MC simulations. 
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(a) 
 
(b) 
 
(c) 
 
Figure 6.6: The efficiency values for 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎), 𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(𝟏𝟏𝟏𝟏𝟎𝟎), 𝒇𝒇(𝟎𝟎,∞), and 𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(∞) 
calculated at the (a) centre and (b) periphery of the body phantom, and for (c) the 
weighted values using Body-360 protocol derived by MC simulations. 
  
0
0.2
0.4
0.6
0.8
1
1.2
0 50 100 150 200 250 300
Ef
fi
ci
en
cy
 (
ε c
)
Beam width (W) (mm)
f(0,150)c f100(150)c
f(0,∞)c f100(∞)c
0
0.2
0.4
0.6
0.8
1
1.2
0 50 100 150 200 250 300
Ef
fi
ci
en
cy
 (
ε p
)
Beam width (W) (mm)
f(0,150)p f100(150)p
f(0,∞)p f100(∞)p
0
0.2
0.4
0.6
0.8
1
1.2
0 50 100 150 200 250 300
Ef
fi
ci
en
cy
 (
ε w
)
Beam width (W) (mm)
f(0,150)w f100(150)w
f(0,∞)w f100(∞)w
121 
 
  
Figures 6.3 - 6.6 (b) show that the difference between the contributions of 
the primary beam and scattered radiation to the cumulative dose at the 
peripheral axes under scatter equilibrium and non-equilibrium conditions 
was much lower than that at the central axis. For W = 300 mm, the 
differences between 𝜀𝜀𝐸𝐸(𝑓𝑓(0,150)) and 𝜀𝜀𝐸𝐸(𝑓𝑓(0,∞)), and 𝜀𝜀𝐸𝐸(𝑓𝑓100(150)) and 
𝜀𝜀𝐸𝐸(𝑓𝑓100(∞)) were 6% and 10%, respectively, for the head phantoms 
(Figures 6.3 - 6.4 (b)), 8% and 10%, respectively, for the body phantoms 
(Figures 6.3 - 6.6 (b)). 
The weighted values for 𝜀𝜀𝑤𝑤(𝑓𝑓(0,150)), 𝜀𝜀𝑤𝑤(𝑓𝑓100(150)), 𝜀𝜀𝑤𝑤(𝑓𝑓(0,∞)), and 
𝜀𝜀𝐸𝐸(𝑓𝑓100(∞)) resulting from the values at the centre (Figures 6.3 - 6.6 (a)) 
and the periphery (Figures 6.3 - 6.6 (b)) of the phantoms simulated are 
shown in Figures 6.3 - 6.6 (c). From Figures 6.3 - 6.6, it can be seen that 
the scan mode (full or half) has a negligible effect on the efficiency values, 
where the differences between both the modes at the centre and periphery 
of the phantoms and the weighted values were all within 1%.  
6.3.2 Experimental Measurements 
Table 6.2 shows CTDI100, CTDIIEC, 𝑓𝑓(0,150), 𝑓𝑓100(150) and 𝑓𝑓(0,∞) values 
measured experimentally using the clinical beam width of 198 mm and the 
Head-200 and Body-360 scanning protocols. CTDI∞ values for each scan were 
estimated by the application of correction factors (𝐶𝐶𝑓𝑓) as in the previous 
chapter (Table 5.3) (CTDI∞ = 𝐶𝐶𝑓𝑓 × CTDIIEC). The efficiency values for all the 
dose indices including CTDI100 and CTDIIEC were compared to the MC results. 
The efficiency values based on the experimental measurements agreed 
with the MC dose ratios within 3% (Figures 6.3 - 6.6). For all scanning 
protocols, 𝑓𝑓(0,∞) values were higher than those of the other approaches, 
and provided the closest dose quantities to CTDI∞ values. 𝑓𝑓(0,∞)𝑤𝑤 values 
were within 3% and 1% of CTDI∞,w values for the head and body scanning 
protocols, respectively. 
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Table 6.2: Experimental measurements (Exp) for CTDI100, CTDIIEC, 𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(𝟏𝟏𝟏𝟏𝟎𝟎), 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎), and 𝒇𝒇(𝟎𝟎,∞) for the head and body scanning protocols using 
the clinical beam width W = 198 mm. The correction factors used to estimate CTDI∞ values were derived from MC simulations and are given in 
parentheses. 
 CTDI100 (a) CTDIIEC (a) 𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(𝟏𝟏𝟏𝟏𝟎𝟎) 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎) 𝒇𝒇(𝟎𝟎,∞) CTDI∞ 
100 kV, 147 mAs Head scan (mGy) 
Centre 1.72 3.06 3.40 3.51 3.68 4.01 
Average periphery 1.62 2.84 3.23 3.21 3.32 3.32 
Weighted (1/3 c + 2/3 p) 1.66 2.92 3.29 3.31 3.44 3.56 
𝜀𝜀𝑐𝑐 
Exp 0.43 0.76 0.85 0.87 0.91  
MC 0.41 (1.31) 0.83 0.89 0.94  
𝜀𝜀𝐸𝐸 
Exp 0.49 0.86 0.97 0.97 1.00  
MC 0.47 (1.17) 0.94 0.97 1.00  
𝜀𝜀𝑤𝑤 
Exp 0.47 0.82 0.92 0.93 0.97  
MC 0.45 (1.22) 0.90 0.93 0.98  
125 kV, 264 mAs Body scan (mGy) 
Centre 1.73 2.95 3.40 3.62 4.28 4.81 
Average periphery 2.47 4.24 4.86 5.05 5.24 5.1 
Weighted (1/3 c + 2/3 p) 2.21 3.81 4.38 4.57 4.92 4.95 
𝜀𝜀𝑐𝑐 
Exp 0.36 0.61 0.71 0.75 0.89  
MC 0.35 (1.63) 0.70 0.75 0.87  
𝜀𝜀𝐸𝐸 
Exp 0.48 0.83 0.95 0.99 1.03  
MC 0.49 (1.20) 0.98 1.00 1.04  
𝜀𝜀𝑤𝑤 
Exp 0.45 0.77 0.88 0.92 0.99  
MC 0.44 (1.30) 0.89 0.92 0.98  
(a) CTDI100 and CTDIIEC reported in the previous chapter. 
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6.3.3 The Use of Cumulative Dose Indices for CBCT Dosimetry 
In recent years, CBCT dosimetry has received attention from the research 
community in relation to implementing an appropriate quality assurance 
(QA) and dosimetry system. The present study investigated the cumulative 
dose measurements under scatter equilibrium and non-equilibrium 
conditions. Results for CTDI∞ were used as standard values for comparison 
to examine the efficiency of the dose indices studied in reporting CTDI∞ 
values. It is recognised that 𝑓𝑓(0,150) and CTDI∞ do not represent an exact 
comparison, since one is a measure of point dose and the other an integral 
of dose from a whole scan. However, the relationship between these 
variables is an important part of developing a coordinated approach to 
CBCT dosimetry. The MC results for the dose indices (Figures 6.3 - 6.6) 
indicated that 𝑓𝑓(0,∞), which has been proposed by (AAPM, 2010) and is 
equal to the peak value of a CBCT beam profile, provides a good method 
for estimating CTDI∞ values. However, the results at the periphery of the 
phantoms (Figures 6.3 - 6.6 (b)) showed that 𝑓𝑓(0,∞)𝐸𝐸 and 𝑓𝑓100(∞)𝐸𝐸 
overestimated CTDI∞,p values for W ≥ 200 mm and W ≥ 220 mm, respectively, 
for the head phantom, and for W ≥ 160 mm and W ≥ 180 mm respectively, 
for the body phantom. These overestimations resulted in 𝑓𝑓(0,∞)𝑤𝑤 and 
𝑓𝑓100(∞)𝑤𝑤 values exceeding CTDI∞,w values within both the phantoms, as the 
peripheral results have a higher weighting (2/3) than those at the centre 
(1/3) (Figures 6.3 - 6.6 (c)). This observation is in agreement with findings 
from a study conducted with W = 160 mm using a 320 detector row CT 
scanner (Aquilion ONE) (Geleijns et al., 2009). In their study, 𝑓𝑓100(150)𝐸𝐸 at 
the periphery of a standard body phantom using 120 kV was a factor of 1.06 
greater than CTDI300,p, which was taken to represent CTDI∞,p. 
The possible reasons for the overestimation may be: (1) the actual beam 
width, which is represented by the full width at half maximum (FWHM) at 
the periphery of the phantom, is less than the nominal beam width. For 
example, Figure 6.7 shows a FWHM for a beam of a nominal width of 200 
mm at the peripheral axes of body and head phantoms. For the body 
phantom, FWHM = 170 mm at the side from which the x-ray source is 
incident and FWHM = 230 mm at the other side, and FWHM = 186 mm and 
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214 mm on either side of the head phantom. This variation in the beam 
width results from the beam divergence. The diameter of the phantom 
plays a major role in determining the magnitude of this variation, as this 
determines the distance of the measuring chamber from the isocentre. The 
differences between the actual width (FWHM) and the nominal width at the 
periphery, which is closer to the kV source, for all beam widths W = 40 – 
300 mm were 7% and 15% for the head and body phantoms respectively. 
The main concept for estimating 𝑓𝑓(0,∞) and 𝑓𝑓100(∞) values differs from 
that for CTDI∞. 𝑓𝑓(0,∞) and 𝑓𝑓100(∞) are based on averaging the dose over 
arbitrary chamber lengths regardless of the beam width, whereas CTDI∞ is 
based on dividing the dose measured over arbitrary chamber lengths by the 
nominal beam width. The difference between the FWHM and the nominal 
width has been shown to have a significant influence on CTDI∞.p values 
(Figures 6.3 - 6.6 (b)) (Geleijns et al., 2009). 𝑓𝑓(0,∞) and 𝑓𝑓100(∞) 
measurements are also influenced by this difference when the FWHM of the 
beam at the peripheral axis is less than 20 mm and 100 mm, respectively, 
as the whole chambers were not exposed and the dose was averaged over 
the lengths. This influence disappears for wider beams, when the chambers 
were entirely within the FWHM of the beam. 
(a) (b) 
  
Figure 6.7: The actual beam width at the peripheral axes of (a) head and (b) body 
phantoms for a beam of a nominal width 200 mm. 
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In order to indicate the impact of using the nominal widths and the FWHM 
on the efficiency values, Figure 6.8 shows a comparison involving 
normalization of 𝑓𝑓(0,∞)𝐸𝐸 and 𝑓𝑓100(∞)𝐸𝐸 values to CTDI∞.p values calculated 
using the FWHM instead of the nominal width. The use of the FWHM of the 
beams studied increased CTDI∞.p values by 7% and 15%, on average, for the 
head and body phantoms, respectively, and hence brought the efficiency 
values below unity (Figure 6.8). 
(a) 
 
(b) 
 
Figure 6.8: A comparison between the use of the nominal widths (T) and the FWHM of 
the beams to calculate CTDI∞,p values within the head (a) and body (b) phantoms. T is 
used for the nominal width instead of W, so that it is not confused with the weighted 
values. 
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peripheral axes is lower than to those at the centre. Figure 6.9 shows the 
contribution of the scattered radiation resulting from tails of the beam 
profiles at the centre and periphery of the phantoms. In both the phantoms, 
the scattered radiation at the centre is higher than that at the periphery, 
and this increases with increasing phantom diameter (Boone, 2009). The 
scatter to primary ratio (SPR) values at the periphery of the head and body 
phantoms were in the range (0.8 – 1.5) for x-ray tube potentials of (100 – 
130 kV), whereas the SPR values were (3.0 – 13.0) at the centre of the 
phantoms for the same x-ray tube potentials (Tsai et al., 2003, Boone, 
2009, Li et al., 2013b). Thus, the SPR values at the periphery were lower 
by factors of ~2 and ~7 than those at the centre of the head and body 
phantoms, respectively. When the incident beam becomes wider than the 
nominal width at the peripheral axis on the side away from the x-ray source 
(Figure 6.7), the beam intensity is lower because of attenuation in the 
phantom, so that it has less impact on the dose at the periphery. This means 
that by far the larger component of the dose measurements at the 
peripheral axes are from the primary beam which has a FWHM lower than 
the nominal width (Figure 6.7). These two points are considered to be the 
reasons why values for 𝑓𝑓(0,∞)𝐸𝐸 and 𝑓𝑓100(∞)𝐸𝐸 at the periphery of the 
phantoms overestimated CTDI∞,p values. 
From Figure 6.9, it can be seen that the dose at the centre of the body 
phantom (Figure 6.9 (b)) was lower than that at the periphery. This is 
because of the large diameter of the phantom 32 cm, i.e. more attenuation 
of the primary beam. However, the dose at the centre of the head phantom 
(Figure 6.9 (a)) was higher than that at the periphery, and this is because 
of the build up of scattered radiation from the wider beam. For CT scans, 
it has been shown that the dose at the centre of the body phantom was 
lower than that at the periphery for all scan lengths, whereas the dose at 
the centre of the head phantom was higher for the scan lengths ≥ ~135 mm 
(ICRU, 2012). 
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(a) 
 
(b) 
 
Figure 6.9: The beam profiles at the centre and periphery of the head (a) and body 
phantoms (b). The dose values are normalized with respect to the central value at (𝒛𝒛 = 𝟎𝟎) of the dose profile of the central axis. 
 
6.3.4 The Small and Pencil Chambers for Cumulative Dose 
Measurements 
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20 mm. As the 𝑓𝑓100(150) and 𝑓𝑓100(∞) measurements with the 100 mm 
chamber were averaging the dose over the chamber length, the length of 
the exposed part played a major role in determining the magnitudes of the 
measurements, as discussed in section 6.3.3. However, when the entire 100 
mm chamber was irradiated, the differences were reduced, but the 20 mm 
chamber still gave a higher value (Figures 6.3 - 6.6). 
Fahrig et al. (2006) and Dixon and Boone (2010) have stated that the use of 
the 100 mm chamber is inappropriate for cumulative dose measurements, 
which should equate to point dose measurements as proposed by (Dixon, 
2003). However, results in the present study showed that the differences 
between measurements obtained with the 20 mm chamber and those of the 
100 mm chamber were not significant for the weighted values being within 
4% and 3% for the head and body phantoms, respectively (Figures 6.3 - 6.6 
(c)). These findings were in agreement with other studies (Table 6.3), and 
support the suggestions proposed by (Amer et al., 2007, Geleijns et al., 
2009, Li et al., 2014b) that the 100 mm chamber can be used for the 
cumulative dose measurements for CBCT provided beam width more than 
120mm.  
6.3.5 Scatter Equilibrium and Non-Equilibrium Conditions 
The use of the infinitely long phantoms that provide the scatter equilibrium 
condition was proposed to measure the cumulative dose (AAPM, 2010). The 
findings in the present study showed that the cumulative dose for W ≤ 140 
mm calculated with the 20 mm and 100 mm chambers within the infinitely 
long phantoms did not differ significantly from those calculated within the 
standard phantoms (Figures 6.3 - 6.6), but when wider beams were used, 
the differences became obvious. As expected, the largest differences 
between the cumulative dose calculated within the standard phantoms and 
those within the long phantoms were found at the centre of the body 
phantoms, as the diameter of the phantom enhances contributions from the 
scattered radiation to the measurements at the centre as discussed 
section 6.3.3. 
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Table 6.3: A comparison between dose ratios for the cumulative dose values calculated with the small (20 mm) and pencil (100 mm) chambers in 
standard and infinitely long head and body phantoms obtained in this study using MC and experimental measurements (Exp) and those published in 
other studies. 
Investigator Scanner Method 
Tube 
voltage 
(kV) 
Scanning 
mode Phantom 
Beam 
width 
(mm) 
𝑓𝑓(0,150)𝑥𝑥/𝑓𝑓100(150)𝑥𝑥 𝑓𝑓(0,∞)𝑥𝑥/𝑓𝑓100(∞)𝑥𝑥 
𝑥𝑥 =  𝑛𝑛 𝑥𝑥 =  𝑝𝑝 𝑥𝑥 =  𝑤𝑤 𝑥𝑥 =  𝑛𝑛 𝑥𝑥 =  𝑝𝑝 𝑥𝑥 =  𝑤𝑤 
(Li et al., 
2014b) 
Somatom 
Definition 
dual source 
MC 100 
Full Fan Head 
200 1.05 1.02 1.03 1.02 1.01 1.01 
This study OBI Exp 100 198 1.03 0.99 1.01    
This study OBI MC 100 200 1.05 1.03 1.04 1.02 1.02 1.02 
(Geleijns et 
al., 2009) 
Toshiba 
Aquilion ONE MC 120 Full Fan Body 
160   1.04   1.02 
This study OBI MC 125 160   1.04   1.03 
(Osei et al., 
2009) 
Varian On 
Board Imager Exp 125 
Full Fan Body 
206 1.08 1.03 1.03    
(Li et al., 
2014b) 
Somatom 
Definition 
dual source 
MC 120 200 1.07 1.03 1.03 1.03 1.02 1.02 
This study OBI MC 125 200 1.06 1.03 1.04 1.02 1.01 1.02 
(Osei et al., 
2009) 
Varian 
OnBoard 
Imager 
Exp 125 
Half Fan Body 
206 1.07 1.04 1.05    
This study OBI Exp 125 198 1.06 1.04 1.04    
This study OBI MC 125 200 1.06 1.03 1.04    
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Table 6.4: A comparison between dose ratios for the cumulative dose values calculated within standard and infinitely long head and body phantoms 
obtained in this study using MC and those published in other studies. 
Investigator Scanner Method 
Tube 
voltage 
(kV) 
Phantom 
Length of 
infinitely 
long 
phantom 
(mm) 
Beam 
width 
(mm) 
𝑓𝑓(0,150)𝑥𝑥/𝑓𝑓(0,∞)𝑥𝑥 𝑓𝑓100(150)𝑥𝑥/𝑓𝑓100(∞)𝑥𝑥 
𝑥𝑥 =  𝑛𝑛 𝑥𝑥 =  𝑝𝑝 𝑥𝑥 =  𝑤𝑤 𝑥𝑥 =  𝑛𝑛 𝑥𝑥 =  𝑝𝑝 𝑥𝑥 =  𝑤𝑤 
(Li et al., 
2014b) 
Somatom 
Definition 
dual 
source 
MC 100 
Head 
900 140 – 240 
0.98 – 
0.91 
1.0 – 
0.95 
0.99 – 
0.94 
0.97 – 
0.88 
0.99 – 
0.93 
0.98 – 
0.92 
This study OBI MC 100 600 140 – 240 
0.98 – 
0.90 
0.99 – 
0.95 
0.98 – 
0.94 
0.97 – 
0.87 
0.99 – 
0.94 
0.98 – 
0.92 
(Geleijns et 
al., 2009) 
Toshiba 
Aquilion 
ONE 
MC 120 
Body 
700 160   0.98   0.96 
This study OBI MC 125 900 160   0.97   0.96 
(Li et al., 
2014b) 
Somatom 
Definition 
dual 
source 
MC 120 
Body 
900 140 – 240 
0.92 – 
0.81 
0.99 – 
0.95 
0.97 – 
0.92 
0.90 – 
0.77 
0.96 – 
0.94 
0.97 – 
0.90 
This study OBI MC 125 900 140 – 240 
0.94 – 
0.81 
0.99 – 
0.95 
0.97 – 
0.91 
0.92 – 
0.78 
0.98 – 
0.93 
0.97 – 
0.89 
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The influence of the infinitely long phantoms at the peripheral axes was 
minimal, as the contribution from scattered radiation to the peripheral 
measurements is much less. The differences between the cumulative dose 
𝑓𝑓(0,150) and 𝑓𝑓100(150) calculated within the standard body phantom and 
𝑓𝑓(0,∞) and 𝑓𝑓100(∞) calculated within the infinitely long phantoms 
(Figures 6.3 - 6.6) were in good agreement with other studies (Table 6.4). 
6.4 Conclusion 
The efficiencies of four dose indices 𝑓𝑓(0,150), 𝑓𝑓100(150), 𝑓𝑓(0,∞), and 
𝑓𝑓100(∞) relative to CTDI∞ have been calculated in BEAMnrc and DOSXYZnrc 
codes using four different scanning protocols. 𝑓𝑓(0,∞) gave the highest dose 
values compared with the other approaches, and its values were the closet 
to CTDI∞ values, especially for wider beams. Dose values obtained with the 
20 mm and 100 mm chambers for the cumulative dose measurements were 
substantially different for W < 120 mm, but the differences fell with 
increasing beam width and became approximately comparable. The need 
for infinitely long phantoms to be used for the cumulative dose 
measurements was not significant for W ≤ 140 mm, but such phantoms are 
required for wider beams to account for all the contributions arising from 
the primary beam and the scattered radiation that cannot be captured 
within the standard phantoms. The results of this study have been published 
in (Abuhaimed et al., 2015). 
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Chapter 7  
The Use of 𝑮𝑮𝑬𝑬(𝑳𝑳) Function for CBCT Dosimetry 
7.1 Introduction 
The AAPM dosimetry method presented in Chapter 2 section 2.6.4 requires 
measuring cumulative dose within phantoms that are impractical for 
regular use in hospitals because they are long and heavy. This chapter 
investigates the use of a practical approach proposed by ICRU Report–87 to 
utilize the AAPM method, but avoid the difficulty of using the long 
phantoms (ICRU, 2012). This approach aims to keep the CTDI100 dosimetry 
equipment. It is based on the application of a function called 𝐺𝐺𝑥𝑥(𝐿𝐿), which 
is measured within the ICRU/AAPM phantom shown in Figure 2.10 (b) of 
Chapter 2.  
Li et al. (2013a) proposed a practical approach to avoid the use of long 
phantoms, which is suitable for stationary or moving table MSCT scans with 
beams of width ≤ 40 mm. This approach is based on the use of the CTDI100, 
the efficiency of CTDI100, and a function known as the approach to 
equilibrium function. Furthermore, Li et al. (2014b) proposed another 
practical approach for the stationary table mode employed for CBCT scans 
with beams of width 30 – 250 mm. This requires measurement of the 
cumulative dose using a small ionization chamber or a standard 100 mm 
long pencil ionization chamber within the standard PMMA phantoms, and 
the application of correction factors, which are equal to the ratios of the 
cumulative doses within infinitely long PMMA phantoms to those within the 
standard 150 mm long phantoms. 
Dixon and Boone (2014) also introduced two methods to address the long 
phantom issue for scans obtained with the stationary table mode. The first 
method requires a single measurement of cumulative dose for a beam of 
full width at half maximum (FWHM) > 24 mm within a long phantom as 
described in (AAPM, 2010) TG – 111. Subsequently, the cumulative dose for 
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any beam width of interest can be evaluated by multiplying the cumulative 
dose measured by the ratio of the approach to equilibrium functions for the 
beam width of interest H(a') and for the measured beam width H(a), where 
H(a) and H(a') are calculated using theoretical equations based on a 
mathematical model (Dixon and Boone, 2010). The second method is based 
on the use of an analytical formula to evaluate the cumulative dose for a 
given scan by calculating the primary beam dose component in CTDI100. 
The 𝐺𝐺𝑥𝑥(𝐿𝐿) function was investigated in ICRU Report–87 using MSCT scanners. 
However, dosimetry of the moving table mode differs slightly from that of 
the stationary table mode, which is the basis for CBCT scans such as those 
used in IGRT, in perfusion scans, in dental scans, and with interventional 
radiology and cardiology C-arm equipment. This chapter describes an 
investigation into the extension of the 𝐺𝐺𝑥𝑥(𝐿𝐿) function to CBCT applications. 
7.2 Materials and Methods 
7.2.1 The 𝑮𝑮𝑬𝑬(𝑳𝑳) Function 
Initially, the 𝐺𝐺(𝐿𝐿) function, proposed by ICRU, is defined as the ratio of the 
cumulative dose DL(0) at the middle (z = 0) of an infinitely long phantom, 
for a MSCT scan of length (L), to CTDIvol for the scan, as follows (ICRU, 
2012): 
𝐺𝐺(𝐿𝐿)  =  𝐷𝐷𝐿𝐿(0) 𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝑣𝑣𝑣𝑣𝑣𝑣 (7.1) 
Experimental measurements of the 𝐺𝐺(𝐿𝐿) function at the central axis of the 
ICRU/AAPM phantom at 120 kV reported in (ICRU, 2012) for three different 
MSCT scanners showed insignificant variations between the scanners. In 
addition, identical 𝐺𝐺(𝐿𝐿) functions were obtained for four different tube 
potentials 80, 100, 120 and 140 kV for one MSCT scanner. The 𝐺𝐺(𝐿𝐿) function, 
therefore, appeared to be independent of scan parameters such as tube 
potential, beam width, bowtie filter, SID, scanner table composition, and 
CT scanner model (ICRU, 2012). This independence occurs because the 
influence of scan parameters is cancelled out by the normalization of 𝐷𝐷𝐿𝐿(0) 
with respect to CTDIvol, and as a consequence, each phantom will have a 
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unique 𝐺𝐺(𝐿𝐿) function that can be used for any CT scanner depending only 
on phantom diameter and composition. This feature makes the ICRU 
approach efficient and practical in the clinical environment. When the 𝐺𝐺(𝐿𝐿) 
function is known, 𝐷𝐷𝐿𝐿(0) can be estimated for any scan of specified scan 
length (L) as 𝐷𝐷𝐿𝐿(0) =  𝐺𝐺(𝐿𝐿)  ×  𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝑣𝑣𝑣𝑣𝑣𝑣, where the CTDIvol is displayed on the 
console. 
Although the 𝐺𝐺(𝐿𝐿) function was only investigated at the central axis of the 
ICRU/AAPM phantom, ICRU suggested that the use of the 𝐺𝐺(𝐿𝐿) function can 
be extended to the periphery of the phantom and hence the weighted 
value. It can also be employed with other phantoms of varying composition 
and diameter such as head or body phantoms made of PMMA or water (ICRU, 
2012). Therefore, the 𝐺𝐺(𝐿𝐿) function of Eq.(7.1) can be redefined as:  
𝐺𝐺𝑥𝑥(𝐿𝐿)  =  𝐷𝐷𝐿𝐿(0)𝑥𝑥 𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝑣𝑣𝑣𝑣𝑣𝑣 (7.2) 
where the x indicates the position of the measurement within a phantom, 
with 𝑥𝑥 =  𝑛𝑛 for the centre or 𝑥𝑥 =  𝑝𝑝 for the periphery, and 𝑥𝑥 =  𝑊𝑊 for the 
weighted average measurements in the weighted function 𝐺𝐺𝑊𝑊(𝐿𝐿). 
7.2.2 Modified Function for CBCT Scans 
ICRU investigated and proposed the 𝐺𝐺𝑥𝑥(𝐿𝐿) function Eq.(7.2) for use with 
MSCT scanners with a moving table. The arrangement for CBCT usually uses 
a single rotation with a broader beam, a flat panel detector, and a 
stationary table. Therefore, the equivalent function should take the 
differences between conventional CT and CBCT scanners into account. The 
cumulative dose for CBCT scans at z = 0, which is equivalent to 𝐷𝐷𝐿𝐿(0)𝑥𝑥 in 
Eq.(7.2), is equal to 𝑁𝑁𝑓𝑓(0)𝑥𝑥, called 𝑁𝑁𝑓𝑓(0,∞)𝑥𝑥 in this project and presented 
in Chapter 2 section 2.6.4. 
The standard dose quantity CTDIvol will be replaced by CTDIw in Eq.(7.2), 
since there is no table movement and so no pitch to take into account. The 
length of the scan (L) equates to the beam width (W), as this determines 
the axial extent of the scan along the z-axis, i.e. rotation axis (Dixon and 
Boone, 2010). Therefore, 𝐺𝐺𝑥𝑥(𝐿𝐿) transforms to a function of beam width (W), 
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i.e. 𝐺𝐺𝑥𝑥(𝑊𝑊), and an equation of similar form to Eq.(7.2) can be defined for 
CBCT scans as: 
𝐺𝐺𝑥𝑥(𝑊𝑊)  =  𝑁𝑁𝑓𝑓(0,∞)𝑥𝑥 𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝑤𝑤  (7.3) 
The symbol (W) for the beam width of a CBCT scan should not be confused 
with (w) for the weighted CTDI (CTDIw). Both 𝐷𝐷𝐿𝐿(0)𝑥𝑥 and 𝑓𝑓(0,∞)𝑥𝑥 in the 
numerators of Eqs.(7.2) and (7.3) approach asymptotic values as the scan 
length (L) and the beam width (W), respectively, increase. This is because 
contributions from scatter originating further from the measurement point 
decline exponentially (ICRU, 2012, Dixon and Boone, 2010, Dixon and 
Boone, 2011). Therefore, 𝑓𝑓(0,∞)𝑥𝑥 in Eq.(7.3) can be expressed as 𝑓𝑓𝑊𝑊(0,∞)𝑥𝑥 
in a manner similar to that for 𝐷𝐷𝐿𝐿(0)𝑥𝑥, but to avoid confusion with the 
weighted value (w), 𝑓𝑓(0,∞)𝑥𝑥 notation has been used in this study. 
However, the fact that 𝐺𝐺𝑥𝑥(𝐿𝐿) is a function of the scan length, whereas 
𝐺𝐺𝑥𝑥(𝑊𝑊) is a function of the beam width means that Eqs.(7.2) and (7.3) are 
fundamentally different. This is because the denominators in the equations 
differ, CTDIvol for MSCT scans is independent of scan length L, whereas 
CTDIw for CBCT scans decreases with beam width W. The cumulative dose 
𝐷𝐷𝐿𝐿(0)𝑥𝑥 in the 𝐺𝐺𝑥𝑥(𝐿𝐿) function Eq.(7.2) is normalized with respect to CTDIvol. 
Thus, as the scan length (L) increases, 𝐷𝐷𝐿𝐿(0)𝑥𝑥 at the central and peripheral 
axes also increases, but approaches an equilibrium value at a length known 
as the equilibrium length (Leq), after which further contributions from 
scattered radiation to 𝐷𝐷𝐿𝐿(0)𝑥𝑥 become negligible (AAPM, 2010). The 
asymptotic curve that describes the dependence of 𝐷𝐷𝐿𝐿(0)𝑥𝑥 on scan length, 
reaches 98% of the equilibrium cumulative dose 𝐷𝐷𝑊𝑊𝑒𝑒(0)𝑥𝑥 at Leq, and is known 
as the approach to equilibrium function (AAPM, 2010). The 𝐺𝐺𝑥𝑥(𝐿𝐿) function 
has a similar dependence on L to  𝐷𝐷𝐿𝐿(0)𝑥𝑥 as CTDIvol in the denominator is 
constant. In contrast to 𝐺𝐺𝑥𝑥(𝐿𝐿), the 𝐺𝐺𝑥𝑥(𝑊𝑊) function in Eq.(7.3) increases 
almost linearly with beam width. Although 𝑓𝑓(0,∞)𝑥𝑥 values approach an 
equilibrium value in the same manner as 𝐷𝐷𝐿𝐿(0)𝑥𝑥 (Dixon and Boone, 2010), 
they are normalized with respect to the CTDIw, which decreases with 
increasing beam width (Boone, 2007, Kyriakou et al., 2008). In order to 
obtain a function with a similar asymptotic behaviour to 𝐺𝐺𝑥𝑥(𝐿𝐿), CTDIw has 
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been measured with a reference beam width (W ≤ 40mm) and the 𝐺𝐺𝑥𝑥(𝑊𝑊) 
function in Eq.(7.3) redefined as: 
𝐺𝐺𝑥𝑥(𝑊𝑊)  =  𝑁𝑁𝑓𝑓(0,∞)𝑥𝑥 𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝑤𝑤,𝑊𝑊𝑊𝑊𝑓𝑓 (7.4) 
where (𝐷𝐷𝐷𝐷𝑓𝑓) indicates the reference beam width used for CTDIw. In this 
study, a beam of width 40 mm was used to calculate the 𝐺𝐺𝑥𝑥(𝑊𝑊) functions. 
7.2.3 Monte Carlo for the 𝑮𝑮𝑬𝑬(𝑾𝑾) Functions 
Two scanning protocols (head and body) were used to investigate the 𝐺𝐺𝑥𝑥(𝑊𝑊) 
function. These protocols were almost the same as the Head-360 and Body-
360 listed in Chapter 5 Table 5.1. However, the tube potential was varied 
from 80 - 140 kV in increments of 20 kV, except that 125 kV was used 
instead of 120 kV for the body protocol as this is the potential used in the 
clinic. In addition, the beam widths studied were 40 – 500 mm. Parameters 
of the scanning protocols were used to generate PHSP files using BEAMnrc 
and then run in DOSXYZnrc as described in Chapter 4 section 4.4.2 to 
calculate values for 𝑓𝑓(0,∞) and CTDIw, for each protocol at each tube 
potential. DOSXYZnrc simulations used to calculate 𝑓𝑓(0,∞) and CTDIw were 
run until achieving a statistic uncertainty of <1% for each simulation.  
Eight phantoms made of PMMA, polyethylene (PE), and water representing 
head and body phantoms (Table 7.1) were designed in DOSXYZnrc as 
described in Chapter 4 section 4.4.2. The four PMMA phantoms were 
designed with diameters equal to those of the standard PMMA phantoms, 
and diameters of the head and body water phantoms were those 
recommended by AAPM TG – 111 (AAPM, 2010). It has been shown that CTDI∞ 
calculated in a PE phantom of diameter 160 mm is comparable to that of a 
PMMA phantom of similar diameter (Zhou and Boone, 2008), thus this 
diameter was used for the PE head phantom, whereas the body PE phantom 
recommended by ICRU/AAPM is 300 mm in diameter (Figure 2.10 (b)). The 
short PMMA phantoms (150 mm) represented the standard phantoms used 
for dosimetry in hospitals and were used to calculate CTDI100 values, and 
hence CTDIw values. The longer phantoms (600 mm) were considered to 
emulate the infinitely long phantoms, within which 𝑓𝑓(0,∞)𝑥𝑥 values for the 
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different phantom compositions were calculated. Only a single rotation 
𝑁𝑁 =  1 was used, and the 𝐺𝐺𝑥𝑥(𝑊𝑊) function was evaluated at the middle of 
the central and peripheral axes of the phantom and for the weighted value. 
Therefore, the 𝐺𝐺𝑥𝑥(𝑊𝑊) function was calculated for the PMMA, PE and water 
head and body phantoms using Eq.(7.4) as: 
𝐺𝐺𝑐𝑐(𝑊𝑊) =  𝑓𝑓(0,∞)𝑐𝑐,𝑚𝑚 𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝑤𝑤,40  
 
𝐺𝐺𝐸𝐸(𝑊𝑊) =  𝑓𝑓(0,∞)𝐸𝐸,𝑚𝑚 𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝑤𝑤,40  
 
𝐺𝐺𝑊𝑊(𝑊𝑊)  =  𝑓𝑓(0,∞)𝑤𝑤,𝑚𝑚 𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶𝑤𝑤,40  
(7.5) 
where (𝑚𝑚) represents the composition of the phantom (PMMA, PE or water) 
used to calculate 𝑓𝑓(0,∞)𝑥𝑥 values, and 𝑓𝑓(0,∞)𝑤𝑤 is calculated in a manner 
similar to that used for CTDIw, i.e. �𝑓𝑓(0,∞)𝑤𝑤 = 1/3 𝑓𝑓(0,∞)𝑐𝑐  +  2/3 𝑓𝑓(0,∞)𝐸𝐸�. Outputs from the DOSXYZnrc simulations were subsequently 
analyzed by a MATLAB code built in-house. 
Table 7.1: Densities, chemical compositions, diameters, and lengths of the PMMA, PE, 
and water phantoms used in this investigation. 
Phantom 
material  
Density (ρ) 
(g/cm3) 
Chemical 
composition 
Head 
diameter 
(mm) 
Body 
diameter 
(mm) 
Phantom 
length 
(mm) 
PMMA 1.19 C5O2H8 160 320 
150 
600 
PE 0.97 C2H4 160 300 600 
Water 1.0 H2O 200 300 600 
 
7.2.4 CTDI100 and 𝒇𝒇(𝟎𝟎,∞)𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷 Experimental Measurements 
The experimental set ups used for CTDI100 and 𝑓𝑓(0,∞)𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 measurements 
were similar to those used in Chapter 5 section 5.2.3 for CTDI100 
measurements and Chapter 6 section 6.2.3 for 𝑓𝑓(0,∞)𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 measurements. 
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7.3 Results and Discussion 
7.3.1 Study of the 𝑮𝑮𝑬𝑬(𝑾𝑾) Function as Dosimetry Variable for CBCT 
Assessment 
Figures 7.1 - 7.3 show the 𝐺𝐺𝑐𝑐(𝑊𝑊), 𝐺𝐺𝐸𝐸(𝑊𝑊), and 𝐺𝐺𝑊𝑊(𝑊𝑊) functions for the 
PMMA, PE, and water head and body phantoms for CBCT scans. The 
functions increased with beam width, tending towards equilibrium values 
for beam widths above about 400 mm. There were differences in 𝐺𝐺𝑐𝑐(𝑊𝑊) and 
𝐺𝐺𝐸𝐸(𝑊𝑊) functions with tube potential and these were larger for the body 
phantoms and increased with beam width. The results at the centre of the 
PE body phantom that represented the ICRU/AAPM phantom did not 
replicate the constant relationship with tube potential reported for MSCT 
scanners (ICRU, 2012). For the PMMA body phantom (Figure 7.1 (d – f)), the 
variations between tube potentials at the centre and periphery of the 
phantom for a beam of width 200 mm were in agreement with those for a 
CBCT scan of the same beam width obtained with a conventional CT 
scanner, a Somatom Definition dual source CT scanner, using MC 
simulations and the stationary table mode (Table 7.2) (Li et al., 2014b).  
Table 7.2: A comparison between 𝑮𝑮𝒄𝒄(𝑾𝑾) and 𝑮𝑮𝑬𝑬(𝑾𝑾) functions obtained in the study 
for a beam of width 200 mm calculated within the PMMA body phantom as in Eq.(7.5) 
at 80 – 140 kV and those from (Li et al., 2014b). 
Function 
This study (Li et al., 2014b) 
Centre Periphery Centre Periphery 
Gx(W = 200) – 80 kV 0.94 1.46 0.88 1.78 
Gx(W = 200) – 100 kV 1.04 1.44 0.94 1.75 
Gx(W = 200) – 120/125 kV(a) 1.09 1.41 0.97 1.74 
Gx(W = 200) – 140 kV 1.11 1.40 0.99 1.73 
(a) 125 kV was used for the body phantoms in this study, whereas 120 kV was used in (Li et 
al., 2014b).   
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Figure 7.1: 𝑮𝑮𝒄𝒄(𝑾𝑾), 𝑮𝑮𝑬𝑬(𝑾𝑾), and 𝑮𝑮𝒂𝒂(𝑾𝑾) functions for 𝒇𝒇(𝟎𝟎,∞)𝑬𝑬,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷 values calculated 
within 600 mm long PMMA phantoms and normalized with respect to CTDIw,40 values 
calculated within 150 mm long PMMA phantoms as in Eq.(7.5) using beams of width 
W = 40 – 500 mm. (a – c) for the head phantoms and (d – f) for the body phantoms 
(Table 7.1). 
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Figure 7.2: 𝑮𝑮𝒄𝒄(𝑾𝑾), 𝑮𝑮𝑬𝑬(𝑾𝑾), and 𝑮𝑮𝒂𝒂(𝑾𝑾) functions for 𝒇𝒇(𝟎𝟎,∞)𝑬𝑬,𝑷𝑷𝑬𝑬 values calculated within 
600 mm long PE phantoms and normalized with respect to CTDIw,40 values calculated 
within 150 mm long PMMA phantoms as in Eq.(7.5) using beams of width W = 40 – 500 
mm. (a – c) for the head phantoms and (d – f) for the body phantoms (Table 7.1). 
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Figure 7.3: 𝑮𝑮𝒄𝒄(𝑾𝑾), 𝑮𝑮𝑬𝑬(𝑾𝑾), and 𝑮𝑮𝒂𝒂(𝑾𝑾) functions for 𝒇𝒇(𝟎𝟎,∞)𝑬𝑬,𝒘𝒘𝒂𝒂𝒘𝒘𝒘𝒘𝒘𝒘 values calculated 
within 600 mm long water phantoms and normalized with respect to CTDIw,40 values 
calculated within 150 mm long PMMA phantoms as in Eq.(7.5) using beams of width 
W = 40 – 500 mm. (a – c) for the head phantoms and (d – f) for the body phantoms 
(Table 7.1). 
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Although 𝑓𝑓(0,∞)𝑐𝑐,𝑚𝑚 and 𝑓𝑓(0,∞)𝐸𝐸,𝑚𝑚 values at 140 kV were larger than those 
for other tube potentials as would be expected, values for 𝐺𝐺𝑐𝑐(𝑊𝑊) and 𝐺𝐺𝐸𝐸(𝑊𝑊) 
varied in different ways depending on phantom composition. Values of 
𝐺𝐺𝑐𝑐(𝑊𝑊) increased with tube potential for all phantoms, while those for 
𝐺𝐺𝐸𝐸(𝑊𝑊) decreased with tube potential for the PMMA and water phantoms, 
so that the differences in 𝐺𝐺𝑐𝑐(𝑊𝑊) and 𝐺𝐺𝐸𝐸(𝑊𝑊) tended to cancel to some extent 
in the derivation of 𝐺𝐺𝑊𝑊(𝑊𝑊) (Figures 7.1 - 7.3). The influence of tube 
potential on values for the 𝐺𝐺𝑥𝑥(𝑊𝑊) functions within the PMMA body phantom 
was in agreement with that found for a conventional CT scanner (Table 7.2) 
(Li et al., 2014b), where 𝐺𝐺𝑥𝑥(𝑊𝑊) at 80 kV was lower at the centre of the 
phantom but larger than other tube potentials at the periphery. Whereas 
for the PE phantoms both 𝐺𝐺𝑐𝑐(𝑊𝑊) and 𝐺𝐺𝐸𝐸(𝑊𝑊) increased with tube potential 
(Figure 7.2). The variations resulted from the influence of tube potential 
on the dose level at the centre and periphery of each phantom. Figures 7.2 
- 7.3 present measurements in phantoms made from PE and water, and can 
be compared with the standard PMMA phantoms in Figure 7.1. The reason 
for their contrasting behaviour relates to their different chemical 
compositions (Table 7.1), and the resulting energy dependence of the mass 
energy absorption coefficients, which determine the attenuation and 
distribution of energy absorption within the phantoms. Polyethylene 
contains only carbon and hydrogen atoms, whereas water and PMMA contain 
oxygen atoms. Considering changes in the attenuation as photon energy is 
reduced (<50 keV), the attenuation starts to rise more rapidly at slightly 
higher photon energies in PMMA and water due to the photoelectric 
absorption component than it does for PE. As a result, differences in 𝐺𝐺𝑐𝑐(𝑊𝑊) 
with tube potential are greater for PMMA (Table 7.1 (a and d)) and water 
(Figure 7.3 (a and d)), than for PE (Figure 7.2 (a and d)), while 𝐺𝐺𝐸𝐸(𝑊𝑊) values 
are greater for lower tube potentials for PE (Figure 7.2 (b and e)) than for 
PMMA and water, because the backscatter component is larger and the 
attenuation lower. 
The beam qualities for the kV system used in this study are similar to those 
for conventional CT scanners, the half value layers (HVLs) at 125 kV and 
100 kV being 8.7 mm and 7.55 mm Al, respectively. Moreover, the variations 
with tube potential found in this study are similar in form to those reported 
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for a CBCT scan obtained with a conventional CT scanner (Table 7.2), 
although slightly larger in magnitude. Therefore, it is likely that the 
variations found between the 𝐺𝐺𝑥𝑥(𝑊𝑊) functions (Figures 7.1 - 7.3) are not 
strongly influenced by the type of scanner CT or CBCT, but rather by use of 
the wider beams employed for CBCT scans. The main difference between 
the 𝐺𝐺𝑥𝑥(𝑊𝑊) Eq.(7.4) and 𝐺𝐺𝑥𝑥(𝐿𝐿)  Eq.(7.2) functions is the use of beam width 
(W) instead of scan length (L). In a conventional CT scanner, 𝐷𝐷𝐿𝐿(0)𝑥𝑥 
measurements at the centre and periphery of a phantom are built up from 
rotations of the same fan beam (≤ 40 mm) covering the specified length, 
and subsequently 𝐷𝐷𝐿𝐿(0)𝑥𝑥 values are normalized with respect to CTDIvol for 
the same beam width. However, in a CBCT scan, the beam is varied over a 
wide range of widths to measure 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 and subsequently normalized 
with respect to CTDIw,ref for a reference beam. The influence of scanning 
parameters at the centre and periphery of the phantom varies according to 
the change in geometry as the beam width increases from 40 mm to 500 
mm. Photons near the edges of wider beams pass through the phantoms at 
oblique angles, and are therefore more heavily attenuated. This will change 
the relative magnitudes of doses measured at the centres and peripheries 
of the phantoms, as well as the path length through the phantoms 
contributing to the scatter. All of these factors will change with tube 
potential, which alters the photon energy distribution within the beams. 
Moreover, these differences will also vary with the attenuation and 
scattering properties of the phantom material. For a conventional CT 
scanner, the variation in beam geometry along the phantom is 
comparatively small, and normalization of 𝐺𝐺𝑥𝑥(𝐿𝐿)  with respect to the 
CTDIvol, which averages the dose over the x-y plane, is capable of 
eliminating most of the scan parameter differences. This view is supported 
by the lower differences found at W = 40 mm compared to those for wider 
beams, which increased with beam width (Figures 7.1 - 7.3). However, the 
CTDIw for the narrow reference beam that has been used for normalization 
of 𝐺𝐺𝑥𝑥(𝑊𝑊) Eq.(7.4) will not give the same averaging of the dose that occurs 
with the different widths of cone beams. Therefore, the differences in the 
geometry of the beams is considered to be the main reason for the 
discrepancy found between the results at different tube potentials 
obtained in the study at the centre of the PE body phantom (Figure 7.2 (d)) 
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and those reported at the centre of the ICRU/AAPM phantom for a 
conventional CT scanner (ICRU, 2012). 
The discrepancies between values of the proposed function 𝐺𝐺𝑥𝑥(𝑊𝑊) Eq.(7.4) 
for different tube potentials demonstrate an inherent weakness in its 
application for CBCT scans. These could be reduced by normalizing with 
respect to variables that take more account of the differences in scanning 
parameters and beam width such as: 
(1) To normalize 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 with respect to CTDI100,x measured at the same 
position within the phantom (centre or periphery) instead of CTDIw. 
(2) To normalize every value of 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 with respect to CTDI100,x 
measured using the beam width (W) used for that 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 measurement 
instead of a reference beam width.  
For the first factor, Figures 7.4 - 7.5 show 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 values calculated 
within head and body phantoms of different compositions for beams of 
width 40 – 500 mm normalized with respect to CTDI100,x obtained at the 
same position within the standard PMMA phantoms using a reference beam 
width of 40 mm. This factor reduced the variations with tube potential 
significantly at some positions, such as at the centre of the PMMA body 
phantom (Figure 7.5 (a)), but did not reduce the differences in others, such 
as for the periphery of the PE phantom (Figures 7.4 - 7.5 (d)). However, 
when the second factor was combined with the first, taking account of the 
different beam geometries, the variations with tube potential declined 
markedly at all positions for the head phantoms (Figure 7.6) and body 
phantoms (Figure 7.7). The application of the two factors appeared not 
only to cancel out the influence of the scanning parameters, but also the 
type of the scanner, since results for beams of width 40 – 240 mm calculated 
within the PMMA phantoms were in good agreement with those for a 
conventional CT scanner (Li et al., 2014b) (Figures 7.6 - 7.7 (a – b)), and 
the differences shown in Table 7.2 were eliminated. As the range of beam 
widths used in the present study was wider than that in (Li et al., 2014b) 
(30 – 250) mm, a discrepancy between the results outside this range was 
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anticipated as clearly seen in Figure 7.7 (a). The curves for 
𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚/𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100,𝑥𝑥 (Figures 7.6 - 7.7) were entirely different from those 
for the 𝐺𝐺𝑥𝑥(𝑊𝑊) function (Figures 7.1 - 7.3), as expected from use of the same 
beam width to measure 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 and CTDI100,x as discussed in 
section 7.2.2. 
Although the normalisation of 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 with respect to CTDI100,x measured 
at the same position and beam width (Figures 7.6 - 7.7) allowed the 
variations in the 𝐺𝐺𝑥𝑥(𝑊𝑊) functions with tube potential to be minimized 
(Figures 7.1 - 7.3), the use of CTDI100,x for beams of width > 100 mm does 
not provide a good practical solution as CTDI100 values decline significantly 
when the primary beam width becomes wider than 100 mm as shown in 
Chapter 5 Figures 5.1 - 5.2. The influence of this decline on the 
𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚/𝐶𝐶𝐶𝐶𝐷𝐷𝐶𝐶100,𝑥𝑥 values can be seen clearly in Figures 7.6 - 7.7 as the 
function starts to rise more rapidly at W > 100 mm. Therefore, this work 
recommends that a modification to the denominator of the 𝐺𝐺𝑥𝑥(𝑊𝑊) function 
Eq.(7.4) is proposed to achieve an equation that will tend to an asymptotic 
function for wide beams, in a similar manner to the 𝐺𝐺𝑥𝑥(𝐿𝐿) function, but still 
be independent of scan parameters.  
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Figure 7.4: 𝒇𝒇(𝟎𝟎,∞)𝑬𝑬,𝒎𝒎 values calculated within 600 mm long head phantoms of different 
compositions using beams of width W = 40 – 500 mm and normalized with respect to 
CTDI100,x-40 measured at the same position within a 150 mm long PMMA head phantom 
(centre and periphery) using a reference beam of width W = 40 mm. (a – b) PMMA, (c 
– d) PE, and (e – f) water head phantoms (Table 7.1). 
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Figure 7.5: 𝒇𝒇(𝟎𝟎,∞)𝑬𝑬,𝒎𝒎 values calculated within 600 mm long body phantoms of different 
compositions using beams of width W = 40 – 500 mm and normalized with respect to 
CTDI100,x-40 measured at the same position within a 150 mm long PMMA body phantom 
(centre and periphery) using a reference beam of width W = 40 mm. (a – b) PMMA, (c 
– d) PE, and (e – f) water body phantoms (Table 7.1). 
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Figure 7.6: 𝒇𝒇(𝟎𝟎,∞)𝑬𝑬,𝒎𝒎 values calculated within 600 mm long head phantoms of different 
compositions using beams of width W = 40 – 500 mm and normalized with respect to 
CTDI100,x measured at the same position within a 150 mm long PMMA head phantom 
(centre and periphery) and with the same beam widths. (a – b) PMMA, (c – d) PE, and 
(e – f) water head phantoms (Table 7.1). 
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Figure 7.7: 𝒇𝒇(𝟎𝟎,∞)𝑬𝑬,𝒎𝒎 values calculated within 600 mm long body phantoms of different 
compositions using beams of width W = 40 – 500 mm and normalized with respect to 
CTDI100,x measured at the same position within a 150 mm long PMMA body phantom 
(centre and periphery) and with the same beam widths. (a – b) PMMA, (c – d) PE, and 
(e – f) water body phantoms (Table 7.1). 
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7.3.2 Investigation of a Modified Function 𝑮𝑮𝑬𝑬(𝑾𝑾)𝟏𝟏𝟎𝟎𝟎𝟎 for CBCT Scan 
Dosimetry 
The main concept of the 𝐺𝐺𝑥𝑥(𝐿𝐿) and 𝐺𝐺𝑥𝑥(𝑊𝑊) functions is to evaluate the 
cumulative doses 𝐷𝐷𝐿𝐿(0)𝑥𝑥 and 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚, while preserving the use of the CT 
dosimetry system, with the 100 mm pencil ionization chamber and the 
standard PMMA phantoms, which are available worldwide. Therefore, a 
modification should be applied to the denominator of the 𝐺𝐺𝑥𝑥(𝑊𝑊) function, 
CTDIw,ref. taking into account the influence of the two factors discussed in 
section 7.3.1. The dose index 𝑓𝑓100(150) presented in Chapter 2 section 2.6.3 
is based on evaluation of the dose in the middle of a scan of the standard 
PMMA phantoms averaged over the 100 mm length of a pencil ionization 
chamber. 𝑓𝑓100(150) is independent of wider beam widths, thus it is 
proposed for use in the denominator of a modified function 𝐺𝐺𝑥𝑥(𝑊𝑊)100 
defined as: 
𝐺𝐺𝑥𝑥(𝑊𝑊)100  =  𝑁𝑁𝑓𝑓(0,∞)𝑥𝑥 𝑓𝑓100(150)𝑥𝑥 (7.6) 
As CTDI100 and 𝑓𝑓100(150)𝑥𝑥 values are measured in the same manner, the MC 
results discussed in section 7.3.1 were re-analyzed to calculate 𝐺𝐺𝑥𝑥(𝑊𝑊)100 
as:  
𝐺𝐺𝑐𝑐(𝑊𝑊)100  =  𝑓𝑓(0,∞)𝑐𝑐,𝑚𝑚 𝑓𝑓100(150)𝑐𝑐 
 
𝐺𝐺𝐸𝐸(𝑊𝑊)100  =  𝑓𝑓(0,∞)𝐸𝐸,𝑚𝑚 𝑓𝑓100(150)𝐸𝐸 
 
𝐺𝐺𝑊𝑊(𝑊𝑊)100  =  𝑓𝑓(0,∞)𝑤𝑤,𝑚𝑚 𝑓𝑓100(150)𝑤𝑤 
(7.7) 
 
Figures 7.8 - 7.10 show the 𝐺𝐺𝑥𝑥(𝑊𝑊)100 functions calculated as described in 
Eq.(7.7) for the phantoms studied (Table 7.1). The functions show a weak 
dependency on tube potential with variations at some positions such as the 
periphery of the PE phantoms (Figure 7.9). However, the variations were 
much smaller than those found for the 𝐺𝐺𝑥𝑥(𝑊𝑊) functions (Figures 7.1 - 7.3) 
and did not vary significantly with beam width. The curves for the 𝐺𝐺𝑥𝑥(𝑊𝑊)100 
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functions were different from those for 𝐺𝐺𝑥𝑥(𝐿𝐿) and 𝐺𝐺𝑥𝑥(𝑊𝑊), because of the 
form of the 𝑓𝑓100(150)𝑥𝑥 function in the denominator. 𝐺𝐺𝑥𝑥(𝑊𝑊)100 decreased 
steadily with beam width until ~150 mm after which the functions rose 
slightly. For beams of width < 150 mm, 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 was greater than 
𝑓𝑓100(150)𝑥𝑥, but differences between the values decreased with increasing 
beam width. Values of 𝑓𝑓100(150)𝑥𝑥 were virtually constant for beams wider 
than 150 mm, as the outer parts of the beams did not interact with the 
phantom, whereas 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 values continued to rise approaching the 
equilibrium value 𝑓𝑓𝑊𝑊𝑒𝑒(0,∞)𝑥𝑥,𝑚𝑚. This explains the slight increase in 𝐺𝐺𝑥𝑥(𝑊𝑊)100 
for beams wider than 150 mm, especially at the centres of the phantoms. 
The relationship between the values for 𝑓𝑓100(150)𝑥𝑥 and 𝑓𝑓(0,∞)𝑥𝑥 have been 
discussed in detail in Chapter 6 Figures 6.3 - 6.6.  
The 𝐺𝐺𝑥𝑥(𝑊𝑊)100 function described in Eq.(7.6) provides an option for CBCT 
scans, which is relatively independent of tube potential in the range 80 – 
140 kV (Figures 7.8 - 7.10), that could be used for evaluating cumulative 
doses in long phantoms. This approach is well suited to CBCT applications 
such as those in radiotherapy, where the number of beam diameters and 
scanning parameters used is limited for the majority of examinations, and 
measurements of the 𝑓𝑓100(150)𝑥𝑥 within standard dosimetry phantoms can 
readily be made for the beam widths used clinically. The 𝐺𝐺𝑥𝑥(𝑊𝑊)100 
functions calculated within the PMMA phantoms were in good agreement 
with those calculated in (Li et al., 2014b) within the range 40 – 240 mm 
(Figure 7.8). Li et al. (2014b) used beams of width (30 – 250) mm, whereas 
a wider range was used in this study (40 – 500) mm. Thus, the discrepancy 
between the results outside this range was anticipated as explained earlier 
in section (7.3.1). 
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Figure 7.8: 𝑮𝑮𝒄𝒄(𝑾𝑾)𝟏𝟏𝟎𝟎𝟎𝟎, 𝑮𝑮𝑬𝑬(𝑾𝑾)𝟏𝟏𝟎𝟎𝟎𝟎, and 𝑮𝑮𝒂𝒂(𝑾𝑾)𝟏𝟏𝟎𝟎𝟎𝟎 functions for 𝒇𝒇(𝟎𝟎,∞)𝑬𝑬,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷 values 
calculated within the 600 mm long PMMA phantoms for beams of width 40 – 500 mm 
and normalized with respect to 𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(𝟏𝟏𝟏𝟏𝟎𝟎)𝑬𝑬 values calculated within the standard 150 
mm long PMMA phantoms as in Eq.(7.7). (a – c) for the head phantoms and (d – f) for 
the body phantoms (Table 7.1). Results are compared with values reported in (Li et 
al., 2014b) at 120 kV. 
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Figure 7.9: 𝑮𝑮𝒄𝒄(𝑾𝑾)𝟏𝟏𝟎𝟎𝟎𝟎, 𝑮𝑮𝑬𝑬(𝑾𝑾)𝟏𝟏𝟎𝟎𝟎𝟎, and 𝑮𝑮𝒂𝒂(𝑾𝑾)𝟏𝟏𝟎𝟎𝟎𝟎 functions for 𝒇𝒇(𝟎𝟎,∞)𝑬𝑬,𝑷𝑷𝑬𝑬 values 
calculated within the 600 mm long PE phantoms for beams of width 40 – 500 mm and 
normalized with respect to 𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(𝟏𝟏𝟏𝟏𝟎𝟎)𝑬𝑬 values calculated within the standard 150 mm 
long PMMA phantoms as in Eq.(7.7). (a – c) for the head phantoms and (d – f) for the 
body phantoms (Table 7.1). 
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Figure 7.10: 𝑮𝑮𝒄𝒄(𝑾𝑾)𝟏𝟏𝟎𝟎𝟎𝟎, 𝑮𝑮𝑬𝑬(𝑾𝑾)𝟏𝟏𝟎𝟎𝟎𝟎, and 𝑮𝑮𝒂𝒂(𝑾𝑾)𝟏𝟏𝟎𝟎𝟎𝟎 functions for 𝒇𝒇(𝟎𝟎,∞)𝑬𝑬,𝑾𝑾𝒂𝒂𝒘𝒘𝒘𝒘𝒘𝒘 values 
calculated within the 600 mm long water phantoms for beams of width 40 – 500 mm 
and normalized with respect to 𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(𝟏𝟏𝟏𝟏𝟎𝟎)𝑬𝑬 values calculated within the standard 150 
mm long PMMA phantoms as in Eq.(7.7). (a – c) for the head phantoms and (d – f) for 
the body phantoms (Table 7.1). 
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7.3.3 Derivation of Values of 𝑮𝑮𝑬𝑬(𝑾𝑾)𝟏𝟏𝟎𝟎𝟎𝟎 for Use in CBCT Dosimetry 
The 𝐺𝐺𝑥𝑥(𝑊𝑊)100 functions shown in Figures 7.8 - 7.10 were fitted to sixth-
order polynomial equations in order to allow the functions to be calculated 
for different beam widths. As some of the 𝐺𝐺𝑥𝑥(𝑊𝑊)100 functions were complex 
such as those at the centre of the body phantoms (Figures 7.8 - 7.10 (d)), 
sixth-order equations were required to fit the 𝐺𝐺𝑥𝑥(𝑊𝑊)100 functions with high 
R2 values. However, lower order polynomial equations can be obtained if 
only beams of width > 100 mm are considered. Coefficients of the fitted 
equations are given in Table 7.3, and these can be used to evaluate 
𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 for any beam width in the range 40 – 500 mm at tube potentials 
80 – 140 kV within the PMMA, PE, or water, head and body phantoms used 
in this study (Table 7.1). All that is required are measurements of 
𝑓𝑓100(150)𝑥𝑥 within the standard PMMA phantoms for the beam width (W) 
being used. Subsequently, 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 is calculated as follows: 
𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚  =   𝐺𝐺𝑥𝑥(𝑊𝑊)100 × 𝑓𝑓100(150)𝑥𝑥 (7.8) 
 
Table 7.4 shows experimental measurements for 𝑓𝑓(0,∞)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 made within 
PMMA head and body phantoms of length 450 mm, and for 𝑓𝑓100(150)𝑥𝑥 
measured within the standard 150 mm long PMMA phantoms using the 
clinical beam width 198 mm. These measurements were used to evaluate 
the 𝐺𝐺𝑥𝑥(𝑊𝑊)100 function experimentally as in Eq.(7.7). The experimental 
values for the 𝐺𝐺𝑥𝑥(𝑊𝑊)100 function were, then, compared against those 
calculated by MC (Table 7.3). As shown in Table 7.4, the experimental and 
MC values for the 𝐺𝐺𝑥𝑥(𝑊𝑊)100 function were in good agreement, where the 
average differences within the head and body phantoms were 3.45% and 
2.27%, respectively. 
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Table 7.3: Coefficients and R2 of equations for 𝑮𝑮𝑬𝑬(𝑾𝑾)𝟏𝟏𝟎𝟎𝟎𝟎 as a function of beam width W (in mm) for relationships shown in Figures 7.8 - 7.10. The 
functions were fitted to sixth-order polynomial equations for beams of width 40 – 500 mm at tube potentials 80 – 140 kV. 
𝑮𝑮𝑬𝑬(𝑾𝑾)𝟏𝟏𝟎𝟎𝟎𝟎 =  𝐏𝐏𝟏𝟏 𝐖𝐖𝟔𝟔  +  𝐏𝐏𝟐𝟐 𝐖𝐖𝟏𝟏  +  𝐏𝐏𝟑𝟑 𝐖𝐖𝟒𝟒  +  𝐏𝐏𝟒𝟒 𝐖𝐖𝟑𝟑  +  𝐏𝐏𝟏𝟏 𝐖𝐖𝟐𝟐  +  𝐏𝐏𝟔𝟔 𝐖𝐖 +  𝐏𝐏𝟕𝟕  
Coefficients 
Head Body 
Centre Periphery Weighted Centre Periphery Weighted 
 PMMA 
P1 2.721×10-15 6.906×10-15 5.459×10-15 9.872×10-16 6.396×10-15 5.057×10-15 
P2 -5.402×10-12 -1.304×10-11 -1.040×10-11 -2.301×10-12 -1.223×10-11 -9.778×10-12 
P3 4.339×10-09 9.891×10-09 7.975×10-09 2.154×10-09 9.429×10-09 7.636×10-09 
P4 -1.794×10-06 -3.841×10-06 -3.135×10-06 -1.028×10-06 -3.736×10-06 -3.070×10-06 
P5 3.982×10-04 8.001×10-04 6.618×10-04 2.585×10-04 7.980×10-04 6.659×10-04 
P6 -4.388×10-02 -8.393×10-02 -7.017×10-02 -3.076×10-02 -8.640×10-02 -7.283×10-02 
P7 2.947 4.484 3.956 2.483 4.728 4.183 
R2 0.99 0.99 0.99 0.98 0.99 0.99 
 PE 
P1 3.243×10-15 5.916×10-15 4.996×10-15 1.360×10-15 4.552×10-15 3.768×10-15 
P2 -6.347×10-12 -1.124×10-11 -9.556×10-12 -3.016×10-12 -8.814×10-12 -7.400×10-12 
P3 5.022×10-09 8.587×10-09 7.362×10-09 2.711×10-09 6.890×10-09 5.879×10-09 
P4 -2.046×10-06 -3.360×10-06 -2.909×10-06 -1.255×10-06 -2.772×10-06 -2.407×10-06 
P5 4.481×10-04 7.050×10-04 6.170×10-04 3.090×10-04 6.010×10-04 5.314×10-04 
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P6 -4.885×10-02 -7.417×10-02 -6.551×10-02 -3.611×10-02 -6.562×10-02 -5.861×10-02 
P7 3.135 4.065 3.746 2.769 3.719 3.492 
R2 0.99 0.98 0.98 0.99 0.96 0.96 
 Water 
P1 2.830×10-15 6.777×10-15 5.397×10-15 1.707×10-15 6.711×10-15 5.471×10-15 
P2 -5.607×10-12 -1.286×10-11 -1.032×10-11 -3.652×10-12 -1.292×10-11 -1.063×10-11 
P3 4.493×10-09 9.813×10-09 7.955×10-09 3.183×10-09 1.004×10-08 8.347×10-09 
P4 -1.853×10-06 -3.836×10-06 -3.144×10-06 -1.434×10-06 -4.012×10-06 -3.378×10-06 
P5 4.102×10-04 8.043×10-04 6.671×10-04 3.462×10-04 8.649×10-04 7.378×10-04 
P6 -4.493×10-02 -8.469×10-02 -7.089×10-02 -4.045×10-02 -9.434×10-02 -8.119×10-02 
P7 2.975 4.637 4.064 3.051 5.301 4.756 
R2 0.98 0.99 0.99 0.96 0.99 0.99 
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Table 7.4: Experimental measurements of 𝒇𝒇(𝟎𝟎,∞)𝑬𝑬,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷 within PMMA head and body phantoms 450 mm in length and 𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(𝟏𝟏𝟏𝟏𝟎𝟎)𝑬𝑬 in standard 150 mm 
long PMMA phantoms, using the clinical beam width 198 mm at 100 kV for the head and 125 kV for the body phantom. The 𝑮𝑮𝑬𝑬(𝑾𝑾)𝟏𝟏𝟎𝟎𝟎𝟎 functions for 
PMMA were calculated from the experimental measurements (Exp) using Eq.(7.7) and from the fitted equations in (Table 7.3) derived from MC results. 
The 𝑮𝑮𝑬𝑬(𝑾𝑾)𝟏𝟏𝟎𝟎𝟎𝟎 functions for PE and water were calculated from the fitted equations in (Table 7.3) as in Eq.(7.8). �𝑫𝑫𝑫𝑫𝒇𝒇𝒇𝒇𝒘𝒘𝒘𝒘𝒘𝒘𝑫𝑫𝒄𝒄𝒘𝒘 (%)  =
�𝑮𝑮𝑬𝑬(𝑾𝑾)𝟏𝟏𝟎𝟎𝟎𝟎,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷,𝑴𝑴𝑴𝑴  −  𝑮𝑮𝑬𝑬(𝑾𝑾)𝟏𝟏𝟎𝟎𝟎𝟎,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷,𝑬𝑬𝑬𝑬𝑬𝑬 / 𝑮𝑮𝑬𝑬(𝑾𝑾)𝟏𝟏𝟎𝟎𝟎𝟎,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷,𝑬𝑬𝑬𝑬𝑬𝑬 � ×  𝟏𝟏𝟎𝟎𝟎𝟎�. 
 Head phantom Body phantom 
 Centre Periphery Weighted Centre Periphery Weighted 
 PMMA 
𝑓𝑓(0,∞)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃,𝑃𝑃𝑥𝑥𝐸𝐸 (mGy/100 mAs) 2.50 2.26 2.34 1.62 1.98 1.86 
𝑓𝑓100(150)𝑥𝑥 (mGy/100 mAs) 2.32 2.18 2.22 1.29 1.84 1.66 
𝐺𝐺𝑥𝑥(𝑊𝑊)100,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃,𝑃𝑃𝑥𝑥𝐸𝐸 1.08 1.04 1.06 1.26 1.08 1.12 
𝐺𝐺𝑥𝑥(𝑊𝑊)100,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃,𝑃𝑃𝑀𝑀 1.13 1.07 1.09 1.22 1.06 1.10 
Difference (%) 4.63 2.88 2.83 -3.17 -1.85 -1.79 
 PE 
𝐺𝐺𝑥𝑥(𝑊𝑊)100,𝑃𝑃𝑃𝑃,𝑃𝑃𝑀𝑀 1.13 1.07 1.09 1.33 0.96 1.04 
𝑓𝑓(0,∞)𝑥𝑥,𝑃𝑃𝑃𝑃,𝑃𝑃𝑀𝑀 (mGy/100 mAs) 2.63 2.33 2.42 1.71 1.76 1.74 
 Water 
𝐺𝐺𝑥𝑥(𝑊𝑊)100,𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊,𝑃𝑃𝑀𝑀 1.15 1.20 1.18 1.37 1.29 1.31 
𝑓𝑓(0,∞)𝑥𝑥,𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊,𝑃𝑃𝑀𝑀 2.66 2.62 2.62 1.76 2.37 2.18 
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The experimental measurements for 𝑓𝑓100(150)𝑥𝑥 were also used to assess 
𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 within the PE and water head and body phantoms using Eq.(7.8). 
Table 7.4 shows that the 𝑓𝑓(0,∞)𝑐𝑐  value within the water head phantom was 
slightly larger than those in the PMMA and PE head phantoms, but all were 
within a factor of 1.06. 𝑓𝑓(0,∞)𝑐𝑐  within the water and PE body phantoms 
were comparable within a factor of 1.02 and slightly larger than that for 
the PMMA body phantom. These findings were consistent with CTDI∞ values 
of (Zhou and Boone, 2008). For the periphery, however, values for 𝑓𝑓(0,∞)𝐸𝐸 
calculated within the water head and body phantoms were greater than 
those for the PMMA and PE phantoms. 𝑓𝑓(0,∞)𝐸𝐸 for the water head and body 
phantoms were 16% and 20% larger, respectively, than those in the PMMA 
phantoms. These findings were also in agreement with those of (Zhou and 
Boone, 2008). 
7.3.4 Capability of the 𝑮𝑮𝑬𝑬(𝑾𝑾)𝟏𝟏𝟎𝟎𝟎𝟎 Functions for Different CT and 
CBCT Scanners 
As mentioned previously, ICRU compared the 𝐺𝐺𝑐𝑐(𝐿𝐿) functions for three 
different conventional CT scanners and reported that the parameters of any 
scan are cancelled out by normalization to the CTDIvol, and the effect of CT 
scanner model is also eliminated (ICRU, 2012). Li et al. (2014b) showed that 
their results obtained with a full 360° scan using a Somatom Definition dual 
source CT were in good agreement with those of a C-arm flat detector CT 
(Siemens Axiom Artis) acquired with a partial 200° scan without bowtie 
filters (Kyriakou et al., 2008), a Varian OBI system (Osei et al., 2009), and 
a Toshiba Aquilion ONE CT scanner (Geleijns et al., 2009). These 
investigations, including the (Li et al., 2014b) study as shown in Figure 7.8, 
were in good agreement with the results reported in the previous chapter 
(Tables 6.3 - 6.4). The results for CBCT scans acquired with a partial 200° 
scan were also found to be comparable to the those acquired with a full 
360° scan in Chapter 5 (Figures 5.1 - 5.2) and Chapter 6 (Figures 6.3 - 6.6). 
Moreover, the efficiency values for CTDI100 are comparable for a wide range 
of CT and CBCT scanners as shown in Chapter 5 (Table 5.4). Dixon and Boone 
(2010) compared the approach to equilibrium functions for two MSCT 
scanners (GE 16 channel and 64 channel scanners) and a CBCT scanner (256-
160 
 
 
slice CT scanner) employed with the stationary table mode, and again 
reported good agreement in results between scanners. 
These findings indicate that the effect of CT scanner is cancelled out when 
the effects of the scanning parameters are eliminated by using relative 
measurements, i.e. a dose ratio, of two dose indices measured with 
identical scanning parameters as discussed in sections 7.3.1 and 7.3.2. This 
may give a good indication for the suitability of utilizing the equations 
(Table 7.3) for different CT or CBCT scanners employed with wide beams 
40 – 500 mm and the stationary table mode at 80 – 140 kV taking into 
account the dependence of the functions on diameter and composition of 
the phantom. The functions 𝐺𝐺𝑥𝑥(𝐿𝐿) and 𝐺𝐺𝑥𝑥(𝑊𝑊)100 have been derived to allow 
the new dosimetry quantities to be calculated from measurements made 
with the standard equipment. The main strength of the 𝐺𝐺𝑥𝑥(𝐿𝐿) function for 
MSCT scanners proposed by (ICRU, 2012) and the modified function 
𝐺𝐺𝑥𝑥(𝑊𝑊)100 investigated in the present study is that they are relatively 
independent of scanning parameters including the tube potential. The 
functions enable the evaluation of 𝐷𝐷𝐿𝐿(0)𝑥𝑥 or 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 without the need 
for long phantoms of PMMA, PE, or water, which are heavy and difficult to 
handle in the scanning room and to transport between hospitals. 
7.4 Conclusion 
The aim of this study was to extend application of the 𝐺𝐺𝑥𝑥(𝐿𝐿) function, which 
can be used to derive the cumulative dose 𝐷𝐷𝐿𝐿(0)𝑥𝑥 in larger phantoms for 
standard MSCT scans (ICRU, 2012) to CBCT scans with stationary tables. The 
main difference is that the beam width (W) determines the length of the 
scan along the rotation axis (z–axis) rather than the number and pitch of 
the tube rotations. An analogous function 𝐺𝐺𝑥𝑥(𝑊𝑊) normalized with respect 
to the CTDIw of a narrow reference beam showed a dependence on tube 
potential that varied with phantom composition. This differed from results 
at the centre of the ICRU/AAPM PE body phantom reported for conventional 
CT scanners (ICRU, 2012). This is considered to be due to differences in 
geometry between the narrow fan beams used in MSCT scans and wide 
beams used for CBCT scans. A modified function 𝐺𝐺𝑥𝑥(𝑊𝑊)100, for which 
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cumulative doses 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 are normalized with respect to an alternative 
dose index 𝑓𝑓100(150)𝑥𝑥 measured by a 100 mm ionization chamber with 
similar scan parameters and beam width at the same position within 
standard PMMA phantoms, was found to be relatively independent of beam 
quality over the range of tube potentials 80 – 140 kV. The 𝐺𝐺𝑥𝑥(𝑊𝑊)100 
functions have been fitted to sixth-order polynomial equations, which can 
be utilized to evaluate 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 within infinitely long PMMA, PE and water 
head and body phantoms. These are valid for beam widths of 40 – 500 mm 
at 80 – 140 kV at the centres and peripheries of the phantoms. They allow 
cumulative doses in long phantoms to be evaluated from measurements of 
𝑓𝑓100(150)𝑥𝑥 at the centre and periphery of the standard PMMA phantoms for 
the beam of interest. It may be possible to apply the fitted equations to 
calculate cumulative doses for any CT or CBCT scan acquired with 
stationary table mode. Results of this study have been published in 
(Abuhaimed et al., 2015b). 
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Chapter 8  
The Efficiency of 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎)𝑬𝑬,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷 and 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎)𝑬𝑬,𝑷𝑷𝑬𝑬 in 
Evaluating 𝒇𝒇(𝟎𝟎,∞)𝑬𝑬,𝒎𝒎  
8.1 Introduction 
The suitability of using CTDI100 dosimetry equipment for the estimation of 
𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 was investigated in the previous chapter through the use of 
𝐺𝐺𝑥𝑥(𝑊𝑊)100 function. The 𝐺𝐺𝑥𝑥(𝑊𝑊)100 function has the potential to provide a 
practical approach to dosimetry avoiding the use of long phantoms. It is 
suitable for tube potentials of 80 – 140 kV, and serves as a correction factor 
applied to 𝑓𝑓100(150)𝑥𝑥 for CBCT scans. This chapter presents an investigation 
of two other approaches that might be utilized to avoid the use of long 
phantoms: (1) to investigate the possibility of using a small chamber within 
the standard PMMA phantoms 𝑓𝑓(0,150)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 to evaluate 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 based 
on the AAPM method (AAPM, 2010). This approach is similar to the concept 
behind the 𝐺𝐺𝑥𝑥(𝑊𝑊)100 function. The only difference is in the use a small 
ionization chamber instead of the standard 100 mm pencil ionization 
chamber. (2) As the density of PE is lower than that for PMMA (Chapter 7 
Table 7.1), and is widely available and low cost, the present study also 
investigated the suitability of using 150 mm long PE phantoms 𝑓𝑓(0,150)𝑥𝑥,𝑃𝑃𝑃𝑃 
for assessment of cumulative dose 𝑓𝑓(0,∞)𝑥𝑥,𝑃𝑃𝑃𝑃 within the long PE phantoms 
proposed by ICRU/AAPM shown in Chapter 2 Figure 2.10 (b). The 
relationships between results from the short and long phantoms studied 
using different scan parameters and beams of width 40 – 500 mm and tube 
potentials of 80 – 140 kV, were fitted to polynomial equations, from which 
conversion factors were derived to allow evaluation of the cumulative dose 
within a long phantom from a single measurement made within a standard 
PMMA phantom. 
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8.2 Materials and Methods 
8.2.1 The Efficiency of 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎) 
In order to investigate the possibility of making measurements with a small 
chamber within standard PMMA phantoms to evaluate cumulative doses 
measured under scatter equilibrium conditions in infinitely long phantoms 
𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚, the cumulative dose values measured in 150 mm long phantoms 
𝑓𝑓(0,150)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 were normalized with respect to 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚. The MC 
calculations were performed for head and body phantoms. 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 values 
were calculated in phantoms made from PMMA, PE and water. The results 
are expressed in terms of the efficiency of the standard PMMA phantoms in 
recording 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 as (Li et al., 2014b): 
𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑚𝑚)𝑥𝑥,𝑘𝑘𝑘𝑘  =  𝑓𝑓(0,150)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚  (8.1) 
where 𝑓𝑓(0,150)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 and 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 were calculated with the same 
nominal beam widths (W), scan parameters, and positions within the 
phantoms.  
The influence of the tube potential in the range studied on 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑚𝑚)𝑥𝑥,𝑘𝑘𝑘𝑘 
values was investigated by normalizing 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑚𝑚)𝑥𝑥,80𝑘𝑘𝑘𝑘, 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/
𝑚𝑚)𝑥𝑥,100𝑘𝑘𝑘𝑘 and 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑚𝑚)𝑥𝑥,140𝑘𝑘𝑘𝑘 values with respect to those of 
𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑚𝑚)𝑥𝑥,120𝑘𝑘𝑘𝑘 for the head phantom and 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑚𝑚)𝑥𝑥,125𝑘𝑘𝑘𝑘 for the 
body phantom as follows: 
𝐻𝐻𝐷𝐷𝑊𝑊𝑑𝑑 =  𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑚𝑚)𝑥𝑥,𝑘𝑘𝑘𝑘
𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑚𝑚)𝑥𝑥,120𝑘𝑘𝑘𝑘    ,   𝐶𝐶𝑜𝑜𝑑𝑑𝑦𝑦 =  𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑚𝑚)𝑥𝑥,𝑘𝑘𝑘𝑘𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑚𝑚)𝑥𝑥,125𝑘𝑘𝑘𝑘 (8.2) 
 
The suitability of a 150 mm long PE phantom 𝜀𝜀(𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 for assessment 
of cumulative doses in the ICRU/AAPM phantom was investigated in a 
similar manner and results presented in the form: 
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𝜀𝜀(𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘  =  𝑓𝑓(0,150)𝑥𝑥,𝑃𝑃𝑃𝑃𝑓𝑓(0,∞)𝑥𝑥,𝑃𝑃𝑃𝑃  (8.3) 
 
The scanning parameters employed to evaluate the efficiencies in Eqs.(8.1) 
and (8.3) were similar to those used for the 𝐺𝐺𝑥𝑥(𝑊𝑊)100 function in Chapter 
7, Head-360 and Body-360 presented in section 7.2.3. 
8.2.2 Conversion Factors for 𝒇𝒇(𝟎𝟎,∞)𝑬𝑬,𝒎𝒎 
From the efficiency values obtained in section 8.2.1, conversion factors (𝐶𝐶𝑓𝑓𝑠𝑠) for the scan parameters employed were derived. The main purpose 
was to allow the evaluation of 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 for the infinitely long head and 
body phantoms from single measurements made within standard PMMA 
phantoms 𝑓𝑓(0,150)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃. (𝐶𝐶𝑓𝑓𝑠𝑠) were derived as: 
𝐶𝐶𝑓𝑓(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑚𝑚)𝑥𝑥,𝑘𝑘𝑘𝑘  =  1𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑚𝑚)𝑥𝑥,𝑘𝑘𝑘𝑘  =  𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚𝑓𝑓(0,150)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 (8.4) 
 
Once 𝐶𝐶𝑓𝑓(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑚𝑚)𝑥𝑥,𝑘𝑘𝑘𝑘 is known, the cumulative doses under scatter 
equilibrium conditions for a specific beam width and at a given tube 
potential can then be assessed as: 
𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚  =  𝐶𝐶𝑓𝑓(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑚𝑚)𝑥𝑥,𝑘𝑘𝑘𝑘  ×  𝑓𝑓(0,150)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 (8.5) 
 
8.2.3 Monte Carlo Calculations of the Efficiency  
Parameters of the scanning protocols Head-360 and Body-360 were used to 
generate PHSP files using BEAMnrc and then run in DOSXYZnrc as described 
in section 4.4.2 to calculate the efficiency values as in Eqs.(8.1) and (8.3) 
for each protocol at each tube potential. The efficiency values were, then, 
used to derive the correction factors 𝐶𝐶𝑓𝑓(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑚𝑚)𝑥𝑥,𝑘𝑘𝑘𝑘 as in Eq.(8.4). The 
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phantom compositions and diameters were similar to those employed for 
the 𝐺𝐺𝑥𝑥(𝑊𝑊)100 function listed in Table 7.1. 
8.2.4 Experimental Measurements of 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎)𝑬𝑬,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷 and 
𝒇𝒇(𝟎𝟎,∞)𝑬𝑬,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷 
The accuracy of the correction factors derived from MC calculations in 
section 8.2.2 were evaluated by comparing the MC factors against those 
obtained from experimental measurements using the same scanning 
protocols Head-360 and Body-360. Moreover, in order to investigate the 
sensitively of the MC factors to the different scanning parameters  and 
equipment factors namely the bowtie filter, the scan diameter, and the 
acquisition mode, further experimental measurements were made using 
the scanning protocols Head-200 and Body-200. The set ups used for 
𝑓𝑓(0,150)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 and 𝑓𝑓(0,∞)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 measurements were similar to those 
described in Chapter 4 section 4.4.1.3 for 𝑓𝑓(0,150)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 measurements 
and Chapter 6 section 6.2.3 for 𝑓𝑓(0,∞)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 measurements.  
8.3 Results and Discussion 
8.3.1 The Efficiency of 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎)𝑬𝑬,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷 
Figure 8.1 shows the efficiency values 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑚𝑚)𝑥𝑥,𝑘𝑘𝑘𝑘 calculated using 
Eq.(8.1) at 120 kV for head phantoms and at 125 kV for body phantoms. 
𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 values at the central and peripheral axes declined as 
the beam width increased (Figure 8.1 (a and d)). The central 
𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝑐𝑐,𝑘𝑘𝑘𝑘 values for the head phantom were greater than those 
for the body, and the peripheral 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝐸𝐸,𝑘𝑘𝑘𝑘 ones were almost 
identical for the head and body phantoms, but higher than those at the 
centre. The variations in results at the centres of the phantoms arose from 
the differences in phantom diameters. There was less attenuation of the 
primary beam in the head phantom, so the scatter formed a proportionately 
smaller component of the measurement at the centre. 
In addition, Dixon and Boone (2011) showed that the scatter tails in the 
dose profile from a beam of width 28 mm at the centre of a PMMA body 
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phantom extended to ±200 mm, i.e. 400 mm along the rotation axis (z-
axis). Therefore, the scatter tails extend beyond the length of the standard 
phantoms, thus 𝑓𝑓(0,150)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 will not capture the entire absorbed dose 
that would be deposited in a longer phantom even for a narrow beam 
(Figure 8.1 (a and d)). The extents of the scatter tails, although related to 
the nominal beam width, are influenced by factors such as tube potential, 
phantom composition and diameter, the position within the phantom at 
which the measurements are made, and the use of a bowtie filter (Boone, 
2009, ICRU, 2012, Li et al., 2014a). This, therefore, affects the scatter to 
primary ratio (SPR) values, which were discussed in Chapter 6 section 6.3.3 
(Boone, 2009). The variations in SPR values and the inability of the standard 
phantoms to detect the whole scatter tails determine the variations in 
𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 values between the central and peripheral axes and 
between the phantoms. 
The relationship between 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 and beam width can be 
divided into three regions (Figure 8.1 (a and d)): (1) The first region 
extended from narrow beam widths up to ~150 mm. In this region, the 
whole primary beam was within the phantom length. Therefore, both 
𝑓𝑓(0,150)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 and 𝑓𝑓(0,∞)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 values increased with beam width, 
although the contribution from scattered radiation to 𝑓𝑓(0,∞)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 
increased more rapidly than that to 𝑓𝑓(0,150)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃. (2) The second region 
began at beam widths > 150 mm, when the beam extended beyond the 
length of the standard PMMA phantoms, so that a part of the primary beam 
did not contribute to the scattered radiation. As a result, 𝑓𝑓(0,150)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 
values were virtually constant, as further increases in beam width made a 
negligible contribution to measurements at z = 0. In contrast, 𝑓𝑓(0,∞)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 
continued to rise, and so 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 declined at both the centre 
and periphery of the phantoms. (3) The third region began when further 
increases in beam width led to minimal contributions to 𝑓𝑓(0,∞)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 
values. This occurred when the beam width approached the equilibrium 
value (𝑊𝑊𝑊𝑊𝑒𝑒), at which further increases in beam width made a negligible 
contribution to 𝑓𝑓(0,∞)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 as the scattered radiation did not reach the 
middle of the phantom (𝑧𝑧 =  0) (AAPM, 2010, Dixon and Boone, 2010). The 
equilibrium beam width, which depends on the phantom diameter and the 
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position within the phantom, is larger than 400 mm (AAPM, 2010, ICRU, 
2012). Since the increase in 𝑓𝑓(0,∞)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 in this region was much lower 
compared to the second region, the decline in 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 was 
less and values became virtually constant.  
Li et al. (2014b) studied 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 values for a Somatom 
Definition dual source CT scanner using MC simulations. The efficiency 
values were investigated for standard and 900 mm long head and body 
PMMA phantoms of the same diameters used in this study. The scan 
parameters were a tube potential of 120 kV, a full 360° rotation scan, head 
and body bowtie filters, and beams ranging in width from 30 mm to 250 
mm. As shown in (Figure 8.1 (a and d)), 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 values from 
this study are in good agreement with those of (Li et al., 2014b) within 
±1.53% and ±0.56% at the centre and periphery of the head phantom with 
variations of the mean of 0.72% and 0.10%, respectively, and within ±1.56% 
and ±0.55% for the body phantom with variations in the mean of 0.88% and 
0.28%, respectively. Although the kV systems (CT and CBCT scanners) and 
the lengths of the long phantoms were different in the two studies, the 
differences are minor.  
(Figure 8.1 (b and e)) and (Figure 8.1 (c and f)) show the efficiency values 
for 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 and 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑊𝑊𝑊𝑊𝑊𝑊𝐷𝐷𝐷𝐷)𝑥𝑥,𝑘𝑘𝑘𝑘, respectively. Although there 
are similarities in form with results comparing measurements in standard 
PMMA phantoms, there are substantial differences. 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 
results were for phantoms of similar diameter and composition, and so were 
only influenced by differences in the lengths of the phantoms. However, 
the 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 and 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑊𝑊𝑊𝑊𝑊𝑊𝐷𝐷𝐷𝐷)𝑥𝑥,𝑘𝑘𝑘𝑘 values are from comparisons 
of phantoms with different diameters, compositions, and lengths. 
Differences in diameter will affect attenuation of the transmitted beam 
reaching the centre, while differences in phantom material will alter the 
mass attenuation coefficients and mass energy-absorption coefficients, and 
hence both the attenuation and the extent of the scatter tails (Zhou and 
Boone, 2008, Boone, 2009).   
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Figure 8.1: The efficiency values calculated as in Eq.(8.1) for (a) 𝜺𝜺(𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷/
𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷)𝑬𝑬,𝟏𝟏𝟐𝟐𝟎𝟎𝒌𝒌𝒌𝒌 (b) 𝜺𝜺(𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷/𝑷𝑷𝑬𝑬)𝑬𝑬,𝟏𝟏𝟐𝟐𝟎𝟎𝒌𝒌𝒌𝒌 and (c) 𝜺𝜺(𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷/𝑾𝑾𝒂𝒂𝒘𝒘𝒘𝒘𝒘𝒘)𝑬𝑬,𝟏𝟏𝟐𝟐𝟎𝟎𝒌𝒌𝒌𝒌 at the centre and 
periphery of the head phantoms at 120 kV, and (d – f) for the body phantoms at 125 
kV. 𝜺𝜺(𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷/𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷)𝑬𝑬,𝒌𝒌𝒌𝒌 values for the head and body phantoms (a and d) were 
compared to those of (Li et al., 2014b) obtained within PMMA phantoms using a 
Somatom Definition dual source CT scanner at 120 kV and beams of width 30 – 250 
mm. 
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PMMA has a higher attenuation than both PE and water, and the standard 
PMMA body phantom has a larger diameter than those proposed for other 
phantoms (Table 7.1). Differences in the primary radiation transmitted to 
the centres of the phantoms are apparent in the lower ratios for narrow 
beams (Figure 8.1 (b - c and e - f)). The scatter component in measurements 
at the centres increased with beam width, thus the influence of attenuation 
of the primary beam on the dose level at the centre then declined and the 
efficiency values increased accordingly up to beam widths of the order of 
100 mm. Thereafter, the efficiency versus beam width relationships 
became similar to those from comparisons of PMMA phantoms (Figure 8.1 
(a and d)) and followed similar relationships in the second and third regions. 
The peripheral measurements for narrow beams were affected by the 
different intensities incident on the phantom surfaces, resulting from the 
different compositions, and hence the scattering properties. The ratios 
between PMMA and other materials declined with beam width more than 
the PMMA ratios. The lower ratio for the periphery than the centre for the 
water head phantom was a result of the large difference in PMMA and water 
phantom diameters, as well as the composition (Figure 8.1 (c) and 
Table 7.1).  
8.3.2 The Efficiency of 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎)𝑬𝑬,𝑷𝑷𝑬𝑬 
Comparisons were made between shorter and longer PE phantoms, as PE 
might present an alternative for standard hospital dosimetry phantoms. 
Figure 8.2 (a - b) shows 𝜀𝜀(𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 values at the centre and periphery of 
the head and body phantoms as a function of beam width calculated as in 
Eq.(8.3). Because 𝜀𝜀(𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 values were only affected by the difference 
in phantom lengths, the trends for 𝜀𝜀(𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 were similar to those for 
𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 (Figure 8.1 (a and d)). 𝜀𝜀(𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 values also 
exhibited the three regions observed for 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘. However, 
𝜀𝜀(𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 values within the head at 120 kV and body at 125 kV were 
lower than those for 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 at the same tube potentials by 
up to 1% and 3% at the centre and periphery of the head phantom, 
respectively, and 6% and 7% within the body phantom, respectively 
(Figure 8.2 (c - d)). The variations between 𝜀𝜀(𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 and 
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𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 values were found to increase with beam width 
beyond 150 mm, i.e. the length of the short phantoms. This is caused by 
the increased build-up of scattered radiation within the infinitely long PE 
phantom with increasing beam width due to the lower density compared to 
PMMA (ICRU, 2012). PE phantoms have broader dose spread functions, i.e. 
longer scatter tails (Boone, 2009), so that the decline in 𝜀𝜀(𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 with 
beam width is greater than for 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘. This means that the 
dose underestimation with standard PMMA phantoms will be less than with 
short PE phantoms, thus the current PMMA phantoms provide a better 
option for dosimetry. 
  
  
Figure 8.2: The efficiency values for 𝜺𝜺(𝑷𝑷𝑬𝑬/𝑷𝑷𝑬𝑬)𝑬𝑬,𝒌𝒌𝒌𝒌 calculated as in Eq.(8.3) within (a) 
head phantoms at 120 kV and (b) body phantoms at 125 kV. (c – d) The dose ratios for 
𝜺𝜺(𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷/𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷)𝑬𝑬,𝒌𝒌𝒌𝒌 values normalised with respect to 𝜺𝜺(𝑷𝑷𝑬𝑬/𝑷𝑷𝑬𝑬)𝑬𝑬,𝒌𝒌𝒌𝒌 values at the 
same tube potential and position within (c) head and (d) body phantoms. 
 
8.3.3 The Influence of Tube Potential on the Efficiency Values 
Figures 8.3 and 8.48.3 show the influence of tube potential on the 
efficiency values at the centre and periphery of the head and body 
phantoms. Differences in efficiency with tube potential were less for 
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𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘, where the composition is the same, but larger for 
phantoms of different compositions 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 and 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/
𝑊𝑊𝑊𝑊𝑊𝑊𝐷𝐷𝐷𝐷)𝑥𝑥,𝑘𝑘𝑘𝑘. The influence of tube potential was greater within the body 
phantoms (Figure 8.4) than the head phantoms (Figure 8.3). These 
variations resulted from the difference in diameters and compositions of 
the head and body phantoms and in the scatter tails with tube potentials 
80 – 140 kV (Boone, 2009). For 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘, the efficiency values 
for 80 kV were larger by up to 4.8% than for other tube potentials, but the 
differences between the values for 100 – 140 kV were within ±1%, which is 
in agreement with results of (Li et al., 2014b). 
The differences in efficiency values 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 with tube 
potential were similar at the centres and peripheries of the phantoms and 
increased with beam width, with the variations for the body phantom being 
slightly larger. The increase of the differences with beam width resulted 
from the build-up of scattered radiation. Differences in efficiency ratios for 
phantoms of different dimensions and compositions were larger, being up 
to ±10.5% for 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 and ±6.9% for 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑊𝑊𝑊𝑊𝑊𝑊𝐷𝐷𝐷𝐷)𝑥𝑥,𝑘𝑘𝑘𝑘 within 
the head and body phantoms. These larger variations were caused by the 
differences between the properties of the phantoms. For the peripheral 
measurements, values for 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃)𝐸𝐸,𝑘𝑘𝑘𝑘 at 80 kV were larger for both 
head and body phantoms, while values for 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑊𝑊𝑊𝑊𝑊𝑊𝐷𝐷𝐷𝐷)𝐸𝐸,𝑘𝑘𝑘𝑘 at 140 kV 
were larger. Ratios at the centres of the body phantoms 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃)𝑐𝑐,𝑘𝑘𝑘𝑘 
and 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑊𝑊𝑊𝑊𝑊𝑊𝐷𝐷𝐷𝐷)𝑐𝑐,𝑘𝑘𝑘𝑘 were the reverse of the periphery. This is linked 
to the higher photoelectric component in the attenuation of 80 kV x-rays in 
water than in PMMA, and in PMMA than in PE (Hubbell and Seltzer, 2004, 
Berger et al., 2010). However, the trends in 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃)𝑐𝑐,𝑘𝑘𝑘𝑘 and 
𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑊𝑊𝑊𝑊𝑊𝑊𝐷𝐷𝐷𝐷)𝑐𝑐,𝑘𝑘𝑘𝑘 for the head phantom did not show the same patterns, 
but the variations in dose within these phantoms are much smaller than the 
body phantoms. 
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Figure 8.3: The influence of tube potential on the efficiency values 𝜺𝜺(𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷/
𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷)𝑬𝑬,𝒌𝒌𝒌𝒌, 𝜺𝜺(𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷/𝑷𝑷𝑬𝑬)𝑬𝑬,𝒌𝒌𝒌𝒌, and 𝜺𝜺(𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷/𝑾𝑾𝒂𝒂𝒘𝒘𝒘𝒘𝒘𝒘)𝑬𝑬,𝒌𝒌𝒌𝒌 at the centre (c) and periphery 
(p) of the head phantoms. The efficiency values calculated at 80, 100 and 140 kV were 
normalized with respect to those for 120 kV. 
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Figure 8.4: The influence of tube potential on the efficiency values 𝜺𝜺(𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷/
𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷)𝑬𝑬,𝒌𝒌𝒌𝒌, 𝜺𝜺(𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷/𝑷𝑷𝑬𝑬)𝑬𝑬,𝒌𝒌𝒌𝒌, and 𝜺𝜺(𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷/𝑾𝑾𝒂𝒂𝒘𝒘𝒘𝒘𝒘𝒘)𝑬𝑬,𝒌𝒌𝒌𝒌 at the centre (c) and periphery 
(p) of the body phantoms. The efficiency values calculated at 80, 100 and 140 kV were 
normalized with respect to those for 125 kV. 
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8.3.4 Sensitivity of Conversion Factors for the kV System and Scan 
Parameters 
Conversion factors derived from MC calculations are provided in Tables 8.1 
- 8.3.  
Table 8.4 compares experimental measurements of 𝑓𝑓(0,150)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 and 
𝑓𝑓(0,∞)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 using the scanning protocols Head-200, Head-360, Body-200, 
and Body-360. The 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 values evaluated by using the Tables 8.1 - 8.3 
and Eq.(8.5). The differences between 𝑓𝑓(0,∞)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 values measured 
experimentally and those evaluated by application of the conversion 
factors using Eq.(8.5) were within ±2.9% and ±2.5% for the head and body 
phantoms, respectively ( 
Table 8.4). Although the MC calculations employed phantoms 600 mm in 
length and the experimental measurements were in 450 mm long phantoms, 
the differences between the experimental and calculated 𝑓𝑓(0,∞)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 
values were small. This is consistent with the recommendation of (AAPM, 
2010), where the length of the infinitely long phantom is required to be 
≥450 mm to provide the scatter equilibrium condition for cumulative dose 
measurements. The results provide further confirmation that in practice 
600 mm PMMA phantoms can be replaced by ones 450 mm in length. The 
use of four standard 150 mm long phantoms to create a 600 mm length 
would potentially leave an air gap in the middle parallel to the direction of 
the incidents x-rays, which could produce anomalous results, whereas a 450 
mm long phantom made from three standard ones avoids this issue. The 
differences between the values for 𝑓𝑓(0,∞)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃, 𝑓𝑓(0,∞)𝑥𝑥,𝑃𝑃𝑃𝑃 and 
𝑓𝑓(0,∞)𝑥𝑥,𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊 at the centres of head and body phantoms, and the 
peripheries of PMMA and water phantoms given in  
Table 8.4 were in agreement with results reported by (Zhou and Boone, 
2008, Li et al., 2013b). 
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Table 8.1: Coefficients for fitted equations to calculate the conversion factors 𝑴𝑴𝒇𝒇(𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷/𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷)𝑬𝑬,𝒌𝒌𝒌𝒌 to covert 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎)𝑬𝑬,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷 measurements made 
within the standard PMMA head and body phantoms to 𝒇𝒇(𝟎𝟎,∞)𝑬𝑬,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷 within infinitely long PMMA head and body phantoms as in Eq.(8.5). The 
conversion factors are suitable for beams of width 40 – 500 mm at tube potentials of 80 – 140 kV. 
 𝑴𝑴𝒇𝒇 =  𝑷𝑷𝟏𝟏 𝑾𝑾𝟔𝟔  +  𝑷𝑷𝟐𝟐 𝑾𝑾𝟏𝟏  + 𝑷𝑷𝟑𝟑 𝑾𝑾𝟒𝟒  +  𝑷𝑷𝟒𝟒 𝑾𝑾𝟑𝟑  +  𝑷𝑷𝟏𝟏 𝑾𝑾𝟐𝟐  + 𝑷𝑷𝟔𝟔 𝑾𝑾 +  𝑷𝑷𝟕𝟕 
 𝑯𝑯𝒘𝒘𝒂𝒂𝑯𝑯 −  𝑴𝑴𝒇𝒇(𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷/𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷)𝑬𝑬,𝒌𝒌𝒌𝒌 
 80 kV 100 kV 120 kV 140 kV 
Coefficients Centre Periphery Centre Periphery Centre Periphery Centre Periphery 
P1 -7.785×10-16 -3.793×10-16 -9.064×10-16 -4.597×10-16 -9.411×10-16 -3.897×10-16 -8.206×10-16 -4.657×10-16 
P2 1.248×10-12 6.029×10-13 1.437×10-12 7.181×10-13 1.485×10-12 6.250×10-13 1.312×10-12 7.352×10-13 
P3 -7.426×10-10 -3.560×10-10 -8.476×10-10 -4.170×10-10 -8.715×10-10 -3.722×10-10 -7.818×10-10 -4.314×10-10 
P4 1.965×10-07 9.365×10-08 2.230×10-07 1.081×10-07 2.281×10-07 9.848×10-08 2.076×10-07 1.129×10-07 
P5 -2.134×10-05 -1.012×10-05 -2.422×10-05 -1.156×10-05 -2.461×10-05 -1.063×10-05 -2.265×10-05 -1.222×10-05 
P6 1.002×10-03 4.564×10-04 1.134×10-03 5.245×10-04 1.144×10-03 4.913×10-04 1.088×10-03 5.605×10-04 
P7 0.9899 0.9957 0.9901 0.9948 0.9910 0.9954 0.9910 0.9946 
 𝑩𝑩𝑩𝑩𝑯𝑯𝑩𝑩 − 𝑴𝑴𝒇𝒇(𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷/𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷)𝑬𝑬,𝒌𝒌𝒌𝒌 
 80 kV 100 kV 125 kV 140 kV 
Coefficients Centre Periphery Centre Periphery Centre Periphery Centre Periphery 
P1 -1.298×10-15 -2.901×10-16 -1.587×10-15 -3.892×10-16 -1.498×10-15 -3.560×10-16 -1.522×10-15 -3.574×10-16 
P2 2.126×10-12 4.664×10-13 2.581×10-12 6.359×10-13 2.457×10-12 5.837×10-13 2.477×10-12 5.861×10-13 
P3 -1.304×10-09 -2.808×10-10 -1.579×10-09 -3.896×10-10 -1.512×10-09 -3.595×10-10 -1.516×10-09 -3.602×10-10 
P4 3.608×10-07 7.597×10-08 4.391×10-07 1.080×10-07 4.219×10-07 1.001×10-07 4.216×10-07 9.983×10-08 
P5 -4.197×10-05 -8.511×10-06 -5.263×10-05 -1.276×10-05 -5.037×10-05 -1.181×10-05 -5.031×10-05 -1.164×10-05 
P6 2.153×10-03 4.160×10-04 2.827×10-03 6.592×10-04 2.719×10-03 6.321×10-04 2.734×10-03 6.172×10-04 
P7 0.9871 0.9964 0.9785 0.9933 0.9813 0.9933 0.9805 0.9939 
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Table 8.2: Coefficients of fitted equations to calculate the conversion factors 𝑴𝑴𝒇𝒇(𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷/𝑷𝑷𝑬𝑬)𝑬𝑬,𝒌𝒌𝒌𝒌 to covert 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎)𝑬𝑬,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷 measurements made within 
the standard PMMA head and body phantoms to 𝒇𝒇(𝟎𝟎,∞)𝑬𝑬,𝑷𝑷𝑬𝑬 within infinitely long PE head and body phantoms as in Eq.(8.5). The conversion factors 
are suitable for beams of width 40 – 500 mm at tube potentials of 80 – 140 kV. 
 𝑴𝑴𝒇𝒇 =  𝑷𝑷𝟏𝟏 𝑾𝑾𝟔𝟔  +  𝑷𝑷𝟐𝟐 𝑾𝑾𝟏𝟏  + 𝑷𝑷𝟑𝟑 𝑾𝑾𝟒𝟒  +  𝑷𝑷𝟒𝟒 𝑾𝑾𝟑𝟑  +  𝑷𝑷𝟏𝟏 𝑾𝑾𝟐𝟐  + 𝑷𝑷𝟔𝟔 𝑾𝑾 +  𝑷𝑷𝟕𝟕 
 𝑯𝑯𝒘𝒘𝒂𝒂𝑯𝑯 − 𝑴𝑴𝒇𝒇(𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷/𝑷𝑷𝑬𝑬)𝑬𝑬,𝒌𝒌𝒌𝒌 
 80 kV 100 kV 120 kV 140 kV 
Coefficients Centre Periphery Centre Periphery Centre Periphery Centre Periphery 
P1 -4.650×10-16 -4.884×10-16 -4.307×10-16 -5.701×10-16 -5.628×10-16 -5.002×10-16 -3.823×10-16 -5.040×10-16 
P2 6.672×10-13 8.054×10-13 6.231×10-13 9.317×10-13 8.005×10-13 8.263×10-13 5.370×10-13 8.280×10-13 
P3 -3.149×10-10 -5.106×10-10 -2.906×10-10 -5.826×10-10 -3.802×10-10 -5.218×10-10 -2.346×10-10 -5.190×10-10 
P4 3.686×10-08 1.568×10-07 2.798×10-08 1.746×10-07 4.902×10-08 1.573×10-07 1.073×10-08 1.547×10-07 
P5 1.022×10-05 -2.534×10-05 1.267×10-05 -2.677×10-05 1.053×10-05 -2.407×10-05 1.559×10-05 -2.325×10-05 
P6 -2.008×10-03 2.695×10-03 -2.398×10-03 2.614×10-03 -2.386×10-03 2.366×10-03 -2.735×10-03 2.244×10-03 
P7 1.088 0.8088 1.112 0.8528 1.1290 0.8851 1.1490 0.9077 
 𝑩𝑩𝑩𝑩𝑯𝑯𝑩𝑩 − 𝑴𝑴𝒇𝒇(𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷/𝑷𝑷𝑬𝑬)𝑬𝑬,𝒌𝒌𝒌𝒌 
 80 kV 100 kV 125 kV 140 kV 
Coefficients Centre Periphery Centre Periphery Centre Periphery Centre Periphery 
P1 -1.202×10-15 -4.025×10-16 -1.226×10-15 -3.559×10-16 -1.169×10-15 -5.269×10-16 -1.449×10-15 -4.838×10-16 
P2 1.924×10-12 6.739×10-13 1.968×10-12 6.242×10-13 1.863×10-12 8.876×10-13 2.298×10-12 8.094×10-13 
P3 -1.125×10-09 -4.372×10-10 -1.159×10-09 -4.202×10-10 -1.080×10-09 -5.751×10-10 -1.344×10-09 -5.214×10-10 
P4 2.766×10-07 1.385×10-07 2.890×10-07 1.361×10-07 2.592×10-07 1.790×10-07 3.367×10-07 1.616×10-07 
P5 -2.099×10-05 -2.329×10-05 -2.281×10-05 -2.280×10-05 -1.685×10-05 -2.831×10-05 -2.813×10-05 -2.556×10-05 
P6 7.761×10-05 2.643×10-03 5.196×10-05 2.556×10-03 -5.470×10-04 2.815×10-03 1.341×10-04 2.620×10-03 
P7 1.1460 0.6870 1.139 0.7315 1.1560 0.7617 1.1470 0.7803 
  
 177 
 
Table 8.3: Coefficients for the fitted equations to calculate the conversion factors 𝑴𝑴𝒇𝒇(𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷/𝑾𝑾𝒂𝒂𝒘𝒘𝒘𝒘𝒘𝒘)𝑬𝑬,𝒌𝒌𝒌𝒌 to covert 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎)𝑬𝑬,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷 measurements made 
within standard PMMA head and body phantoms to 𝒇𝒇(𝟎𝟎,∞)𝑬𝑬,𝑾𝑾𝒂𝒂𝒘𝒘𝒘𝒘𝒘𝒘 within infinitely long water head and body phantoms as in Eq.(8.5). The conversion 
factors are suitable for beams of width 40 – 500 mm at tube potentials of 80 – 140 kV. 
 𝑴𝑴𝒇𝒇 =  𝑷𝑷𝟏𝟏 𝑾𝑾𝟔𝟔  +  𝑷𝑷𝟐𝟐 𝑾𝑾𝟏𝟏  + 𝑷𝑷𝟑𝟑 𝑾𝑾𝟒𝟒  +  𝑷𝑷𝟒𝟒 𝑾𝑾𝟑𝟑  +  𝑷𝑷𝟏𝟏 𝑾𝑾𝟐𝟐  + 𝑷𝑷𝟔𝟔 𝑾𝑾 +  𝑷𝑷𝟕𝟕 
 𝑯𝑯𝒘𝒘𝒂𝒂𝑯𝑯 − 𝑴𝑴𝒇𝒇(𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷/𝑾𝑾𝒂𝒂𝒘𝒘𝒘𝒘𝒘𝒘)𝑬𝑬,𝒌𝒌𝒌𝒌 
 80 kV 100 kV 120 kV 140 kV 
Coefficients Centre Periphery Centre Periphery Centre Periphery Centre Periphery 
P1 -5.643×10-16 -7.835×10-16 -7.507×10-16 -8.907×10-16 -8.374×10-16 -8.207×10-16 -7.737×10-16 -7.727×10-16 
P2 8.694×10-13 1.318×10-12 1.164×10-12 1.478×10-12 1.305×10-12 1.372×10-12 1.190×10-12 1.291×10-12 
P3 -4.764×10-10 -8.562×10-10 -6.549×10-10 -9.458×10-10 -7.432×10-10 -8.866×10-10 -6.671×10-10 -8.328×10-10 
P4 1.017×10-07 2.698×10-07 1.534×10-07 2.933×10-07 1.799×10-07 2.778×10-07 1.572×10-07 2.605×10-07 
P5 -3.481×10-06 -4.324×10-05 -1.086×10-05 -4.638×10-05 -1.484×10-05 -4.453×10-05 -1.193×10-05 -4.184×10-05 
P6 -5.984×10-04 3.795×10-03 -1.699×10-05 4.107×10-03 3.152×10-04 4.061×10-03 2.188×10-04 3.903×10-03 
P7 1.0320 0.9997 1.025 0.9599 1.0150 0.9362 1.0120 0.9201 
 𝑩𝑩𝑩𝑩𝑯𝑯𝑩𝑩 − 𝑴𝑴𝒇𝒇(𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷/𝑾𝑾𝒂𝒂𝒘𝒘𝒘𝒘𝒘𝒘)𝑬𝑬,𝒌𝒌𝒌𝒌 
 80 kV 100 kV 125 kV 140 kV 
Coefficients Centre Periphery Centre Periphery Centre Periphery Centre Periphery 
P1 -1.093×10-15 -5.884×10-16 -1.380×10-15 -6.676×10-16 -1.203×10-15 -6.76×10-16 -1.674×10-15 -7.497×10-16 
P2 1.757×10-12 1.015×10-12 2.190×10-12 1.157×10-12 1.966×10-12 1.15×10-12 2.677×10-12 1.272×10-12 
P3 -1.030×10-09 -6.788×10-10 -1.278×10-09 -7.751×10-10 -1.177×10-09 -7.65×10-10 -1.588×10-09 -8.358×10-10 
P4 2.508×10-07 2.211×10-07 3.188×10-07 2.517×10-07 2.990×10-07 2.46×10-07 4.122×10-07 2.667×10-07 
P5 -1.658×10-05 -3.676×10-05 -2.576×10-05 -4.154×10-05 -2.428×10-05 -4.07×10-05 -3.936×10-05 -4.345×10-05 
P6 -1.023×10-03 3.384×10-03 -3.284×10-04 3.823×10-03 -2.269×10-04 3.844×10-03 6.570×10-04 4.029×10-03 
P7 1.2700 1.1140 1.265 1.062 1.2580 1.024 1.2410 1.003 
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Table 8.4: Experimental measurements for 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎)𝑬𝑬,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷 and 𝒇𝒇(𝟎𝟎,∞)𝑬𝑬,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷 performed at the centre (c) and periphery (p) of standard and 450 mm 
long PMMA head and body phantoms using the scanning protocols Head-200, Head-360, Body-200, and Body-360. The 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎)𝑬𝑬,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷 values were 
used to estimate 𝒇𝒇(𝟎𝟎,∞)𝑬𝑬,𝒎𝒎 within the head and body PMMA, PE and water phantoms using the conversion factors given in Tables 8.1 – 8.3 and 
Eq.(8.5). �𝑫𝑫𝑫𝑫𝒇𝒇𝒇𝒇𝒘𝒘𝒘𝒘𝒘𝒘𝑫𝑫𝒄𝒄𝒘𝒘 (%)  =  �𝒇𝒇(𝟎𝟎,∞)𝑴𝑴𝑴𝑴 –  𝒇𝒇(𝟎𝟎,∞)𝑬𝑬𝑬𝑬𝑬𝑬 / 𝒇𝒇(𝟎𝟎,∞)𝑬𝑬𝑬𝑬𝑬𝑬�  ×  𝟏𝟏𝟎𝟎𝟎𝟎�.  
 𝑴𝑴𝒇𝒇−𝑴𝑴𝑴𝑴 
𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎)𝑬𝑬,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷,𝑬𝑬𝑬𝑬𝑬𝑬
mGy/100 mAs 
𝒇𝒇(𝟎𝟎,∞)𝑬𝑬,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷,𝑬𝑬𝑬𝑬𝑬𝑬
mGy/100 mAs 
𝒇𝒇(𝟎𝟎,∞)𝑬𝑬,𝒎𝒎,𝑴𝑴𝑴𝑴 
mGy/100 mAs Difference (%) 
 Partial Head 200° scan – 100 kV 
C-PMMA 
1.076 2.39 2.50 2.57 2.87 
1.069(a)   2.55 2.24 
C-PE 1.068   2.55  
C-Water 1.088   2.60  
P-PMMA 
1.034 2.18 2.26 2.25 -0.24 
1.032(a)   2.25 -0.46 
P-PE 1.029   2.24  
P-Water 1.174   2.56  
 Full Head 360° scan – 100 kV 
C-PMMA 
1.076 2.53 2.65 2.72 2.73 
1.069(a)   2.70 2.11 
C-PE 1.068   2.70  
C-Water 1.088   2.75  
P-PMMA 
1.034 2.27 2.34 2.35 0.33 
1.032(a)   2.34 0.10 
P-PE 1.029   2.34  
P-Water 1.174   2.66  
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 Partial Body 200° scan – 125 kV 
C-PMMA 
1.153 1.59 1.83 1.83 0.20 
1.157(a)   1.84 0.55 
C-PE 1.235   1.96  
C-Water 1.299   2.07  
P-PMMA 
1.036 2.30 2.35 2.38 1.42 
1.032(a)   2.37 0.99 
P-PE 0.953   2.19  
P-Water 1.239   2.85  
 Full Body 360° scan – 125 kV 
C-PMMA 
1.153 1.37 1.62 1.58 -2.48 
1.157(a)   1.59 -2.13 
C-PE 1.235   1.69  
C-Water 1.299   1.78  
P-PMMA 
1.036 1.91 1.98 1.98 -0.04 
1.032(a)   1.97 -0.46 
P-PE 0.953   1.82  
P-Water 1.239   2.37  
(a) Conversion factor calculated from the efficiency values provided in (Li et al., 2014b), which were obtained at 120 kV using a Somatom Definition 
dual source CT scanner. 
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Table 8.4 shows good agreement between experimental results with a 450 
mm phantom and evaluations of 𝑓𝑓(0,∞)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 from shorter phantoms with 
the same conversion factors for partial 200° scans, demonstrating that the 
conversion factors can also be applied to partial scans. This means that the 
conversion factors were relatively insensitive to the bowtie filter, the scan 
diameter, and the acquisition mode. The efficiency values of (Li et al., 
2014b) shown in (Figure 8.1 (a and d)), which were calculated for a 
Somatom Definition dual source CT scanner at 120 kV, were used to derive 
conversion factors using Eq.(8.4), and results using these were again in 
excellent agreement with those derived in this study. Thus the conversion 
factors appear insensitive to differences in scanner type and scan 
parameters. These findings are consistent with the discussion presented for 
the 𝐺𝐺𝑥𝑥(𝑊𝑊)100 function in Chapter 7 section 7.3.4. This insensitivity, 
therefore, provides an efficient method for developing generic 
coefficients, which may be suitable for a range of scanners. 
8.4 Conclusion 
The capability of using a small chamber within standard PMMA head and 
body phantoms 𝑓𝑓(0,150)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 for reporting the cumulative dose within 
infinitely long PMMA, PE and water phantoms 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 has been studied 
using MC calculations. The efficiency values were investigated using head 
and body scanning protocols over a wide range of beam widths from 40 – 
500 mm and tube potentials of 80 – 140 kV. The relationships between 
efficiencies for shorter phantoms of the same composition 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/
𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 and 𝜀𝜀(𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 were similar in form, exhibiting three distinct 
regions, a slow decline, followed by a rapid decline and then a levelling 
off. 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 values were larger than those for 𝜀𝜀(𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘, 
due to differences in density. However, 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 and 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/
𝑊𝑊𝑊𝑊𝑊𝑊𝐷𝐷𝐷𝐷)𝑥𝑥,𝑘𝑘𝑘𝑘 values were also affected by differences in phantom diameters 
and compositions, which influenced both the attenuation and proportion of 
scattered photons. 𝜀𝜀(𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 values were lower than those for 
𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘. Thus, the use of the standard PMMA phantoms to 
181 
 
 
estimate 𝑓𝑓(0,∞)𝑥𝑥,𝑘𝑘𝑘𝑘 provides a better option than the short PE phantoms. 
Tube potential had a minor influence on the efficiency values for 
𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘, but variations were more significant for 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/
𝑃𝑃𝑃𝑃)𝑥𝑥,𝑘𝑘𝑘𝑘 and 𝜀𝜀(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃/𝑊𝑊𝑊𝑊𝑊𝑊𝐷𝐷𝐷𝐷)𝑥𝑥,𝑘𝑘𝑘𝑘. The results indicated that 𝑓𝑓(0,150)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 
underestimated 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 values significantly for wider beams such as 
those used for CBCT scans. Therefore, it is necessary to use long phantoms 
(≥450 mm) to measure cumulative doses for such scans, or the use of 
conversion factors. Based on the efficiency values calculated, conversion 
factors have been derived at the centre and periphery of the phantoms for 
each tube potential to allow evaluation of 𝑓𝑓(0,∞)𝑥𝑥,𝑚𝑚 from single 
measurements of 𝑓𝑓(0,150)𝑥𝑥,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃. Based on comparisons shown in this study 
and those reported in the previous chapter, the conversion factors only 
showed a weak dependency on scanner type, and may be suitable for 
application to different CT and CBCT scanners. Results of this study have 
been published in (Abuhaimed et al., 2015c).  
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Chapter 9  
Dose Indices and Organ Doses 
9.1 Introduction 
Investigations into the dose indices (DIs) proposed for CBCT dosimetry have 
been described for phantoms of homogenous compositions and arbitrary 
diameters in Chapters 5 - 8. An aim in the development of DIs in standard 
phantoms has been to provide a measurement more akin to doses received 
by organs and tissues in the region of a scan (McCollough et al., 2011). But 
since organs are at different depths and inhomogeneous compositions, and 
the radiation fields may only cover parts of particular organs, they are 
regarded as dosimetry quantities and not associated with the doses actually 
received by the exposed organs. If this link could be improved, it would 
allow clinicians and physicists to be more aware of dose levels delivered to 
organs within the scanning field, which would be helpful in establishing a 
better link between the benefits of imaging and the potential risks. The DIs 
recorded in patient records for such exposures, would then be seen as 
giving a more direct assessment of doses from imaging exposures required 
by the Ionising Radiation (Medical Exposure) Regulations 2000, Regulation 
7(8) (IRMER, 2000). In order to assess how closely the various DIs based on 
different concepts can provide assessments of doses to radiosensitive 
organs, this chapter presents a study, which has been made for CBCT scans 
employed in the clinic for image guided radiation therapy (IGRT). The study 
has used MC simulations on the International Commission on Radiological 
Protection ICRP-110 adult male and female reference computational 
phantoms (ICRP, 2009) to evaluate organ doses (ODs). The investigation 
aimed to assess whether any of the DIs for CBCT scans can themselves give 
clinicians reasonable indications of doses to specific organs adjacent to 
those being treated to help inform their risk / benefit judgements.  
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9.2 Materials and Methods 
9.2.1 Dose Indices 
The various DIs investigated in the previous Chapters 5 – 8 were compared 
to ODs. Seven DIs were studied in this investigation: 
1- DI1: CTDI100, presented in Chapter 2 section 2.4. 
2- DI2: CTDIIEC, presented in Chapter 2 section 2.6.5. 
3- DI3: 𝑓𝑓100(150), presented in Chapter 2 section 2.6.3. 
4- DI4: 𝑓𝑓(0,150), presented in Chapter 2 section 2.6.2. 
5-DIs 5 - 7: 𝑓𝑓(0,∞)𝑚𝑚, presented in Chapter 2 section 2.6.4, where DI5: 
𝑓𝑓(0,∞)𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃, DI6: 𝑓𝑓(0,∞)𝑃𝑃𝑃𝑃, and DI7: 𝑓𝑓(0,∞)𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊. 
All the DIs were measured at the middle of the central axis (𝐷𝐷𝐶𝐶𝑐𝑐) and four 
peripheral axes (𝐷𝐷𝐶𝐶𝐸𝐸), from which a weighted DI (𝐷𝐷𝐶𝐶𝑤𝑤) is evaluated to 
account for the dose distribution over the x-y plane in a manner similar to 
that used for CTDIw as: 
𝐷𝐷𝐶𝐶𝑤𝑤  =  13 𝐷𝐷𝐶𝐶𝑐𝑐  +  23 𝐷𝐷𝐶𝐶𝐸𝐸 (9.1) 
where 𝐷𝐷𝐶𝐶𝐸𝐸 is the average of four measurements at the peripheral axes 
(𝐷𝐷𝐶𝐶𝐸𝐸  =  1/4 ∑ 𝐷𝐷𝐶𝐶𝐸𝐸,𝑖𝑖4i=1 ).  
9.2.2 The Scanning Protocols 
Three pre-configured scanning protocols, head, thorax, and pelvis, which 
are commonly employed in IGRT procedures, were studied, and parameters 
of these protocols are given in Chapter 2 Table 2.1. 
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9.2.3 Dose Indices Measurements 
The seven DIs were measured in the previous chapters using the head and 
body scanning protocols studied in this chapter. Values for DI1 and DI2 were 
measured in Chapter 5 and given in Table 5.3. Whereas, values for D3 and 
D4 were presented in Chapter 6 Table 6.2, and DIs 5 – 7 were given in 
Chapter 7 Table 7.4. Parameters of the head protocol were similar to those 
for the head scan (Table 2.1), and parameters of the body protocol were 
similar to those for the thorax and pelvis scans (Table 2.1). 
9.2.4  Monte Carlo Simulations for Organ Doses 
The use of MC simulation is considered as an efficient method for evaluation 
of ODs with a high level of accuracy, and facilitates the time-consuming 
experimental measurements that involve using dosimeters within human-
like phantoms such as anthropomorphic phantoms. MC simulations based on 
different MC systems such as EGSnrc have been utilized extensively to 
estimate ODs from CBCT scans employed in IGRT procedures using CT 
images of different phantoms or real patients as shown in Chapter 2 
Table 2.2. BEAMnrc and DOSXYZnrc were used to calculate ODs in three 
dimensions (3D) in terms of absorbed dose. Two simulations were run in 
BEAMnrc using fields of size 264 × 198 mm2 for the head scan and 478 × 198 
mm2 for the body scans, thorax and pelvis. The simulations were run with 
the same MC parameters used in Chapter 4 section 4.4.2. The PHSP files 
were recorded at a SSD of 75 cm, which subsequently were used in 
DOSXYZnrc as kV sources. 
ODs were evaluated in DOSXYZnrc using the ICRP-110 phantoms, which were 
based on whole body CT scans acquired for real patients, but by necessity 
represent a reference person of average build (ICRP, 2009). The main 
characteristics of the phantoms are given in Table 9.1. Each phantom is 
provided by the ICRP in a 3D matrix with a size of 254 × 127 × 222 and 299 
× 137 × 348 for the male and female phantoms, respectively. Each cell of 
these matrixes contains a unique number (ID) between 1 – 141, which 
represents a pre-defined organ or tissue. Each ID number is assigned to one 
of 53 different mediums, which were defined with different elemental 
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compositions and densities to simulate the organs and tissues. DOSXYZnrc 
format, however, also takes the form of a 3D matrix, but it consists of 
voxels of specific sizes, and each voxel is assigned with a certain medium 
as described in Chapter 3 section 3.7.2. Thus, the first step required is to 
convert the ICRP-110 phantoms to DOSXYZnrc format. A MATLAB-based 
code was developed, and the phantoms were converted using the same 
voxel size used for the ICRP CT scans, 2.137 × 2.137 × 8.0 mm3 for the male 
and 1.775 × 1.775 × 4.84 mm3 for the female. The mediums assigned for 
the DOSXYZnrc voxels were based on the elemental compositions and 
density values used in the ICRP-110 report (ICRP, 2009). All the mediums 
were defined in DOSXYZnrc using PEGS4 code. Figure 9.1 shows the coronal 
and sagittal views of the phantoms converted to DOSXYZnrc format, which 
were in agreement with those given in the ICRP-110 report (ICRP, 2009). 
Table 9.1: The main characteristics of the ICRP-110 male and female reference 
computational phantoms used in this study. The organ and tissue masses are 
reported in detail in ICRP-110 report (ICRP, 2009).  
Property Male Female 
Age (year) 38 43 
Height (m) 1.76 1.63 
Mass (kg) 73.0 60.0 
Slice thickness (voxel height, mm) 8.0 4.84 
Voxel in-plane resolution (mm) 2.137 1.775 
Voxel volume (mm3) 36.54 15.25 
Number of columns 254 299 
Number of rows 127 137 
Number of slices 222 348 
 
All the scans simulated were acquired at a SID of 100 cm, thus the distance 
between the PHSP files and the isocentre in DOSXYZnrc was set to 25 cm. 
For both the phantoms, the centre of the head scan (𝑧𝑧 =  0) was positioned 
at the middle of the head, and centre of the thorax and pelvic scans at the 
middle of the lung and pelvis, respectively. 4 × 109 and 8 × 109 histories 
were run for the male and female phantoms, respectively, to obtain a 
statistical uncertainty of <1% for voxels of all organs and tissues located 
within the scan field. ISOURCE = 8 of DOSXYZnrc code was employed with 
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projection numbers and gantry rotation set to the values listed in Table 2.1. 
The HOWFARLESS technique was not employed as it can only be utilized for 
homogeneous phantoms (Walters and Kawrakow, 2007). 
(a) (b) (c) (d) 
    
Figure 9.1: The coronal and sagittal views of the ICRP-110 (a–b) male and (c–d) female 
reference computational phantoms converted to DOSXYZnrc format. 
 
In order to evaluate the absorbed dose for each organ and tissue in 3D 
efficiently, a MATLAB-based code was developed to analyze the outputs of 
the DOSXYZnrc simulations in (.3ddose) format. As each organ and tissue 
was defined with an ID number, three 3D matrixes were created for each 
simulation. The first matrix was based on the ICRP file, where each cell 
contains an ID number. The second and third matrixes were based on the 
(.3ddose) file, where each voxel of the second matrix contains an absorbed 
dose value, and a statistical uncertainty value in the third matrix. These 
matrixes were linked together in the MATLAB code. The first step was to 
specify coordinates of the voxels that carried the same ID number in the 
first array, and the second step was to obtain the mean absorbed dose (𝐷𝐷𝑃𝑃𝑀𝑀) and the mean statistical uncertainty value for each ID number from 
the second and third matrixes based on the coordinates specified in the 
first step. 
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The mean absorbed dose (𝐷𝐷𝑃𝑃𝑀𝑀) for each organ and tissue is calculated from 
either a single or multiple ID numbers as described in the ICRP-110 (ICRP, 
2009), depending on whether the tissue comprises a single volume or 
separate regions. For example, the dose for the brain is represented by an 
ID number of 61, while that for the salivary glands is calculated from ID 
numbers of 120 and 121, which represent the left and right salivary glands, 
respectively. For organs and tissues evaluated from a single ID number, the 
mean absorbed dose (𝐷𝐷𝑃𝑃𝑀𝑀) was calculated as the mean value over all voxels 
assigned with the same ID number, such as the brain which consists of 37794 
and 81192 voxels for the male and female, respectively. However, for 
organs and tissues with multiple ID numbers, i.e. consisting of several 
separate regions of tissues, (𝐷𝐷𝑃𝑃𝑀𝑀) was calculated as the weighted absorbed 
dose as each ID number had different voxels number (𝑅𝑅𝑁𝑁): 
𝐷𝐷𝑃𝑃𝑀𝑀 =  ∑ 𝐷𝐷𝑃𝑃𝑀𝑀,𝑖𝑖 𝑅𝑅𝑁𝑁𝑖𝑖𝑝𝑝𝑖𝑖=1∑ 𝑅𝑅𝑁𝑁𝑖𝑖𝑝𝑝𝑖𝑖=1  (9.2) 
where 𝑛𝑛 is number of the ID numbers used to calculate the dose for a given 
organ or tissue, and 𝐷𝐷𝑃𝑃𝑀𝑀,𝑖𝑖.is the mean absorbed dose for each ID number. 
For example, 𝑛𝑛 =  2 was used for the salivary glands with 𝑅𝑅𝑁𝑁 being 2228 
and 2229 for the left and right salivary glands for the female, respectively. 
Once (𝐷𝐷𝑃𝑃𝑀𝑀) was calculated for each organ and tissue, it was converted from 
the MC output (𝐺𝐺𝑦𝑦/𝐷𝐷𝑛𝑛𝑛𝑛𝐷𝐷𝑑𝑑𝐷𝐷𝑛𝑛𝑊𝑊 𝑝𝑝𝑊𝑊𝐷𝐷𝑊𝑊𝐷𝐷𝑛𝑛𝑙𝑙𝐷𝐷) to the standard unit (𝐺𝐺𝑦𝑦) using the 
calibration factors (𝐹𝐹𝑃𝑃𝑀𝑀) determined in Chapter 4 section (4.5) as: 
𝑂𝑂𝐷𝐷 =  𝐷𝐷𝑃𝑃𝑀𝑀  ×  𝐹𝐹𝑃𝑃𝑀𝑀  ×  𝑚𝑚𝑃𝑃𝑠𝑠  (9.3) 
 
The statistical uncertainty 𝑆𝑆(𝑁𝑁), which was discussed in Chapter 3 
section 3.8, for each organ and tissue was also calculated as the mean value 
over all voxels assigned with the same ID number. However, the standard 
deviation and the statistical uncertainly values for organs and tissues with 
multiple ID numbers were also calculated as weighted values using: 
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𝑆𝑆(𝑁𝑁) = ��� 𝑅𝑅𝑁𝑁𝑖𝑖(∑ 𝑅𝑅𝑁𝑁𝑖𝑖)𝑝𝑝𝑖𝑖=1  𝑥𝑥𝑖𝑖�2𝑝𝑝𝑖𝑖=1  (9.4) 
where 𝑥𝑥𝑖𝑖 is the 𝑆𝑆(𝑁𝑁) for each ID number. 
The MATLAB code used to analyse (.3ddose) files was validated by 
comparing doses for some organs against known values calculated manually 
and by using STATDOSE code. The ability of each DI to assess ODs, was 
defined in terms of the difference between each DIw and the calculated 
ODs as: 
𝐷𝐷𝐷𝐷𝑓𝑓𝑓𝑓𝐷𝐷𝐷𝐷𝐷𝐷𝑛𝑛𝑛𝑛𝐷𝐷 (%)  =  �1 − 𝑂𝑂𝐷𝐷 
𝐷𝐷𝐶𝐶𝑤𝑤
� × 100 (9.5) 
 
9.3 Results and Discussion 
9.3.1 Organ Doses from the CBCT Scans 
The dose values for organs and tissues located within the field of the 
primary beam for each scan are listed in Tables 9.2 - 9.4. Although the 
scanning protocols were the same for the male and female phantoms, ODs 
were different being greater for the female in the majority of organs. The 
disparities arose from differences in length, weight, gender, and diameter 
between the phantoms (Table 9.1), and were in agreement with ones 
reported in other studies conducted for CT (Zhang et al., 2012a) and dental 
CBCT scans (Morant et al., 2013, Zhang et al., 2013b). For pelvic scans, for 
example, the colon dose in the female was more than double that in the 
male. This resulted partly because the primary beam was more attenuated 
in the thicker male phantom and partly because a larger part of the colon 
for the female was within the scan field because of the shorter length 
(Table 9.1). For both the phantoms, dose to the right eye from the head 
scan was larger than to the left eye by ~17%, because of the asymmetric 
gantry rotation, which began at 90° to left of the phantom and rotated 
through 200° beneath the head to the 290° position with a 20° extra 
rotation on right of the phantom (Table 9.2). 
189 
 
 
Table 9.2: Calculated mean absorbed doses in organs and tissues of the ICRP-110 
reference male and female phantoms in (mGy) from the head scan protocol 
 OD (mGy) 
Organ / Tissue Male Female 
 Head scan 
Bone-marrow (red) 3.8 (1.2 – 6.4) 5.38 (1.69 - 9.07) 
Extrathoracic (ET) region 2.3 (1.6 – 3.0) 3.64 (2.85 - 4.44) 
Oral mucosa 2.3 (1.5 – 3.2) 3.41 (2.56 - 4.26) 
Brain 3.0 (1.4 – 4.7) 3.39 (1.41 - 5.36) 
Salivary glands 4.5 (3.9 – 5.1) 5.35 (4.75 - 5.94) 
Eyes 1.1 (1.0 – 1.2) 1.09 (0.99 - 1.19) 
Eye lens 0.9 (0.9 – 1.0) 1.01 (1.00 - 1.03) 
Lymph nodes 5.8 (3.9 – 7.8) 7.83 (6.18 - 9.49) 
Skin 3.3 (0.8 – 5.8) 3.57 (0.62 - 6.51) 
 
Table 9.3: Calculated mean absorbed doses in organs and tissues of the ICRP-110 
reference male and female phantoms in (mGy) from the thorax scan protocol 
 OD (mGy) 
Organ / Tissue Male Female 
 Thorax scan 
Bone-marrow (red) 6.6 (4.5 – 8.8) 8.1 (6.0 – 10.2) 
Lung 7.6 (6.3 – 8.9) 9.7 (8.4 – 11.0) 
Stomach 3.4 (0.9 – 6.0) 2.7 (0.1 – 5.5) 
Breast 7.5 (7.4 – 7.7) 9.9 (9.4 – 10.5) 
Gall bladder 1.2 (0.8 – 1.7) 1.5 (1.2 – 1.9) 
Lymph nodes 2.8 (0.8 – 6.4) 3.3 (1.0 – 7.6) 
Heart 10.0 (8.3 – 11.7) 12.6 (11.0 – 14.1) 
Pancreas 1.2 (0.9 – 1.5) 0.9 (0.6 – 1.2) 
Spleen 3.4 (1.9 – 4.9) 3.4 (1.6 – 5.2) 
Thymus 11.2 (8.8 – 13.6) 13.2 (12.4 – 14.0) 
Oesophagus 6.1 (3.5 – 8.8) 7.9 (4.5 – 11.3) 
Liver 3.2 (1.1 – 5.3) 4.0 (0.7 – 7.3) 
Thyroid 2.5 (1.8 – 3.2) 3.3 (2.0 – 4.6) 
Skin 2.0 (0.6 – 4.7) 2.7 (0.4 – 5.7) 
Spinal cord 3.0 (0.3 – 5.7) 3.7 (0.2 – 7.1) 
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Table 9.4: Calculated mean absorbed doses in organs and tissues of the ICRP-110 
reference male and female phantoms in (mGy) from the pelvic scan protocol 
 OD (mGy) 
Organ / Tissue Male Female 
 Pelvic scan 
Bone-marrow (red) 29.1 (22.3 – 35.8) 34.0 (28.3 – 39.7) 
Lymph nodes 12.8 (5.9 – 31.5) 13.7 (4.2 – 31.5) 
Kidneys 1.3 (1.0 – 1.6) 2.3 (1.8 – 2.9) 
Colon 10.7 (8.6 – 12.8) 26.9 (20.8 – 33.0) 
Prostate / Uterus 32.4 (30.1 – 34.6) 36.6 (33.5 – 39.7) 
Small intestine 14.3 (0.7 – 29.4) 24.2 (4.4 – 44.1) 
Gonads (Testes / Ovary) 3.4 (2.8 – 4.0) 35.8 (34.7 – 37.0) 
Urinary Bladder 41.6 (32.7 – 50.6) 46.4 (36.0 – 56.8) 
Rectum 36.6 (35.7 – 37.5) 37.6 (35.8 – 39.5) 
Skin 9.8 (5.5 – 25.0) 11.5 (4.8 – 27.8) 
 
The statistical uncertainties in the dose calculations within each voxel for 
the majority of tissues were between 0.1% and 0.6%, with those for the 
lymph nodes and the skin being 1.8 – 2.5% and 2.7 – 3.8%, respectively, for 
scans of the thorax and pelvis. The skin and lymph nodes of the phantoms 
were divided into four regions: head, arms, trunk, and legs (ICRP, 2009), 
some of which were only partially irradiated in scans of the trunk. The 
statistical uncertainties for the male colon and kidney from the pelvic scan 
were relatively large, being 1.2% and 1.6%, respectively, and were larger 
than those for the female. This was related to the difference in the male 
and female phantom voxel sizes and the irradiated parts due to the 
differences in the phantoms. 
Results of this study have been compared with those from a study by 
(Montanari et al., 2014), which was based on MC simulations on CT scans 
for 25 adult brain and 25 prostate cancer patients. They calculated ODs 
resulting from head and pelvic CBCT scans using the same OBI system and 
scanning protocols. The mAs value used for the pelvic scan (686.4 mAs) was 
different from that in this study (1056 mAs), thus 686.4 mAs was used to 
calculate ODs from the pelvic scan for the comparison. Doses for some 
organs in the present study are compared in Table 9.5 and show good 
agreement. 
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Table 9.5: A comparison between organ doses (ODs) calculated in this study using 
ICRP-110 adult male phantom and those from (Montanari et al., 2014) using the same 
OBI system and scanning parameters. 
Organ This study OD (mGy) 
(Montanari et al., 2014)  
OD (mGy) 
 Head scan 
Brain 3.0 (1.4 – 4.7) 2.7 (1.9 – 3.3) 
Eyes 1.1 (1.0 – 1.2) 0.93 (0.3 – 2.4) 
 Pelvic scan 
Prostate 21.0 (19.6 – 22.5) 20.4 (11.6 – 30.6) 
Rectum 23.8 (23.2 – 24.4) 21.8 (14.4 – 28.8) 
Bladder 27.1 (21.2 – 32.9) 21.3 (11.5 – 31.5) 
 
9.3.2 Correlation between Dose Indices and Organ Doses 
Table 9.6 shows values for the DIs studied using the scanning parameters 
listed in Table 2.1. The DI1:CTDIw,100 was substantially lower than other 
indices, since the full width of the cone beam was not captured in the 100 
mm length of the measurement, although the result was divided by the full 
beam width.  
Table 9.6: Values for DIw in (mGy) for the DIs described in section 9.2.1 (DI1:CTDIw,100, 
DI2:CTDIw,IEC, DI3:𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(𝟏𝟏𝟏𝟏𝟎𝟎)𝒘𝒘, DI4:𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎)𝒘𝒘, DI5:𝒇𝒇(𝟎𝟎,∞)𝒘𝒘,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷, DI6: 𝒇𝒇(𝟎𝟎,∞)𝒘𝒘,𝑷𝑷𝑬𝑬, and 
DI7: 𝒇𝒇(𝟎𝟎,∞)𝒘𝒘,𝑾𝑾𝒂𝒂𝒘𝒘𝒘𝒘𝒘𝒘) using the three scanning protocols studied. 
Protocol DI1 DI2 DI3 DI4 DI5 DI6 DI7 
Head 1.66 2.92 3.29 3.31 3.59 3.59 3.88 
Thorax 2.21 3.81 4.38 4.57 4.82 4.56 5.74 
Pelvis 8.84 15.25 17.50 18.29 19.25 18.20 22.93 
 
Figures 9.2 - 9.4 show the difference values for the DIs calculated as in 
Eq.(9.5) to give an indication of their potential ability to evaluate ODs 
resulting from the scans studied. Since there were variations between ODs 
in the phantoms (Tables 9.2 - 9.4), the difference values varied. The 
relationship between the DIs and ODs varied for different scanning 
protocols: 
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The head scan (Figure 9.2): With the exception of DI1:CTDIw,100, for which 
results are plotted on a separate bar chart at the end, generally the DIs 
overestimated doses to eyes and eyes lens and underestimated doses to 
bone marrow, salivary gland and lymph nodes for both the phantoms. Doses 
to the male ET region, oral mucosa, and brain were overestimated, but 
were overestimated and underestimated differently by DIs for the female 
phantom. The skin dose for both the phantoms were overestimated by some 
DIs, but underestimated by the other DIs. The best evaluation by the DIs 
was obtained for skin and brain within ±22% for the male and female 
phantoms, and the largest differences were for lymph node dose up to 100% 
for the male and 168% for the female. All the DIs apart from DI1:CTDIw,100 
overestimated the doses to the eyes and eye lenses by 62 – 76%, as might 
be expected since the eyes were only exposed indirectly to x-rays that had 
first passed through the head. DI5: 𝑓𝑓(0,∞)𝑤𝑤,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 was larger than the eye 
lens and skin doses by 74% and 7%, respectively, for the male and by 72% 
and 1%, respectively, for the female. This was in agreement with a dose 
study for CT neuro-perfusion scans using different MC adult phantoms and 
scanners employed with different tube potentials (Zhang et al., 2013a), 
where the differences ranged from -9% to 66% for the eyes lens and from -
14% to 33% for the skin. DI1:CTDIw,100, underestimated doses to the bone 
marrow, brain, salivary glands, lymph nodes, and skin significantly for both 
the phantoms by up to 372%. In general, the difference values between ODs 
and the DIs for the male phantom were lower than those for the female 
one. 
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Figure 9.2: The ability of the DIs to evaluate organ doses listed in Table 9.2 in terms of the difference as in Eq.(9.5) for the head scan using the ICRP-
110 reference male and female phantoms. (DI1:CTDIw,100, DI2:CTDIw,IEC, DI3:𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(𝟏𝟏𝟏𝟏𝟎𝟎)𝒘𝒘, DI4:𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎)𝒘𝒘, DI5:𝒇𝒇(𝟎𝟎,∞)𝒘𝒘,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷, DI6: 𝒇𝒇(𝟎𝟎,∞)𝒘𝒘,𝑷𝑷𝑬𝑬, and 
DI7: 𝒇𝒇(𝟎𝟎,∞)𝒘𝒘,𝑾𝑾𝒂𝒂𝒘𝒘𝒘𝒘𝒘𝒘). The difference values for DI1:CTDIw,100 were shown separately due to the large differences. O1: Bone marrow (red) followed by O2: 
(ET) region, and etc. 
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The thorax scan (Figure 9.3): Most DIs other than DI1:CTDIw,100 
overestimated doses to the stomach, lymph nodes, spleen, liver, thyroid, 
spinal cord and skin by less than 50% and pancreas and gall bladder by up 
to 84%. Doses to the bone marrow, lung, breast, and oesophagus were 
underestimated by between 7% and 161%, and some DIs underestimated 
dose to the heart and thymus by over 200%. The difference values between 
the male and female scans for each organ were less than those for the head 
scan (Figure 9.2). The lowest differences found between the DIs and ODs 
were for the male stomach and spleen within 44% and for the female liver 
within 31%, and the largest differences were for thymus doses up to 194% 
for the male and 246% for the female. Overall, differences between the IDs 
and ODs were lower for the male than the female, as with the head scan. 
DI1:CTDIw,100 underestimated doses for organs significantly such as the bone 
marrow, lung, breast, heart thymus and oesophagus for both the phantoms 
by 178 – 497%. 
The pelvic scan (Figure 9.4): Doses evaluated by most DIs for lymph nodes, 
colon, small intestine and skin, other than DI1:CTDIw,100, were within ±50% 
of the ODs. The DIs overestimated doses for the lymph nodes, kidney and 
skin, but underestimated those for the bone marrow, prostate, uterus, 
urinary bladder, and rectum. Doses for the colon, small intestine and 
gonads were overestimated by the DIs for the male but underestimated for 
the female. The best estimation was obtained for the male small intestine 
within 38% and the female lymph nodes within 40%, and the largest 
differences were for urinary bladder doses up to 77% and 204% for the male 
and female, respectively. The differences between the DIs and ODs were 
lower for the male phantom than for the female one, as for the head and 
thorax scans, and most of the female organs 7/10 were underestimated. 
The CTDIw,100 values were much lower than most of the ODs, and 
underestimated them by up to 371% and 425% for the male and female, 
respectively. 
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Figure 9.3: The ability of the DIs to evaluate organ doses listed in Table 9.3 in terms of the difference as in Eq.(9.5) for the thorax scan using the ICRP-
110 reference male and female phantoms. (DI1:CTDIw,100, DI2:CTDIw,IEC, DI3:𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(𝟏𝟏𝟏𝟏𝟎𝟎)𝒘𝒘, DI4:𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎)𝒘𝒘, DI5:𝒇𝒇(𝟎𝟎,∞)𝒘𝒘,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷, DI6: 𝒇𝒇(𝟎𝟎,∞)𝒘𝒘,𝑷𝑷𝑬𝑬, and 
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DI7: 𝒇𝒇(𝟎𝟎,∞)𝒘𝒘,𝑾𝑾𝒂𝒂𝒘𝒘𝒘𝒘𝒘𝒘). The difference values for DI1:CTDIw,100 were shown separately due to the large differences. O1: Bone marrow (red) followed by O2: 
Lung, and etc. 
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Figure 9.4: The ability of the DIs to evaluate organ doses listed in Table 9.4 in terms of the difference as in Eq.(9.5) for the pelvic scan using the ICRP-
110 reference male and female phantoms. (DI1:CTDIw,100, DI2:CTDIw,IEC, DI3:𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(𝟏𝟏𝟏𝟏𝟎𝟎)𝒘𝒘, DI4:𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎)𝒘𝒘, DI5:𝒇𝒇(𝟎𝟎,∞)𝒘𝒘,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷, DI6: 𝒇𝒇(𝟎𝟎,∞)𝒘𝒘,𝑷𝑷𝑬𝑬, and 
DI7: 𝒇𝒇(𝟎𝟎,∞)𝒘𝒘,𝑾𝑾𝒂𝒂𝒘𝒘𝒘𝒘𝒘𝒘). The difference values for DI1:CTDIw,100 were shown separately due to the large differences. O1: Bone marrow (red) followed by O2: 
Lymph nodes, and etc. 
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In general the differences between DI1: CTDIw,100 and ODs was larger than 
for the other IDs (Figures 9.2 - 9.4), thus it was not included in the general 
discussion. The purpose of the DIs is to provide practical measures that can 
be used to evaluate scanner performance that have a link to the dose within 
the body of a patient (Kalender, 2014). Doses to radiosensitive organs 
determine the risk from radiation and it has become clear in recent years 
that any assessment of risk should be based on doses to individual patients 
(McCollough et al., 2011, AAPM, 2011). It would be helpful to have more 
direct links between the measured dose quantities and ODs, in order to 
improve the knowledge and understanding of radiation professionals in 
healthcare. The uncertainties in any assessment of organ doses are large 
by their very nature (Martin, 2007), being based on simulations involving 
reference phantoms, which cannot represent even subtle differences 
between individuals, let alone large differences in body size and shape. It 
is apparent that even differences between the heads of reference male and 
female phantoms can give different doses, of the order of ±100% 
(Figure 9.2), thus it would be a vain hope that any DI could achieve an 
accurate evaluation for ODs. It is apparent from the analyses of differences 
between the DIs and ODs (Figures 9.2 - 9.4) that some DIs could provide 
values for doses to organs within the scan field. This would provide the 
radiotherapy clinician with an indication of the doses that are being 
delivered by imaging to other organs in the region of the body close to the 
radiotherapy target volume.  
From the results (Figures 9.2 - 9.4), it is apparent that the DIs give 
assessments for doses to a number of organs in the reference phantom 
within about ±50%, which is similar to the uncertainty in the dose 
calculations for many organs (Martin, 2007). Doses to more distributed 
tissues such as the skin, lymph nodes and bone marrow had high 
uncertainties and are difficult to visualize in terms of doses to organs within 
the field. Doses to some organs were deviated by much more than 50%, such 
as the heart, pancreas, breast, gall bladder and thymus in the thorax scans, 
and the kidneys, prostate, bladder, rectum and gonads in the pelvic scans. 
However, focussing on the more exposed organs and those known to have 
a higher associated stochastic risk, Table 9.7 shows the differences 
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between ODs and some of the DIs, DI2:CTDIw,IEC, DI3: 𝑓𝑓100(150)𝑤𝑤, 
DI4: 𝑓𝑓(0,150)𝑤𝑤, and DI6: 𝑓𝑓(0,∞)𝑤𝑤,𝑃𝑃𝑃𝑃, where DI6 represented measurements 
within the ICRU/AAPM phantom. The DIs underestimated doses to the lungs 
and female breast, but doubling these DIs would give values close to the 
ODs. Thus multiplying the dose index by two provides a possible option and 
is included in Table 9.7. Moreover, DI3: 𝑓𝑓100(150)𝑤𝑤 and DI4: 𝑓𝑓(0,150)𝑤𝑤 could 
be taken as a reasonable indication of doses to selected organs for each 
type of scan. 
Table 9.7: The differences between some of the DIs, DI2:CTDIw,IEC, DI3: 𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(𝟏𝟏𝟏𝟏𝟎𝟎)𝒘𝒘, 
DI4: 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎)𝒘𝒘, and DI6: 𝒇𝒇(𝟎𝟎,∞)𝒘𝒘,𝑷𝑷𝑬𝑬 and some organs of the ICRP-110 reference male 
and female phantoms, which have a higher associated stochastic risk. 
Phantom Male Female 
DIs DI2 DI3 DI4 DI6 DI2 DI3 DI4 DI6 
 Deviation (%) Deviation (%) 
Organ Head scan 
Brain -4 7 8 15 -16 -3 -2 -5 
Salivary glands -55 -38 -37 -26 -38 -63 -62 -49 
 Thorax scan 
Breast     -161 -127 -117 -118 
Breast (DIs × 2)     -30 -13 -9 45 
Lung -100 -74 -67 -67 -154 -121 -112 -113 
Lung (DIs × 2) 0 13 17 58 -27 -11 -6 47 
Stomach 10 22 25 25 28 38 40 40 
Liver 16 27 30 30 -5 9 13 13 
Thyroid 34 42 45 45 13 24 27 27 
 Pelvic scan 
Colon 30 39 41 62 -76 -54 -47 -48 
 
For some superficial organs such as eyes and breast, the use of DIs at the 
peripheries of the phantoms (DIp) decreases the differences between DIs 
and ODs. Figure 9.5 shows a comparison between using the weighted and 
peripheral values of the DIs to estimate the breast dose for the female 
phantom. Differences between DIp and breast dose were reduced by 4 – 24% 
compared to the DIw. However, the reduction between DIp and the eyes 
dose was lower, where the differences were by up to 4%. This is related to 
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that the differences between the dose at the centre and periphery of the 
head phantoms, which are lower than those for the body phantoms.  
   DIp  DIw   
 
Figure 9.5: A comparison between using the dose at the periphery of the phantoms 
(DIp) and the weighted values (DIw) of the DIs studied to estimate the breast dose for 
the female phantom.  
 
9.4 Conclusion 
The ability of seven DIs to provide a surrogate index for ODs resulting from 
three CBCT scans has been investigated using the ICRP-110 male and female 
reference computational phantoms. The ability of each DI to assess ODs, 
was defined in terms of the difference between DIw and the calculated ODs. 
With the exception of DI1:CTDI100,w, lower differences were found for the 
head scan compared to the thorax and pelvis, where the differences for 
both the phantoms ranged from -168% to 76% for the head scan, from -246% 
to 84% for the thorax scan, and from -204% to 94% for the pelvic scan. The 
differences for the male phantom were smaller than those for the female 
phantom, and DI1:CTDI100,w, underestimated most of the ODs for all the 
scanning protocols by up to 497%. By comparing the DIs to the dose of each 
organ resulting from the three scanning protocols, DI2:CTDIw,IEC and DIs 5 - 
7: 𝑓𝑓(0,∞)𝑤𝑤,𝑚𝑚 had slightly lower differences. The DIs can give a reasonable 
measure of doses to the brain and salivary glands for head scans, the breast, 
lung, stomach, liver and thyroid for thorax scans, and the colon for scans 
of the pelvis. Multiplication of the DIs by a factor of 2 is proposed for 
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assessment of doses to the lungs and female breast for scans of the thorax. 
For practical application, any of the DIs 2 - 7 could be used to give an 
indication of doses to more exposed and more radiosensitive organs. Results 
of this study have been submitted for publication. 
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Chapter 10  
Conclusion and Future Work 
10.1 Conclusion 
EGSnrc-based user codes BEAMnrc and DOSXYZnrc were employed to 
simulate the OBI system. The MC technique was utilized to investigate the 
performance of various methods for dosimetry of CBCT scans, which are 
presented in Chapters 5 – 9. The main aims of these studies were (1) to 
compare dose indices based on different approaches in terms of their 
suitability for CBCT dosimetry, and (2) to facilitate utilizing the AAPM 
approach which is based on heavy and long phantoms, and takes into 
account almost all the radiation contributing to patient doses. 
This project investigated various aspects with the aim of contributing 
effectively to the body of knowledge on CBCT dosimetry. The efficiency of 
CTDI100 and CTDIIEC were discussed (Chapter 5). This was followed by 
another investigation that looked into different methods proposed for CBCT 
dosimetry and is based on the cumulative dose concept (Chapter 6). As the 
AAPM method is based on evaluating the cumulative dose within long and 
heavy phantoms, alternative methods to simplify the AAPM method were 
studied. A function called 𝐺𝐺𝑥𝑥(𝑊𝑊)100, which was shown to be relatively 
independent of the tube potential, was proposed (Chapter 7). The use of 
small phantoms and developing correction factors were investigated 
(Chapter 8). The dose indices based on the different methods investigated 
in Chapters 5 - 8 were compared against organ doses resulting from three 
CBCT scans, head, thorax and pelvis to assess which method gives the best 
estimations for organ doses (Chapter 9). Based on these investigations, 
various recommendations and conclusions can be presented from this 
project: 
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10.1.1 Approaches for CBCT Dosimetry 
Since the advent of CBCT, different dosimetric approaches have been 
proposed. Although almost all the different international organizations 
agreed on the failure of CTDI100 in providing a satisfactory dose descriptor 
for CBCT scans, no standard approach has been agreed globally and as a 
result it is difficult to progress developments in measurement equipment 
and techniques. Each dose index has advantages and disadvantages, which 
make choosing a dosimetric method for CBCT scans difficult. However, a 
comparison between the dose indices can be provided, from which a dose 
index based on a specific approach is recommended in this project. This 
recommendation aims to contribute to the literature, which may help the 
scientific community and international organizations in reaching consensus 
on CBCT dosimetry methods. In order to compare the approaches based on 
a scientific ground, three main factors can be considered: (1) The efficiency 
of the approach as a dose descriptor to report CTDI∞ for CBCT scans.  
(2) The simplicity of the application of the approach in the clinical 
environment in terms of availability of the measuring instruments, 
simplicity of the technique, and the number of the scans required to 
accomplish a QA assessment, i.e. the QA time.  
(3) The ability of the approach for evaluating organ doses resulting from 
the scans.  
Table 10.1 shows a comparison between the different dose indices studied 
in Chapters 5 - 6 taking into account the first and second factors. 
Considering the first factor, Figure 10.1 illustrates the ability of each 
approach to report the CTDI∞,w values, i.e. the efficiency. All the 
approaches were strongly dependent on the beam width with the exception 
of the CTDIIEC. However, for the beams of width W > 100 mm, the other 
approaches were able to provide values larger than those of CTDIIEC and so 
closer to CTDI∞. The highest values were obtained with 𝑓𝑓(0,∞) 
(Figure 10.1). Moreover, it can be seen that values for 𝑓𝑓(0,150) and 
𝑓𝑓100(150) became virtually constant for beam widths W > 150 mm. 
211 
 
 
By taking the second factor into account and based on the comparison 
presented in (Table 10.1), measurements of 𝑓𝑓(0,150) and 𝑓𝑓100(150) require 
lower numbers of acquisitions compared to those required for CTDIIEC, and 
hence a shorter time is required for the QA work. Moreover, 𝑓𝑓(0,150) and 
𝑓𝑓100(150) are measured within the standard PMMA phantoms, thus there is 
no need to use the long phantoms required for 𝑓𝑓(0,∞) and 𝑓𝑓100(∞) 
measurements. Therefore, from this point of view, the dose indices 
𝑓𝑓(0,150) and 𝑓𝑓100(150) seem to be more practical for routine application in 
the clinic than the other approaches. 
Considering the third factor, which considers the performance of the 
different dose indices in terms of predicting organ doses, Figures 10.2 - 10.3 
show ranges between the maximum underestimation and overestimation 
values obtained for each dose index investigated in Chapter 9. The range 
in Figure 10.2 covers all organs studied for each scanning protocol 
presented in Figures 9.2 - 9.4 Chapter 9, whereas only the radiosensitive 
organs selected in Table 9.7 Chapter 9 are considered in Figure 10.3 . Note 
that, DI1:CTDI100,w was not included into the plots due to its larger 
deviations as discussed previously. The IEC (DI2) and AAPM (DIs 5 - 7) 
approaches were closest to respective organ doses in more cases, although 
deviations were variable (Figures 9.2 - 9.4). However, these approaches are 
considered the least practical in the clinical environment as shown in 
Table 10.1. The DIs that could be more readily assessed and are more 
practical for use in the clinic environment are DI3: 𝑓𝑓100(150)𝑤𝑤 and 
DI4: 𝑓𝑓(0,150)𝑤𝑤. As shown in Figures 10.2 - 10.3, generally, the maximum 
underestimation and overestimation of these DIs are comparable to those 
for the other approaches. DI3: 𝑓𝑓100(150)𝑤𝑤 and DI4: 𝑓𝑓(0,150)𝑤𝑤 could provide 
an estimate that is good enough, bearing in mind the overall accuracy, to 
give operators and clinicians a reasonable indication of the doses delivered 
to the designated organs within the scan field. 
The comparisons between the different approaches presented in Table 10.1 
and Figures 10.1 - 10.3 show that all the approaches investigated in this 
project, except CTDI100, are comparable and suitable for CBCT dosimetry. 
However, based on the three factors considered earlier, and on the fact 
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that most of CBCT scans are conducted with a beam of width greater than 
80 mm, this project recommends the 𝑓𝑓(0,150) approach, as the best dose 
index for CBCT dosimetry. 𝑓𝑓(0,150)𝑤𝑤 values for W ≥ 80 mm were higher 
than CTDIIEC,w and 𝑓𝑓100(150)w values for the head and body phantoms 
(Figure 10.1). 𝑓𝑓(0,150)𝑤𝑤 values for W ≥ 80 ranged from 0.79 to 0.95 of 
CTDI∞,w values within the head phantom, and from 0.77 to 0.92 within the 
body phantom. Moreover, 𝑓𝑓(0,150)𝑤𝑤 values were approximately stable for 
W > 150 mm at ~0.94 and ~0.92 of CTDI∞,w, on average, for the head and 
body phantoms, respectively. These underestimations, however, can be 
overcome by the application of correction factors. Although 𝑓𝑓(0,∞)𝑤𝑤 and 
𝑓𝑓100(∞)w values were higher than those of 𝑓𝑓(0,150)𝑤𝑤, the 𝑓𝑓(0,150) 
approach is more practical in the clinical environment in terms of the 
handling and availability of equipment and the QA measurement time, and 
deviations of DI4: 𝑓𝑓(0,150)𝑤𝑤 were comparable to those for the other 
approaches. 
This project suggests that if a small chamber is unavailable, the 𝑓𝑓100(150) 
approach can also be employed instead of the 𝑓𝑓(0,150) approach. 𝑓𝑓100(150) 
was shown to be practical and has most of the 𝑓𝑓(0,150) advantages. The 
efficiency values for 𝑓𝑓100(150) were lower than those for 𝑓𝑓(0,150) as 
discussed in detail in Chapter 6. However, the differences between the 
efficiency values were constant for the beam width > 150 mm at ~3% and ~ 
2% for the head and body phantoms, respectively. 
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Table 10.1: A comparison between five different methods for CBCT dosimetry and the standard CTDI100. The dose ratios were calculated with beams 
of width W = 40 – 300 mm. 
 CTDI100 CTDIIEC 𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎) 𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(𝟏𝟏𝟏𝟏𝟎𝟎) 𝒇𝒇(𝟎𝟎,∞) 𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(∞) 
Chamber length (mm) 100 100, 300 20 100 20 100 
Phantom type Standard Standard Free in air Standard Standard Long Long 
Number of measurements 5 7, 8, 9,etc (a) 5 5 5 5 
Affected by the nominal 
beam width (W) Yes No Yes Yes Yes Yes 
Availability of equipment 
worldwide Yes Yes Yes Yes No No 
𝜀𝜀𝑐𝑐 
Head 0.74 – 0.28 0.76 ± 0.01 0.50 – 0.90 0.30 – 0.85 0.51 – 1.01 0.30 – 1.00 
Body 0.58 – 0.24 0.60 ± 0.01 0.36 – 0.75 0.23 – 0.72 0.37 – 0.99 0.25 – 0.97 
𝜀𝜀𝐸𝐸 
Head 0.84 – 0.32 0.86 ± 0.01 0.73 – 0.99 0.34 – 0.97 0.74 – 1.05 0.34 – 1.04 
Body 0.82 – 0.34 0.83 ± 0.01 0.76 – 1.02 0.33 – 1.02 0.77 – 1.11 0.33 – 1.10 
𝜀𝜀𝑤𝑤 
Head 0.80 – 0.31 0.82 ± 0.01 0.65 – 0.95 0.32 – 0.92 0.65 – 1.03 0.32 – 1.03 
Body 0.75 – 0.31 0.76 ± 0.01 0.64 – 0.94 0.30 – 0.91 0.64 – 1.07 0.30 – 1.06 
(a) Number of the measurements required for CTDIIEC is based on the beam width and length of the ionization chamber. 
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(a) 
 
(b) 
 
Figure 10.1: A comparison between the weighted efficiency values (𝜺𝜺𝒘𝒘) for four 
different dose indices for CBCT dosimetry and CTDI100 for (a) head and (b) body 
phantoms. For clarity, 𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(∞)𝐰𝐰 values were not added to the figure, but they are 
presented in Figures 6.3 - 6.6 (c) of Chapter 6. 
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Figure 10.2: The maximum underestimation and overestimation for each DI in evaluating organ doses resulting from head, thorax, and pelvic scans 
on the ICRP-110 male and female reference computational phantoms. (DI2:CTDIw,IEC, DI3:𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(𝟏𝟏𝟏𝟏𝟎𝟎)𝒘𝒘, DI4:𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎)𝒘𝒘, DI5:𝒇𝒇(𝟎𝟎,∞)𝒘𝒘,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷, DI6: 𝒇𝒇(𝟎𝟎,∞)𝒘𝒘,𝑷𝑷𝑬𝑬, 
and DI7: 𝒇𝒇(𝟎𝟎,∞)𝒘𝒘,𝑾𝑾𝒂𝒂𝒘𝒘𝒘𝒘𝒘𝒘). 
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Figure 10.3: The maximum underestimation and overestimation for each DI in evaluating doses for some of radiosensitive organs resulting from head 
(Brain and Salivary Glands), thorax (Breast, Lung, Stomach, Liver, and Thyroid), and pelvic (Colon) scans on the ICRP-110 male and female reference 
computational phantoms. (DI2:CTDIw,IEC, DI3:𝒇𝒇𝟏𝟏𝟎𝟎𝟎𝟎(𝟏𝟏𝟏𝟏𝟎𝟎)𝒘𝒘, DI4:𝒇𝒇(𝟎𝟎,𝟏𝟏𝟏𝟏𝟎𝟎)𝒘𝒘, DI5:𝒇𝒇(𝟎𝟎,∞)𝒘𝒘,𝑷𝑷𝑴𝑴𝑴𝑴𝑷𝑷, DI6: 𝒇𝒇(𝟎𝟎,∞)𝒘𝒘,𝑷𝑷𝑬𝑬, and DI7: 𝒇𝒇(𝟎𝟎,∞)𝒘𝒘,𝑾𝑾𝒂𝒂𝒘𝒘𝒘𝒘𝒘𝒘). 
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10.1.2 The Use of CBCT in Radiotherapy 
As mentioned previously in the introduction and Chapter 2 section 2.7.6, 
there is a hope to acquire a CBCT scan on a daily basis and include the 
imaging dose within the treatment dose. This is because the cumulative 
dose resulting from daily scans is non-negligible. For example, if a CBCT 
scan is acquired on a daily basis using the scanning protocols used in 
Chapter 9 for a patient undergoing a treatment of 40 fractions, i.e. the 
maximum number of fractions, by the end of the treatment course, the 
cumulative organ doses resulting from the head scan will be in the range of 
0.04 - 0.23 Gy, and in the range of 0.05 - 0.45 Gy and 0.05 – 1.66 Gy for 
thorax and pelvic scans, respectively. These ranges are in the same order 
of those reported by (Spezi et al., 2012, Nelson and Ding, 2014) as discussed 
in Chapter 2 section 2.7.6. At the present time, the current protocols in 
our centre requires a daily CBCT scan for SABR patients, while a weekly 
CBCT scan is taken for patients undergoing other treatment modalities such 
as IMRT and VMAT. Typically, most of SABR patients are treated with a few 
fractions 5 – 6, whereas 5 – 6 weeks are required for IMRT and VMAT 
patients. Thus, 5 CBCT scans can be considered as the average number of 
the scans acquired during the treatment course. As a result, the range of 
the cumulative organ doses for 5 scans will be 0.01 – 0.03 Gy, 0.01 – 0.06 
Gy, and 0.01 – 0.21 Gy for the head, thorax, and pelvic scans, respectively. 
Requirements for adjustment of these ranges will depend on the perceived 
need in the future to record more accurate data on patient doses for 
imaging procedures linked to treatment. They become important when 
decisions are made about optimization of clinical protocols for treatment. 
This involves balancing different objectives including:  
• Increasing the frequency of CBCT scans to achieve optimal dose 
delivery to the target for each treatment fraction. 
• Ensuring that the numbers of scans performed do not contribute 
more dose to surrounding tissues than is justified by the 
improvement in treatment. 
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• Choosing the optimal level of image quality to provide the 
information needed for organ delineation, while keeping the CBCT 
scan doses to a minimum. 
Dose information may also be required if in the future doses from imaging 
are taken into account in determination of the treatment dose. 
10.1.3 Facilitating the Use of Long Phantoms 
The use of long phantoms such as the ICRU/AAPM phantom to measure 
𝑓𝑓(0,∞) is impractical in the clinical environment. The 𝐺𝐺𝑥𝑥(𝑊𝑊)100 function 
proposed in Chapter 7 and the correction factors provided in Chapter 8 are 
considered to be practical ways to facilitate use of the long phantom 
dosimetry quantities. The 𝐺𝐺𝑥𝑥(𝑊𝑊)100 functions are utilized with CTDI100 
dosimetry equipment, and the correction factors can be employed with the 
standard PMMA phantoms and a small chamber. The 𝐺𝐺𝑥𝑥(𝑊𝑊)100 function was 
shown to have minimal variations with the tube voltage for all phantom 
compositions. The correction factors only showed a weak dependence on 
the tube voltage when the dose index was measured within short and long 
phantoms of a similar composition. The difference in the phantom 
compositions, however, was found to play a significant role in the influence 
of tube potential on the correction factors. Therefore, the use of the 
𝐺𝐺𝑥𝑥(𝑊𝑊)100 function appears to be a better option for performing 
measurements in long phantoms compared to the use of correction factors. 
10.1.4 Suitability Results of this Project to Other kV Systems 
The results in this project and those from various studies published in the 
literature, which were conducted with different kV systems, have been 
shown to be in good agreement, based on results presented in Chapters 5 – 
8. This agreement gives an indication that the efficiency values, the 
𝐺𝐺𝑥𝑥(𝑊𝑊)100 function and the correction factor given in the chapters, may be 
relatively independent of the kV system, i.e. scanner, as only small 
variations were observed between the different systems. In addition, it is 
anticipated that deviations of the dose indices studied from organ doses 
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resulting from the different scans will be of the same order for other kV 
systems (Turner et al., 2010, Zhang et al., 2013a). 
10.2 Future Work 
Further to the different investigations presented in this study, various 
aspects may be studied in the future. One of these studies might be related 
to the displayed value CTDIw, which is given on console of the Varian OBI 
system. This value is based on the measurement obtained with a reference 
narrow beam width of 20 mm and the standard PMMA head and body 
phantoms. This value was measured for each scanning protocol used for the 
CBCT scans, and is given prior to each scan. The main aim of this value is 
to compare between different scanners and scanning protocols under a 
reference condition. This value can be utilized by linking the displayed 
value to organ doses resulting from the different CBCT scans. This could 
provide the practitioners with an estimate of the organ doses received by 
patients undergoing the scans. 
Although comparisons between results obtained from this project and other 
studies showed a minimal influence for the kV system, the majority of the 
studies used for the comparisons were conducted with CT scanners. 
Therefore, one area suggested for more work might be the study of another 
CBCT scanner used in IGRT procedures such the Elekta XVI system as this 
project was based on simulating the Varian OBI system. Thus, sensitivity of 
the efficiency values for the dose indices studied, the 𝐺𝐺𝑥𝑥(𝑊𝑊)100 function, 
and the ability of the dose indices in evaluating organ doses for other kV 
systems might be investigated. This will assist the scientific community in 
obtaining generic 𝐺𝐺𝑥𝑥(𝑊𝑊)100 functions and correction factors suitable for 
most of the kV systems covering CT and CBCT scanners employed with wide 
beams.  
Another future work might be developing conversion factors from one of 
the dose indices studied in the project to organ doses resulting from CBCT 
scans under different conditions. This requires covering a wide range of 
patient sizes. The conversion factors resulting from these different sizes, 
then, could be tabulated so that patient-specific organ doses resulting from 
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a given scan are estimated with a reasonable level of accuracy. These 
conversion factors would allow clinicians to be more aware of dose levels 
absorbed by the patients during a scan acquired using certain parameters, 
which would be helpful in establishing a better link between the benefits 
of imaging and the potential risks. However, the main challenge is that 
when the isocentre of the CBCT scan is set at the centre of a tumour at a 
distance of (x, y) from the original isocentre (0, 0). In this case, the 
ioscentre is different for each patient as it is patient-dependent. The 
influence of shifting the isocentre on the patient doses has been 
investigated in several studies such as (Chow, 2009, Nelson and Ding, 2014) 
as discussed in Chapter 2 section 2.7.7. 
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